<<<<<<< HEAD
Index,ID,Study Type,Arm Group Type,Intervention Type,Interventional Study Model,Observational Study Model,Target Duration,Sampling Method,Phase
=======
Rank,ID,Study Type,Arm Group Type,Intervention Type,Interventional Study Model,Observational Study Model,Target Duration,Sampling Method,Phase
>>>>>>> main
1,BTX-BCI-016-PRT,Observational,,Diagnostic Test,,Case-Only,5 Years,Non-Probability Sample,
2,2018-TJ-BCD,Observational,,"Diagnostic Test, Diagnostic Test",,Case-Control,,Non-Probability Sample,
3,Breast cancer,Observational,,"Genetic, Other",,Case-Control,,Probability Sample,
4,BC-BOMET,Observational,,"Other, Other",,Case-Control,,Non-Probability Sample,
5,241391,Observational,,Diagnostic Test,,Cohort,1 Year,Non-Probability Sample,
6,IL-TM-B1-01,Observational,,"Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
7,FH-Risk 2.0 Research Protocol,Observational,,Other,,Other,,Non-Probability Sample,
8,ID-RPSBC-01-20201012,Observational,,Diagnostic Test,,Case-Control,3 Months,Probability Sample,
9,IRST174.22,Interventional,"No Intervention, Experimental, Experimental",Diagnostic Test,Parallel Assignment,,,,Not Applicable
10,ANILERGÄ°NN,Observational,,Diagnostic Test,,Cohort,10 Years,Probability Sample,
11,32155120.7.0000.0072,Observational,,Behavioral,,Cohort,,Probability Sample,
12,GCO 17-2188,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
13,233756,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
14,D16196,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
15,RO1912-30902,Interventional,"Other, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
16,UMCC 2021.087,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
17,LNs Staging of Breast cancer,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
18,SA18i0002,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
19,494936,Interventional,Experimental,Genetic,Single Group Assignment,,,,Not Applicable
20,042210,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
21,Yuan Shifang-1,Observational,,Device,,Cohort,,Probability Sample,
22,(818)109A-57,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
23,21 SEIN 01,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
24,18-181,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
25,catheter guided chemo-infusion,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
26,2020/132,Interventional,"Experimental, No Intervention",Behavioral,Single Group Assignment,,,,Not Applicable
27,17-689,Interventional,Experimental,"Device, Device",Single Group Assignment,,,,Not Applicable
28,831804,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
29,PI-2842,Observational,,Behavioral,,Cohort,,Probability Sample,
30,NCC2985,Observational,,Procedure,,Cohort,,Non-Probability Sample,
31,260281,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
32,V1 11.12. 2020 (C.I.R.E.C.),Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
33,154/2019,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
34,Amr Ahmed,Interventional,"Experimental, Experimental",Combination Product,Parallel Assignment,,,,Early Phase 1
35,CLM-INS-004,Observational,,Other,,Cohort,,Probability Sample,
36,2022-11-076-002,Interventional,"Experimental, Experimental",Diagnostic Test,Crossover Assignment,,,,Not Applicable
37,Health Literacy of Breast Ca,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
38,miRNA in breast cancer,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
39,MC1933,Observational,,Procedure,,Case-Only,,Probability Sample,
40,RADIOVAL,Observational,,Other,,Cohort,,Non-Probability Sample,
41,CE21096B,Observational,,Procedure,,Case-Control,,Non-Probability Sample,
42,ZY(2018-2020)-CCCX-2005-04,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
43,MicroRNA in breast cancer,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
44,GEICAM/2016-04,Observational,,,,Case-Only,,Probability Sample,
45,22IC7498,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
46,BMIBC,Observational,,,,Case-Control,,Probability Sample,
47,3.0840453,Observational,,Other,,Case-Control,,Probability Sample,
48,18 SEIN 11,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 2
49,HKG-KZ-BrCa-101,Observational,,,,Case-Control,,Non-Probability Sample,
50,Hibiscuss,Observational,,Device,,Other,,Probability Sample,
51,Pro00107118,Observational,,Procedure,,Cohort,1 Year,Probability Sample,
52,SNAPS Breast Cancer,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
53,17-447,Interventional,Experimental,"Drug, Device",Single Group Assignment,,,,Phase 1
54,22-509,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
55,ZCHBC022,Observational,,Drug,,Cohort,,Non-Probability Sample,
56,R.18.02.34.R1.R2,Observational,,,,Case-Control,,Non-Probability Sample,
57,ID-BCRPS-02-20220913,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
58,112991,Observational,,Radiation,,Cohort,,Non-Probability Sample,
59,17-01549,Interventional,"Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
60,TET-21-001,Observational,,,,Case-Control,,Probability Sample,
61,202101073,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
62,"estPerMed 1, Breast",Interventional,"Active Comparator, Active Comparator, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
63,68824072019,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
64,3055,Observational,,Other,,Cohort,,Non-Probability Sample,
65,20220303swj0211,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
66,RC20_0532,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
67,Breast Cancer Risk,Observational,,,,Cohort,,Non-Probability Sample,
68,KMUHIRB-E(I)-20200041,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
69,VGHKS18-CT11-17,Observational,,Device,,Cohort,,Non-Probability Sample,
70,832165,Observational,,Drug,,Case-Only,,Non-Probability Sample,
71,ICO-2019-08,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
72,biomarkers in breast cancer,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
73,GEICAM/2017-07,Observational,,,,Case-Only,,Non-Probability Sample,
74,LCCC2207,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
75,MCC-21448,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
76,4452,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
77,2017-0588,Observational,,Other,,Cohort,,Non-Probability Sample,
78,SK-421-BRCA,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
79,autotaxin1,Interventional,"Active Comparator, Sham Comparator",Biological,Parallel Assignment,,,,Not Applicable
80,UPCC 19121,Observational,,Other,,Case-Control,,Non-Probability Sample,
81,DS8201-A-U302,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
82,CCR 5113,Interventional,"No Intervention, No Intervention, Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
83,21-480,Observational,,"Behavioral, Behavioral",,Cohort,,Non-Probability Sample,
84,LQ005,Observational,,Drug,,Cohort,,Probability Sample,
85,ICO-N-2017-02,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
86,medicin,Interventional,"Experimental, Placebo Comparator","Diagnostic Test, Radiation, Diagnostic Test, Diagnostic Test, Radiation, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Other, Other",Parallel Assignment,,,,Not Applicable
87,METCZ20200211,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
88,2021LC2210,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",,Case-Only,,Probability Sample,
89,17-581,Observational,,Other,,Other,,Probability Sample,
90,2020-A00058-31,Interventional,"Other, Other, Other",Other,Parallel Assignment,,,,Not Applicable
91,NCC3299,Observational,,Other,,Other,,Non-Probability Sample,
92,351-19,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
93,ESR-21-21505,Observational,,Other,,Other,,Probability Sample,
94,LUMHS/REC/-17,Observational,,Other,,Cohort,,Non-Probability Sample,
95,PekingUPH10B004,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
96,2014P002688a,Observational,,Other,,Cohort,,Non-Probability Sample,
97,ODELIA,Observational,,Other,,Cohort,,Non-Probability Sample,
98,CD3-MUC1 in breast cancer,Interventional,"Experimental, Active Comparator, No Intervention","Biological, Procedure",Parallel Assignment,,,,Phase 2
99,LCCC 1829,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
100,2022-080,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
101,2018-TJ-BCP,Observational,,"Other, Other",,Other,,Non-Probability Sample,
102,20218,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
103,2017-03-002A,Observational,,Radiation,,Cohort,40 Weeks,Non-Probability Sample,
104,LA LEAST,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
105,1905795920,Observational,,,,Cohort,,Non-Probability Sample,
106,2015-004027-31,Interventional,"Other, Other",Radiation,Parallel Assignment,,,,Not Applicable
107,4-2018-0254,Observational,,Procedure,,Cohort,,Non-Probability Sample,
108,BREACE,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
109,495077,Interventional,"Other, Other",Other,Parallel Assignment,,,,Not Applicable
110,CCR4684,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
111,211753,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
112,1705018188,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
113,22-136,Interventional,Experimental,"Diagnostic Test, Radiation, Procedure",Single Group Assignment,,,,Phase 1
114,CDK-HeCOG-2019,Observational,,,,Cohort,,Non-Probability Sample,
115,2020-0327,Observational,,"Drug, Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
116,RECO_CT29B,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
117,SH ABCD,Observational,,Other,,Cohort,5 Years,Non-Probability Sample,
118,D8531C00002,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
119,SOLTI-1910,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
120,1905202-3,Observational,,,,Case-Only,,Probability Sample,
121,Targeted axillary dissection,Interventional,Experimental,Procedure,Single Group Assignment,,,,Phase 4
122,2022-8048-23560,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
123,2021-0215,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
124,GFY202001,Observational,,,,Cohort,,Non-Probability Sample,
125,2019-A01861-56,Observational,,Other,,Cohort,,Probability Sample,
126,18-634,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
127,20 KHCC 202,Observational,,,,Cohort,,Probability Sample,
128,IRB # 21-0026,Observational,,Other,,Cohort,,Non-Probability Sample,
129,IRB00002991,Observational,,Radiation,,Cohort,,Probability Sample,
130,17-398,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
131,LCCC 1954,Observational,,Other,,Cohort,,Probability Sample,
132,ESR-17-12934,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
133,69HCL22_0613,Observational,,Other,,Cohort,,Non-Probability Sample,
134,LCCC2213,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
135,IC 2018-01,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
136,IC 2020 08,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
137,PI17/00834,Interventional,,Other,Single Group Assignment,,,,Not Applicable
138,PekingUMCH-FAPI-BC-1,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
139,PekingUMCH-FAPI-BC-2,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
140,FMASUMD232/2021,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
141,Breast immune checkpoint,Observational,,Diagnostic Test,,Case-Control,2 Weeks,Non-Probability Sample,
142,180034,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
143,IRB17-0721,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
144,BCL IDE,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
145,REO 027,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
146,CentroHLO_EFBreastCancer,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
147,elastography in breast cancer,Observational,,Device,,Cohort,,Non-Probability Sample,
148,2018-177-IMP-EXP-4,Observational,,Other,,Case-Control,,Non-Probability Sample,
149,V3-MOMMO-01,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
150,PROICM 2020-01 OST,Observational,,Other,,Cohort,,Probability Sample,
151,077-2019,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
152,18-281,Observational,,Other,,Other,,Probability Sample,
153,2021-A02676-35,Observational,,Other,,Cohort,,Probability Sample,
154,84434789,Observational,,,,Case-Crossover,,Probability Sample,
155,2021-004,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
156,CBS-PIK3CA,Observational,,Diagnostic Test,,Other,,Probability Sample,
157,JuÃ§ara Phd Thesis,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
158,18 SEIN 08,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
159,ARNA Breast 2021,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
160,SNP-17-001,Observational,,,,Cohort,,Probability Sample,
161,2021-012,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
162,69HCL18_0769,Observational,,Other,,Ecologic or Community,,Non-Probability Sample,
163,2394,Observational,,,,Cohort,,Probability Sample,
164,CASE12119,Interventional,"Experimental, Active Comparator","Genetic, Genetic, Other, Other, Device",Parallel Assignment,,,,Not Applicable
165,18-124,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
166,18-461,Observational,,Behavioral,,Case-Only,,Non-Probability Sample,
167,2020-KY-064,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Probability Sample,
168,3049,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
169,EFC16133,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
170,82944089,Observational,,,,Case-Crossover,,Probability Sample,
171,NewGiza University Protocol 1,Observational,,Drug,,Case-Control,,Non-Probability Sample,
172,s66248,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
173,964635,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
174,3/19,Observational,,Other,,Cohort,,Non-Probability Sample,
175,SCCC-11118; STU-2018-0015,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
176,19-003085,Observational,,Genetic,,Cohort,,Non-Probability Sample,
177,2019402,Interventional,"Experimental, Experimental, Other","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
178,RADIO-SLEEP,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
179,Protocol EMIT-1,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
180,17/09/621_Myosin VI,Observational,,Other,,Other,,Non-Probability Sample,
181,2017/1356,Observational,,,,Case-Only,,Non-Probability Sample,
182,IC 2016-07,Observational,,Other,,Cohort,,Non-Probability Sample,
183,left breast cancer,Observational,,,,Case-Control,,Non-Probability Sample,
184,180212-1,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
185,19-001,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
186,CTRP6 in Breast Cancer,Observational,,Other,,Case-Control,,Probability Sample,
187,CESM in breast cancer,Observational,,,,Cohort,,Probability Sample,
188,UCaenNormandie,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
189,SOLTI-1903,Observational,,Other,,Other,,Probability Sample,
190,Vitamin D in breast cancer,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
191,17-552,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
192,CCR5348,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
193,19HLSEIN02,Observational,,Other,,Cohort,,Probability Sample,
194,STUDY00011606,Interventional,"Experimental, Experimental, Experimental, Experimental, No Intervention","Other, Other, Other, Other",Factorial Assignment,,,,Not Applicable
195,03/21,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
196,AHQU-2021007,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
197,D8530C00003,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
198,2019-05-157,Interventional,Other,Diagnostic Test,Sequential Assignment,,,,Not Applicable
199,200056,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Biological, Biological",Sequential Assignment,,,,Phase 1
200,182-20-CA,Interventional,"Experimental, Experimental",Diagnostic Test,Parallel Assignment,,,,Phase 2
201,Shengjing-LCG008,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 3
202,NeoRadUKD,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
203,KY20192114-C-1,Observational,,"Diagnostic Test, Procedure",,Cohort,,Non-Probability Sample,
204,STUDY19060359,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
205,2019.089,Observational,,,,Case-Only,4 Years,Probability Sample,
206,Xist,Observational,,Genetic,,Case-Control,,Probability Sample,
207,UEM0002,Interventional,"Experimental, Experimental, Placebo Comparator","Other, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
208,004181,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
209,HERMIONE 13,Observational,,,,Case-Only,,Non-Probability Sample,
210,STANDPOINT,Observational,,"Procedure, Drug",,Case-Only,,Probability Sample,
211,NL75855.091.21,Observational,,Device,,Cohort,,Probability Sample,
212,CASE5118,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
213,21 SEIN 09,Interventional,Other,"Other, Other",Single Group Assignment,,,,Not Applicable
214,CINEICC-3-IAT,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
215,Bakircay University,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
216,HR-HER2-RWS-01,Observational,,Drug,,Cohort,,Non-Probability Sample,
217,01-BR-003,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
218,21149002,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
219,21-528,Observational,,Other,,Cohort,,Non-Probability Sample,
220,DS8201-0002-EAP-MA,Observational,,Drug,,Cohort,,Non-Probability Sample,
221,AAAU1629,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
222,BC-NEO-IIT-SHR1316-SHR6390-RT,Interventional,"Experimental, Experimental","Drug, Drug, Radiation",Parallel Assignment,,,,Not Applicable
223,2020-12/898,Observational,,"Drug, Procedure, Drug",,Cohort,,Probability Sample,
224,CHUBX 2016/19,Observational,,Other,,Case-Only,,Non-Probability Sample,
225,IRB202100182 -N,Interventional,"Experimental, Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
226,PI-0538-2017,Observational,,,,Case-Control,,Probability Sample,
227,21/4657,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
228,2020[84],Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Early Phase 1
229,2019-KY-001-003,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
230,AbantIBU,Interventional,"Experimental, Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
231,121K686,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
232,06-2020,Observational,,,,Case-Only,,Non-Probability Sample,
233,NADOPTIC,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
234,CHIR-07-Sentimag,Observational,,"Procedure, Procedure, Procedure",,Case-Only,,Non-Probability Sample,
235,Pro00020917,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
236,Breast Cancer,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
237,BSU,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
238,URomLS Prot.0930/2021Rif. 6528,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
239,SOLTI-1716,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
240,2020-0724,Observational,,"Procedure, Procedure, Other",,Case-Control,,Non-Probability Sample,
241,LCCC 1749,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,,,,Not Applicable
242,GIMI-IRB-20005,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
243,22-x145,Interventional,"Experimental, Active Comparator, Other, Experimental","Device, Procedure",Parallel Assignment,,,,Not Applicable
244,17-PP-19,Observational,,Other,,Case-Control,,Probability Sample,
245,2015-4-6-003,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
246,FIRST,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
247,PUMCH-BREAST-ctDNA screening,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
248,147/19,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
249,STUDY00001641,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
250,PetrovRIO,Interventional,"Experimental, Experimental",Procedure,Single Group Assignment,,,,Not Applicable
251,MD 177/2021,Observational,,,,Cohort,,Non-Probability Sample,
252,A5481177,Observational,,,,Cohort,,Non-Probability Sample,
253,2017-KY-19,Observational,,Other,,Cohort,,Probability Sample,
254,Radiotherapy in breast cancer,Observational,,Radiation,,Cohort,,Non-Probability Sample,
255,19-001004,Observational,,,,Case-Control,,Non-Probability Sample,
256,19049,Observational,,Other,,Other,,Probability Sample,
257,Z211100002921033,Observational,,Drug,,Cohort,,Non-Probability Sample,
258,CFDAIIUASABFDOBC,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
259,Breast cancer neoadjuvant,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
260,wanghaibo,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
261,2020-KY-063,Observational,,,,Cohort,,Probability Sample,
262,PUMCH-BC502,Observational,,,,Cohort,,Non-Probability Sample,
263,852-20,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
264,SYSEC-KY-2018-018,Observational,,Procedure,,Cohort,,Non-Probability Sample,
265,19-045,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
266,PROICM 2019-16-BCU,Observational,,Other,,Other,,Probability Sample,
267,IBCSG 59-19,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
268,33293720.9.0000.5505,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
269,199080,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
270,SLN SPECT,Interventional,"Active Comparator, Active Comparator","Device, Device",Sequential Assignment,,,,Not Applicable
271,SOLTI-1907,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
272,SDS-HER-01-2018,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
273,APHP211502,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
274,ISTMET-BHWGI2022-1,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
275,SCHBCC-N024,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
276,Cpetptmrbc,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
277,4817,Observational,,Genetic,,Cohort,,Non-Probability Sample,
278,EEBC,Observational,,"Procedure, Drug",,Cohort,,Non-Probability Sample,
279,symptom of breast cancer,Observational,,"Behavioral, Behavioral",,Cohort,,Non-Probability Sample,
280,IEO 0761/,Observational,,,,Case-Only,,Non-Probability Sample,
281,CELC-G-301,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
282,CARMA-2101,Observational,,,,Cohort,,Non-Probability Sample,
283,RWD_abemaciclib,Observational,,,,Cohort,30 Months,Non-Probability Sample,
284,Tiresias,Observational,,Diagnostic Test,,Cohort,5 Years,Probability Sample,
285,A5481125,Observational,,,,Cohort,,Non-Probability Sample,
286,20-1789.cc,Observational,,Behavioral,,Cohort,,Probability Sample,
287,ML40952,Observational,,,,Cohort,,Non-Probability Sample,
288,DBCG Proton trial,Interventional,"Active Comparator, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
289,OOTR-N016/KBCRN-B-003/HT-PAB,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
290,710/2021,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
291,19-003028,Observational,,Procedure,,Case-Control,,Non-Probability Sample,
292,KL166-IIS-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
293,V2_16-04-2020,Observational,,Device,,Cohort,,Probability Sample,
294,N19ASC,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
295,SNBvsPET/MRI 2,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
296,dingxwyh01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
297,SNUH_FMI,Interventional,Other,Genetic,Single Group Assignment,,,,Not Applicable
298,2022/0035986,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
299,RF-2013-02358165,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
300,18-516,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
301,2022106,Observational,,Drug,,Cohort,,Non-Probability Sample,
302,19-147,Interventional,Experimental,"Diagnostic Test, Other",Single Group Assignment,,,,Phase 1
303,dingxwyh02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
304,19 SEIN 14,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
305,AURORA,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
306,17/0765,Observational,,Procedure,,Cohort,,Non-Probability Sample,
307,BR02/03/21,Interventional,Experimental,Device,Sequential Assignment,,,,Phase 1
308,2018-9529,Interventional,"Other, Other","Device, Procedure",Parallel Assignment,,,,Not Applicable
309,1186,Observational,,Genetic,,Cohort,,Probability Sample,
310,REaCT-HER TIME,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
311,01-2021,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
312,D9673R00011,Observational,,,,Cohort,,Probability Sample,
313,APHP211593,Observational,,Other,,Other,,Non-Probability Sample,
314,SOLTI-1911,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
315,IC 2018-08,Interventional,Experimental,"Genetic, Genetic, Behavioral",Single Group Assignment,,,,Not Applicable
316,AHQU-2021006,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
317,Breast Cancer,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
318,FLA 18-057,Observational,,Procedure,,Cohort,,Non-Probability Sample,
319,V2011201,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
320,HERdi PREDICT,Observational,,Other,,Cohort,,Non-Probability Sample,
321,HCB-ONC001 (ML41519),Interventional,"Experimental, No Intervention",Biological,Single Group Assignment,,,,Phase 2
322,IRB-300002157,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
323,IAyas2,Observational,,,,Case-Control,,Non-Probability Sample,
324,A5481176,Observational,,,,Cohort,,Non-Probability Sample,
325,Shengjing-LCG009,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
326,OTT-19-06,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
327,20210312,Observational,,Drug,,Cohort,,Probability Sample,
328,FAST feasibility in CU,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
329,Sentinel lymph node biopsy,Observational,,Procedure,,Cohort,,Non-Probability Sample,
330,BC001,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
331,SOC.04/20-21,Observational,,Other,,Cohort,,Probability Sample,
332,UT BCS ECS Study,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
333,oddie2,Observational,,Device,,Cohort,,Probability Sample,
334,FMASU R61/2020,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
335,18-109,Observational,,Drug,,Cohort,,Probability Sample,
336,19-509,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
337,19-277,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
338,UW 20-064,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
339,UC-0105/1701,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
340,20-1039,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
341,BRAR1,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
342,18-1025,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
343,IRB16-0396,Observational,,"Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
344,09.2019.984,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Not Applicable
345,O4M-B001,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
346,TaiHao TVGH2020-07-006AC#1,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
347,STGKS001,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
348,19-086,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
349,CNER 202107/05,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
350,Optimune Trial,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
351,1808019498,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Radiation, Drug, Biological",Parallel Assignment,,,,Phase 2
352,Emotional security&mastectomy,Observational,,,,Case-Only,,Non-Probability Sample,
353,HYGEE,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
354,A5481115,Observational,,,,Cohort,,Non-Probability Sample,
355,Breast Audit,Observational,,,,Other,,Non-Probability Sample,
356,STU-2018-0370,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
357,MRI in breast cancer,Observational,,Device,,Other,,Non-Probability Sample,
358,Prix Ruban Rose/2021/FF-01,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
359,Pyrotinib neoadjuvant,Interventional,"Experimental, Active Comparator","Combination Product, Combination Product",Parallel Assignment,,,,Phase 2
360,FUSCC-OMIT,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
361,SMC 2021-02-102,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
362,BSMMU/2019/8874,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Not Applicable
363,20210601,Observational,,Procedure,,Cohort,3 Years,Non-Probability Sample,
364,99mTc-ADAPT6 vs 99mTc-DARPinG3,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
365,Telemonitoring BCS,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
366,CCTG MA.39,Interventional,"Active Comparator, Active Comparator","Radiation, Other",Parallel Assignment,,,,Phase 3
367,IRB-2022-166,Observational,,Other,,Other,,Non-Probability Sample,
368,2490,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
369,19/317-2101,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
370,2021-1116,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
371,SPT-2021-002,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
372,s66248-aim2,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
373,Cardiac safety study,Observational,,Drug,,Cohort,,Non-Probability Sample,
374,BGB-290-201,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
375,10038,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
376,Pro00085352,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
377,EORTC 1745-ETF-BCG,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
378,4523,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
379,17-455,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Crossover Assignment,,,,Phase 2
380,01AB21- PIK3CA,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
381,ICO-N-2017-12,Interventional,"Experimental, Experimental, Experimental","Procedure, Biological, Behavioral",Parallel Assignment,,,,Not Applicable
382,Optimune Trial Add-on,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
383,2018396H,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
384,PROICM 2020-05 SKY,Interventional,"Experimental, Placebo Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
385,GEICAM/2019-01,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
386,69HCL18_0310,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
387,2004-261-112,Observational,,Diagnostic Test,,Cohort,2 Years,Non-Probability Sample,
388,MA-BC-â¡-040,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
389,APHP190505,Observational,,Other,,Case-Control,,Probability Sample,
390,2019-1183,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 1
391,IJB-NERABRAIN-ODN-007,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
392,19-066,Interventional,"Experimental, Experimental, No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
393,EH18-203,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
394,22-280,Observational,,"Other, Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
395,BakircayU,Observational,,"Other, Other, Other, Other, Other, Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
396,A211801,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
397,SGK-SFC-001,Observational,,,,Other,10 Years,Non-Probability Sample,
398,CAAE: 39277420.8.0000.5313,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
399,D361DC00001,Interventional,"Experimental, Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
400,PekingUMCH-NM25,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
401,5354-CL-1201,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 2
402,MO39485,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Probability Sample,
403,SOC.03/20-21,Observational,,"Other, Other, Diagnostic Test",,Cohort,,Probability Sample,
404,2019-228,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
405,800646,Interventional,"Experimental, No Intervention",Behavioral,Sequential Assignment,,,,Not Applicable
406,NP 1521/19,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
407,DARE,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
408,M2020 UK01,Observational,,Device,,Other,,Probability Sample,
409,[2019]52,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
410,TRA05-GEFPICS,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
411,NOV2016PhD818,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
412,BCP28,Observational,,,,Cohort,,Probability Sample,
413,GEICAM/2017-01_IBCSG 62-20_BIG,Interventional,"Experimental, Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
414,PekingUMCH-FES-BC-1,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
415,GCO 17-00563,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
416,EudraCT 2020-005200-19,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
417,D9673C00007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
418,LY2022-028-B,Observational,,Drug,,Cohort,,Probability Sample,
419,ATADEK-2021/14/16,Observational,,Other,,Case-Control,,Probability Sample,
420,J21125,Interventional,Other,"Other, Other, Behavioral, Behavioral, Other, Other, Behavioral, Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
421,2018-9567,Observational,,"Diagnostic Test, Diagnostic Test",,Other,,Non-Probability Sample,
422,UBRS20139,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
423,TQB3616-III-03,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
424,20 SEIN 13,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
425,MD.21.09.521.R,Observational,,Procedure,,Other,6 Months,Probability Sample,
426,20190283,Interventional,Experimental,Radiation,Sequential Assignment,,,,Not Applicable
427,FISH in breast cancer,Observational,,,,Case-Control,,Non-Probability Sample,
428,NCC3075,Interventional,"Experimental, Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
429,CSPC-DMS-BC-13,Observational,,,,Case-Control,,Non-Probability Sample,
430,19900601,Interventional,"Experimental, No Intervention",Behavioral,Factorial Assignment,,,,Not Applicable
431,DBCG RT Recon,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
432,PROICM 2019-11 PRA,Interventional,"Experimental, Placebo Comparator","Drug, Other, Radiation",Parallel Assignment,,,,Phase 3
433,201819010.4,Observational,,"Genetic, Drug",,Cohort,,Non-Probability Sample,
434,2018NTLS176,Observational,,Radiation,,Cohort,,Non-Probability Sample,
435,SPHIC-TR-BCa2022-01,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 1
436,SRMBCNabP2022,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
437,C3441020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
438,18ON009,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
439,FDRT-BC009,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
440,18-223,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
441,MCC-20897,Interventional,Experimental,"Biological, Biological",Sequential Assignment,,,,Phase 1
442,21-3576.cc,Observational,,,,Cohort,,Probability Sample,
443,IIT2018-01-McArthur-IPI,Interventional,Experimental,"Drug, Drug, Procedure, Procedure",Single Group Assignment,,,,Phase 2
444,BCHRD201,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
445,BrIMA,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
446,ChanghaiHTB,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Procedure, Drug",Sequential Assignment,,,,Not Applicable
447,2018-00838; ch20Weber2,Interventional,"Active Comparator, Active Comparator","Procedure, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
448,WSG-AM09,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
449,UC-0107/1903,Interventional,"Other, Other, No Intervention","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
450,PANONC-1 Version: 1.1,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,10 Years,Non-Probability Sample,
451,AB-MR for Second Breast Cancer,Observational,,,,Cohort,,Non-Probability Sample,
452,AHQU-2021005,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
453,2019/FO244363,Observational,,,,Cohort,,Non-Probability Sample,
454,BC-2019,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
455,KYJJ-2021-186,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
456,18-058,Observational,,"Behavioral, Other, Other, Other, Procedure",,Cohort,,Non-Probability Sample,
457,19-188,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
458,BCSCO003,Observational,,,,Cohort,,Non-Probability Sample,
459,SP00049673,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
460,DSCN-EHT-NIS-BC001,Observational,,Other,,Cohort,,Non-Probability Sample,
461,17-512,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
462,SCBCS025,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
463,19-239,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
464,LC2019L06,Interventional,"Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 2
465,GEICAM/2016-03,Observational,,,,Cohort,,Non-Probability Sample,
466,Breast Screening with DWI,Observational,,,,Cohort,,Non-Probability Sample,
467,HNCH-BC003,Interventional,"Experimental, Active Comparator","Combination Product, Other",Parallel Assignment,,,,Phase 2
468,21-183,Observational,,Procedure,,Cohort,,Non-Probability Sample,
469,02AB21-TucErBit,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
470,IRB-48150,Interventional,Experimental,"Drug, Procedure, Procedure, Device",Single Group Assignment,,,,"Phase 1, Phase 2"
471,ICO-2019-03,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
472,Soh-Med-23-01-07,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
473,IUSCC-0613,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
474,Breast Cancer Screening,Observational,,,,Cohort,1 Year,Non-Probability Sample,
475,16-145,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
476,A5481144,Observational,,,,Cohort,,Non-Probability Sample,
477,D133FR00138,Observational,,,,Other,18 Months,Non-Probability Sample,
478,State University of SÃ£o Paulo,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
479,21-440,Interventional,"Experimental, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
480,YM107109E,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
481,GEICAM/2020-08,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
482,2023-09,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
483,ARV-471-BC-201,Interventional,"Experimental, Active Comparator","Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
484,grid.412416.4,Observational,,,,Other,,Probability Sample,
485,18-333,Interventional,Experimental,"Device, Device",Single Group Assignment,,,,Not Applicable
486,MA-BC-II-024,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
487,intestinal flora study,Observational,,Drug,,Case-Only,,Non-Probability Sample,
488,ML42450,Observational,,,,Cohort,,Probability Sample,
489,GNC-035-103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
490,DS8201-A-U301,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
491,2018-09-007A,Observational,,Procedure,,Cohort,,Probability Sample,
492,M18DMB,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
493,ZNJC201935,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
494,Microbiome_BC&PnC,Observational,,"Drug, Drug, Drug, Drug, Drug",,Cohort,,Probability Sample,
495,R148/2021,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
496,SCHBCC0N026,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
497,MUKDEN-09,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
498,NACAGEP,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
499,2017MayPR898,Observational,,Other,,Cohort,,Probability Sample,
500,RGT-419B_01-101,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
501,NCC 2019-0098,Observational,,Other,,Case-Only,,Probability Sample,
502,21-003046,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 2
503,SSGJ-302H-mBC-IIT-01,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,,,,Phase 4
504,KY2019-070,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
505,A5481155,Observational,,,,Cohort,,Non-Probability Sample,
506,D8530C00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
507,APHP191059,Observational,,,,Cohort,,Non-Probability Sample,
508,BT006,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
509,1R01CA236860-01A1,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
510,310-17-SZMC,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
511,CINDERELLA,Interventional,"Experimental, Other",Device,Parallel Assignment,,,,Not Applicable
512,2017-01282 (BASEC),Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
513,CCR5214,Interventional,"Experimental, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
514,MCC-21757,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 2
515,K2022-025-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
516,PUMCH-MUSD,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
517,0720222005,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
518,D967UC00001,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
519,PLEASURABLE,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
520,21822,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
521,CTNZ-2017-01,Interventional,"Other, Other","Drug, Drug",Crossover Assignment,,,,Phase 2
522,20-649,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,,,,Phase 2
523,2020-08-06R,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
524,Qassim QDs-VELD,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
525,HR-BLTN-III-EBC,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
526,COV-19 BUMDC,Observational,,Procedure,,Case-Only,18 Months,Non-Probability Sample,
527,14-833-02,Interventional,"Active Comparator, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
528,17-519,Interventional,Experimental,"Drug, Procedure",Single Group Assignment,,,,Phase 2
529,Radiotherapy in Breast Cancer,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Phase 3
530,2020-A01423-36,Observational,,,,Cohort,,Probability Sample,
531,STML-ELA-0222,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
532,C3441055,Observational,,Drug,,Cohort,,Non-Probability Sample,
533,CRF-NHI01,Observational,,,,Cohort,,Non-Probability Sample,
534,H-41818,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
535,CLUE-BCL,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
536,nihan25,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
537,2020-0927,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
538,2020FES,Interventional,Experimental,Radiation,Single Group Assignment,,,,"Phase 1, Phase 2"
539,PRO00034502,Observational,,Other,,Case-Crossover,,Non-Probability Sample,
540,Breast cancer in females,Observational,,Other,,Other,,Non-Probability Sample,
541,SCLND0919,Interventional,"Experimental, Active Comparator","Procedure, Radiation",Parallel Assignment,,,,Not Applicable
542,PUMA-NER-6203,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
543,KBCSG-24,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
544,AHQU-2021001,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
545,Fenofibrate in Breast Cancer,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
546,AHQU-2021003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
547,2018LS148,Interventional,"Experimental, Active Comparator","Procedure, Behavioral",Parallel Assignment,,,,Not Applicable
548,PekingUMCH-BCa093,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,"Phase 1, Phase 2"
549,ADA,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
550,514-0213/21-5000,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Not Applicable
551,CentroHLOBreastUnit,Interventional,"Experimental, No Intervention, Other, Other",Drug,Parallel Assignment,,,,Phase 4
552,CCR4965,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
553,GCO 21-0699,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
554,DBCG RT Natural Trial,Interventional,"Active Comparator, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
555,IPNCb-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
556,CSPC-KAL-BC-12,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
557,003-2017,Interventional,Experimental,Radiation,Sequential Assignment,,,,Not Applicable
558,Breast cancer treatment,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
559,18-561,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
560,E19137,Observational,,,,Case-Control,,Non-Probability Sample,
561,Vitamin D and breast cancer,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
562,SYSEC-KY-KS-2021-182,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
563,CASE6119,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Early Phase 1
564,KX-ORAX-CN-007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
565,NCC2018M-042,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
566,CTO-IUSCCC-0803,Observational,,,,Case-Only,,Probability Sample,
567,55791222.0.0000.5313,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
568,UF-BRE-002,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
569,18-010602,Observational,,Device,,Case-Only,,Non-Probability Sample,
570,GIM21 - LiqERBcept,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
571,BREAST-SK-001,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
572,LR19/011/50551,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
573,STU00201961A,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
574,18-641,Interventional,"Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
575,CLEE011O12301C,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 3
576,HIRSLANDEN 01 SAKK 23/18,Interventional,Experimental,Procedure,Sequential Assignment,,,,Not Applicable
577,CCH-IRB-190414-P,Interventional,"Experimental, Active Comparator, Active Comparator","Device, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
578,348455,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
579,SOLTI-2101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
580,Zz123456.,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
581,GBG102 - SASCIA,Interventional,"Experimental, Other","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
582,PROICM 2018-05 BCU,Observational,,Other,,Other,,Probability Sample,
583,CAAE: 91570318.5.0000.5149,Observational,,Other,,Cohort,,Probability Sample,
584,FWA00015574/6-01-2019/korany,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 2
585,SYSKY-2022-030-01,Observational,,Other,,Cohort,,Non-Probability Sample,
586,UI-ROD-OCTU02,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
587,KY20182079-F-1,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",,Case-Only,,Probability Sample,
588,PN-301-21,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
589,Radiation in breast cancer,Observational,,Radiation,,Cohort,,Non-Probability Sample,
590,4-2018-0160,Observational,,"Radiation, Radiation",,Cohort,,Non-Probability Sample,
591,ROCK,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
592,SOLTI-1805,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Early Phase 1
593,KY20202075-F-2,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
594,06805118.2.1001.5404,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
595,ID4060,Observational,,Drug,,Cohort,,Non-Probability Sample,
596,AN.MCME.CR.12,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
597,MedOPP293,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
598,iOM-110383,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
599,IRST174.25,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
600,EUROPA,Interventional,"Experimental, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 3
601,HM022BC3C01,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
602,UF-BRE-007,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
603,SOLTI-2103,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
604,SOLTI-1503,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Early Phase 1
605,0023041/i,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
606,LQ009,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
607,BGB-900-2001-IIT,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
608,CLEE011H2301,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
609,2020_61,Observational,,Other,,Cohort,,Non-Probability Sample,
610,ONAWA (SOLTI-1802),Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
611,1,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
612,STUDY00010776,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
613,CASE13119,Interventional,"Experimental, Placebo Comparator","Biological, Other",Parallel Assignment,,,,Not Applicable
614,ZX-2021-FES-ESTROTIMP-4,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
615,2017-0499,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
616,IIT-UM2018001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
617,UPCC 17120,Interventional,Experimental,"Behavioral, Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
618,Shengjing_002,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
619,IRB-57723,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
620,3764,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
621,D8530C00006,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
622,115858,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
623,CCH-IRB-190414-R,Interventional,"Experimental, Active Comparator, Active Comparator","Device, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
624,UCCS20110,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 1
625,Shengjing-LJY04,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
626,2019-004559-35,Interventional,Experimental,"Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 2
627,GEICAM/2017-04,Observational,,,,Case-Only,,Probability Sample,
628,KARMA Kontrast,Interventional,Other,Combination Product,Single Group Assignment,,,,Not Applicable
629,ACE-Breast-03,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
630,BREAST,Observational,,,,Cohort,2 Years,Non-Probability Sample,
631,FMBSUREC/10102021/Rabie,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
632,1808-42,Observational,,Other,,Cohort,,Non-Probability Sample,
633,2020-535,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
634,RP-20-013,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 4
635,EF141,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
636,STUDY00001225,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
637,CCR5119,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
638,3475-756,Interventional,"Experimental, Placebo Comparator","Biological, Drug, Drug, Drug, Drug, Drug, Drug, Radiation, Procedure",Parallel Assignment,,,,Phase 3
639,21-271,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
640,STUDY2019000317,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
641,FirstHCMU_CB_001,Observational,,"Drug, Drug, Drug, Drug, Drug",,Other,,Probability Sample,
642,2022-0055,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
643,WEFITTER,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
644,A5481178,Observational,,,,Cohort,,Non-Probability Sample,
645,ARO-2015-1,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
646,HNCH-MBC11,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
647,SOLTI-1507,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
648,DKFZ-2019-008,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, No Intervention","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
649,20170328,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
650,SHPD005,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
651,dAGEs,Observational,,Other,,Cohort,,Non-Probability Sample,
652,20-124,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
653,NIR-THERMA-02,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
654,LaPemERLA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
655,E7389-M082-602,Observational,,Drug,,Cohort,,Probability Sample,
656,Pro00020138,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
657,18-394,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
658,2019SABE028,Interventional,"Experimental, Active Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
659,IIBSP-PRO-2021-10,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
660,SYSUCC-015,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
661,REO 026-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
662,STUDY00001233,Observational,,Device,,Cohort,,Non-Probability Sample,
663,2019.429,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
664,CP7-005,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
665,2021/193780(REK),Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
666,INCASE0518,Observational,,Other,,Cohort,,Non-Probability Sample,
667,123123,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
668,JTU-6H-20211011001,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
669,INST 1607,Observational,,Other,,Cohort,,Non-Probability Sample,
670,CIMS-4FMFES-2021-3966,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Phase 2
671,SOLTI-1718,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
672,Yunwei Wei 2019-09-13,Observational,,Drug,,Case-Control,,Probability Sample,
673,HLX11-BC301,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
674,Zoledronic Acid In Breast Ca,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 3
675,6788,Observational,,,,Cohort,,Non-Probability Sample,
676,Tacrolimus_2020,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
677,KSRAD001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
678,Stage 2 compression therapy,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
679,CASE5120,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
680,PROICM 2020-07 VIS,Interventional,Other,"Other, Other",Single Group Assignment,,,,Not Applicable
681,CL1-81694-003,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
682,Shengjing-LCG005,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
683,2020.KB.SAG.069,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
684,NCC1824,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
685,INNOVBC,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,"Phase 2, Phase 3"
686,R20-003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
687,MedOPP319,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
688,WO39391,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
689,NCC1867,Observational,,Other,,Other,,Non-Probability Sample,
690,20-157,Interventional,"Experimental, Experimental, Experimental","Radiation, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
691,2-102-21,Observational,,"Diagnostic Test, Biological",,Case-Control,,Probability Sample,
692,HunanCH-BC-001,Observational,,Drug,,Case-Only,,Non-Probability Sample,
693,2021.693,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
694,GENEXAN,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
695,HSC20160245H,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
696,GRO-06-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
697,Neveen,Observational,,,,Case-Control,,Non-Probability Sample,
698,Melody_002,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
699,REC-H-PHBSU-21010,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
700,16D.674,Interventional,Other,"Procedure, Other, Other",Single Group Assignment,,,,Not Applicable
701,YOUNGBC-22,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
702,SMC- 5725-18,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
703,2000025837,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
704,DS8201-A-U305,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
705,2020/33,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
706,2018.016,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
707,HE071-CSP-021,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
708,Shengjing_001,Observational,,Drug,,Case-Only,,Probability Sample,
709,PREDIX II HER2,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
710,ATADEK 2022-17/27,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
711,CHIR-01-sentinel,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
712,R.20.05.834,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
713,MCC-20902,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
714,D3615C00001,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
715,SMC-2019-05-021 (2),Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
716,PUMCH-BC501,Observational,,,,Cohort,,Non-Probability Sample,
717,17/209,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
718,PCS-001,Observational,,Procedure,,Cohort,,Non-Probability Sample,
719,1563/2018,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
720,C3441053,Observational,,Drug,,Cohort,,Non-Probability Sample,
721,18-603,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
722,2021-0170,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
723,PUMCH-SBSBC,Interventional,"Experimental, Other","Drug, Behavioral",Parallel Assignment,,,,Phase 3
724,B27IB3856,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
725,2018.08.ST,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
726,YYS-20200305,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
727,CAN04CLIN005,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
728,ORIN1001-001,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
729,YOUNGBC-7,Observational,,,,Cohort,,Non-Probability Sample,
730,LUN_MMG_121,Observational,,Radiation,,Cohort,,Probability Sample,
731,Breast Cancer-RISS,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,,,,Phase 4
732,LCCC2105,Observational,,Behavioral,,Case-Only,,Non-Probability Sample,
733,STML-ELA-0322,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
734,RJrapidplan,Observational,,Radiation,,Cohort,,Non-Probability Sample,
735,2-049-18,Observational,,,,Case-Control,,Probability Sample,
736,MIES-BCNAT,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
737,MACSSI (ET18-150),Observational,,Other,,Cohort,,Non-Probability Sample,
738,HNCH-BC010,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
739,22SCH740,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
740,eMOUVOIR-1901,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
741,NCC2019-0142,Observational,,,,Cohort,,Non-Probability Sample,
742,20G.605,Interventional,Experimental,"Procedure, Drug, Procedure",Single Group Assignment,,,,Early Phase 1
743,19-002792,Interventional,"Active Comparator, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
744,UT BCS Sleep Study,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
745,919PP17,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 2
746,H-50349,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
747,NIS12501,Observational,,,,Cohort,,Non-Probability Sample,
748,B002-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
749,"2016-051-000001, 2563",Interventional,"Other, Other, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
750,MCC-21378,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Biological",Sequential Assignment,,,,Phase 1
751,010006,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
752,20210504,Observational,,,,Cohort,,Probability Sample,
753,2021-0358,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
754,18-2444.cc,Observational,,Other,,Cohort,,Non-Probability Sample,
755,LACUDY,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
756,CSPC-DMS-BC-17,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
757,UC-0105/1815,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
758,NCC3340,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
759,YOMA,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
760,2022-7735,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
761,IRB00130428,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Phase 2
762,GS-US-595-6184,Interventional,"Experimental, Active Comparator","Biological, Biological, Drug",Parallel Assignment,,,,Phase 3
763,HR BLTN 014,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
764,C4891023,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 2
765,SYSU-2022-02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
766,GO40987,Interventional,"Experimental, Experimental, Experimental","Drug, Procedure",Parallel Assignment,,,,Phase 1
767,HR-BLTN-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
768,OkanU2,Observational,,Other,,Other,2 Years,Non-Probability Sample,
769,HNCH-MBC08-BM02,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
770,TRICIA,Observational,,Other,,Cohort,,Probability Sample,
771,19-003532,Observational,,,,Case-Only,,Non-Probability Sample,
772,PALBOCOMP,Observational,,Drug,,Cohort,,Non-Probability Sample,
773,SNF4,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
774,MA-BC-II-006,Interventional,Experimental,"Biological, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
775,17/013,Interventional,"Active Comparator, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 2
776,LACOG 0221,Observational,,,,Cohort,,Non-Probability Sample,
777,SNF3,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
778,1780,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
779,2020 - 176,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
780,HR-TNBC-HN100,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
781,YANWQ002,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
782,2018-68-1461,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
783,STU00206180,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
784,MR-01,Observational,,Other,,Cohort,,Non-Probability Sample,
785,2019-09-09,Interventional,"Active Comparator, Experimental, Experimental, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
786,UBRS20013,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
787,HR-BLTN-014,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
788,SPI-POZ-101,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
789,EC/TMC/108/17,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
790,SGRT-BC,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,"Phase 2, Phase 3"
791,CMUH108-REC3-090,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
792,PALBOSPAIN,Observational,,Drug,,Cohort,,Non-Probability Sample,
793,RC48-C012,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
794,261\\2021,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
795,ERIBRAIN-IPC 2017-014,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
796,CYH33-G103,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
797,OTT 18-02,Interventional,"Active Comparator, Active Comparator",Combination Product,Parallel Assignment,,,,Phase 4
798,SYSA1901-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
799,YBCSG-21-03,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
800,EBaran,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
801,99mTc-ADAPT6,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
802,2019-0088,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
803,R20-030,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
804,NL77000.029.21,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
805,MUKDEN 07,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
806,OstacoliMIND&BC,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
807,NCC3286,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 2
808,HR-BLTN-010,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
809,CMUH106-REC3-137,Interventional,"Experimental, Experimental, Experimental",Drug,Crossover Assignment,,,,Not Applicable
810,2010134480,Interventional,"Other, Other","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
811,DS8201-A-U303,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
812,H18-02581,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
813,SMX 22-002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
814,18-371,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
815,K171005J,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
816,X-XJTU1AFLSY-93,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
817,9745,Observational,,Device,,Case-Crossover,,Non-Probability Sample,
818,2019/2452,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
819,J1836,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
820,20-104,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
821,SCHBCC-N030,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
822,D967JC00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
823,STUDY00022698,Observational,,"Other, Other, Other, Other, Other",,Other,,Non-Probability Sample,
824,CLEE011AUS64,Observational,,"Drug, Drug, Drug",,Cohort,,Probability Sample,
825,SCAN-B-rec,Observational,,Diagnostic Test,,Cohort,10 Years,Non-Probability Sample,
826,LMengmeng,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
827,NCC1888,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
828,XZP-3287-3002,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
829,R21-072,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
830,HCI131027,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
831,SCHBCC-N025,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
832,ERC/2020/10/11 (26/10/2020),Interventional,"No Intervention, Experimental","Device, Other, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
833,19-055,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
834,SLNB-ACP,Observational,,,,Cohort,6 Years,Non-Probability Sample,
835,20F.259,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,"Phase 2, Phase 3"
836,AI-BMRI,Observational,,Other,,Cohort,,Probability Sample,
837,2019/1318,Interventional,"Experimental, No Intervention, Other",Behavioral,Parallel Assignment,,,,Not Applicable
838,BC-P29,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
839,Smart,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
840,OMICS Mark,Observational,,Drug,,Case-Control,5 Years,Non-Probability Sample,
841,RS-NAT01,Interventional,"Active Comparator, No Intervention, Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
842,2021/32,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
843,SMX 20-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
844,BOMB,Interventional,"Experimental, Active Comparator","Procedure, Radiation, Other",Parallel Assignment,,,,Not Applicable
845,XuzhouMedSch3,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
846,MC220301,Interventional,Experimental,"Procedure, Drug, Other, Procedure",Single Group Assignment,,,,Phase 2
847,FUSCC-TNBC-BLIS,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
848,TeMP 2021,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
849,SMC 2018-07-014-011,Observational,,Drug,,Case-Only,12 Months,Non-Probability Sample,
850,D931CC00001,Interventional,"Experimental, Experimental","Drug, Combination Product",Parallel Assignment,,,,Phase 2
851,WuhanU,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
852,2022-017,Observational,,"Other, Other",,Cohort,,Probability Sample,
853,Stage 1 Compression Therapy,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
854,GEICAM/2018-03,Observational,,,,Cohort,10 Years,Non-Probability Sample,
855,4298,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
856,018-745,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
857,20-371,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
858,HBMUFH-101,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
859,2019-KY-051,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
860,GCX-BCT-06,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
861,213355,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
862,2022-0056,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
863,20192755,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
864,K3_K1_2,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
865,MEDOPP437,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
866,BC-P31,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
867,EORTC-1550-BCG,Observational,,Procedure,,Cohort,,Non-Probability Sample,
868,D9670C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
869,ACR A4707,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
870,42127,Observational,,Genetic,,Cohort,,Non-Probability Sample,
871,handan1,Observational,,Diagnostic Test,,Case-Control,3 Years,Probability Sample,
872,IOM-120465,Observational,,Drug,,Cohort,,Non-Probability Sample,
873,2-025-19,Observational,,Procedure,,Case-Control,,Probability Sample,
874,OTT 20-11 (IT-02),Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
875,PREBCA,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
876,OBU-SC-BB-BC-II-010,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
877,20-09022641,Interventional,"Active Comparator, Active Comparator","Radiation, Drug, Drug",Parallel Assignment,,,,Phase 2
878,D9673R00025,Observational,,Other,,Other,,Non-Probability Sample,
879,SaglikBilimleriU_DU,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
880,mTPVB SPPB Ver 2,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
881,SYSKY-2023-129-01,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
882,R868/18-IEO 916,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
883,309424,Observational,,Radiation,,Case-Control,,Non-Probability Sample,
884,Melody_001,Observational,,Other,,Cohort,,Non-Probability Sample,
885,UW20035,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
886,19-1812.cc,Observational,,,,Cohort,,Probability Sample,
887,I3Y-NS-O003,Observational,,Drug,,Case-Only,,Probability Sample,
888,ID-TMS-02-20201012,Interventional,"Experimental, No Intervention",Drug,Single Group Assignment,,,,Not Applicable
889,ACE-Breast-07,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
890,CABC012,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
891,2019-053,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
892,SNB vs PET/MRI 1,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
893,NIHR 128311,Interventional,"Experimental, Active Comparator","Procedure, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
894,AITIC,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
895,Pro00104868,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
896,RG_16-108,Observational,,Procedure,,Cohort,,Probability Sample,
897,STUDY00000023,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
898,2022/0132,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
899,2021C0128,Observational,,,,Cohort,,Non-Probability Sample,
900,GMI-1359-210,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
901,20_RIPH3_06,Observational,,Other,,Cohort,,Probability Sample,
902,SHERO,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
903,MA-BC-II-023,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
904,0494-22-RMB,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
905,ICO-A-2018-10,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
906,REG-074-2020,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
907,Woman health,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
908,CSIIT-C39,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
909,99mTc-ZHER2,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
910,HCC 22-003,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
911,FAST-F-PG01,Observational,,Radiation,,Cohort,,Non-Probability Sample,
912,20-001670,Observational,,Procedure,,Cohort,,Non-Probability Sample,
913,CSIIT-C03,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
914,IBCSG 55-17,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
915,WO42633,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
916,2022-05093-02,Interventional,"No Intervention, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
917,NRG-BR007,Interventional,"Active Comparator, Active Comparator","Other, Drug",Parallel Assignment,,,,Phase 3
918,NCCH2113,Observational,,,,Cohort,3 Years,Probability Sample,
919,YU-FTR-ST-01,Observational,,,,Case-Only,,Non-Probability Sample,
920,CLP0008,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,,,,Phase 2
921,18-040,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 1
922,UPCC 01121,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
923,Molecular imaging of HER2,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
924,OP-1250-002,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
925,GEICAM/2018-06,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
926,26272819.3.0000.0068,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
927,SA20I0060,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
928,1094/2020,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
929,WO42133,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
930,Soh-Med-23-01-34,Observational,,,,Other,,Probability Sample,
931,110-163-F,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
932,MUKDEN 06,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
933,KN035-TH-HER2,Interventional,Experimental,"Biological, Biological, Drug",Single Group Assignment,,,,Phase 2
934,HNCH-MBC09-BM03,Observational,,,,Cohort,,Non-Probability Sample,
935,COSMOPOLITAN,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
936,21-VIN-0166/SAN-0647,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,,,,Phase 1
937,E19059,Observational,,,,Cohort,,Probability Sample,
938,ISB 1302-103,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
939,0063-17,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
940,M16-735,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
941,NCT20210157-AI-ROL,Observational,,Other,,Cohort,,Non-Probability Sample,
942,19-524,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
943,HR-BLTN-002,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
944,CTO-IUSCC-0684,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
945,Tele-Relax,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
946,NCC1865,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
947,A5481126,Interventional,"Other, Other",Device,Single Group Assignment,,,,Not Applicable
948,KCSG BR18-16,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
949,D9673R00028,Observational,,,,Cohort,,Non-Probability Sample,
950,LY01005/CT-CHN-303,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
951,IFG-08-2019,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
952,BC-Genetics,Observational,,,,Cohort,,Probability Sample,
953,XZP-3287-3001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
954,GEP,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
955,2019/2632,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
956,BTCRC-BRE18-337,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
957,UMMCHTNBC,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
958,J18138,Interventional,Other,"Procedure, Device",Single Group Assignment,,,,Not Applicable
959,19-09020752,Interventional,"Active Comparator, Active Comparator","Radiation, Drug, Drug",Parallel Assignment,,,,Phase 2
960,RC31/21/0368,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
961,20-503,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
962,PGG-BCA2121 / MK-3475-C99,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
963,ACTRN1261000928213,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
964,Pro2020002182,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
965,160178,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
966,MRG002-004,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
967,BC-Pyrotinib-NVB,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
968,SYSUCC-016,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 3
969,19-396,Interventional,Other,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
970,Shengjing-LJY07,Interventional,"Experimental, Experimental, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
971,HMPL-012-SPRING-R103,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
972,CA209-7FL,Interventional,"Experimental, Placebo Comparator","Biological, Drug, Other, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 3
973,NCC2021291,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
974,2022-A02271-42,Observational,,Other,,Cohort,,Non-Probability Sample,
975,20-2338,Interventional,"Other, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
976,CNIL-2033408,Observational,,,,Cohort,,Non-Probability Sample,
977,22-5307,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
978,CEP0431/2018 arm 2,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
979,REG-028-2021,Observational,,Other,,Cohort,12 Months,Probability Sample,
980,MA-BC-II-035,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
981,F2017000 (UAB 17112),Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
982,22040,Interventional,Experimental,"Drug, Behavioral",Single Group Assignment,,,,Phase 2
983,CTMS 17-0037,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
984,D0816R00025,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
985,201801559A3,Observational,,Combination Product,,Cohort,,Non-Probability Sample,
986,MedOPP238,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
987,BTCRC-BRE19-409,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
988,2020-0342,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
989,25IB-0023,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
990,919PP18,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
991,18-002,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
992,CMTNCMB,Observational,,Combination Product,,Other,,Probability Sample,
993,ZYYY-BC-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
994,CAAE: 82691818.0.0000.5154,Interventional,"Other, Experimental, Experimental, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
995,2022/0226,Observational,,"Other, Other, Other, Other, Other, Other, Other, Other",,Case-Control,,Probability Sample,
996,PMD-026-1-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
997,SYSUCC-011,Observational,,,,Cohort,,Probability Sample,
998,18432,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other, Other, Other, Behavioral",Parallel Assignment,,,,Not Applicable
999,2020-KY-140,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
<<<<<<< HEAD
1000,18432,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other, Other, Other, Behavioral",Parallel Assignment,,,,Not Applicable
=======
1000,2020-KY-125,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
>>>>>>> main
1001,CAAE 42627521600005274,Interventional,"Experimental, Experimental, No Intervention, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1002,20201101.2,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1003,20-1866.cc,Observational,,Behavioral,,Cohort,,Probability Sample,
1004,SYSUCC-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1005,RS1637/21,Observational,,Other,,Cohort,24 Months,Non-Probability Sample,
1006,S64752,Observational,,Diagnostic Test,,Case-Control,,Probability Sample,
1007,SURVIVE,Interventional,"Active Comparator, Placebo Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test, Other",Parallel Assignment,,,,Not Applicable
1008,4352,Interventional,"Experimental, Experimental, Sham Comparator","Other, Behavioral, Other",Parallel Assignment,,,,Not Applicable
1009,CDR0000643461,Observational,,"Other, Procedure",,Case-Only,,Non-Probability Sample,
1010,SPHIC-TR-BCa2022-02,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1011,CRE2018013,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1012,IRB_00137018,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
1013,2022-0353,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Phase 1
1014,MCC-19765,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
1015,OSU-21065,Observational,,"Procedure, Procedure, Other",,Cohort,,Non-Probability Sample,
1016,LCCC 1931,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1017,A5481167,Observational,,Drug,,Cohort,,Probability Sample,
1018,4-2018-0264,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1019,2018/TMC/133/IRB/31,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1020,ENDO-RESIST,Observational,,,,Cohort,,Probability Sample,
1021,BRE 354,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 2
1022,IR-1.1,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1023,SYSUCC-017,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1024,IB 2015-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1025,20-5215.0,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
1026,MEN1611-01,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
1027,21-325,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1028,SGNTUC-028,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1029,EORTC QLQ BR45,Observational,,,,Cohort,,Non-Probability Sample,
1030,SYSUCC-020,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1031,BC-RWS,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1032,C4891001,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1033,1234,Observational,,,,Case-Control,,Non-Probability Sample,
1034,CCR4884,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1035,2016-0537,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug, Drug, Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
1036,BreastctDNA01,Observational,,Genetic,,Other,,Probability Sample,
1037,69HCL21_1085,Interventional,"Active Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
1038,SGNTUC-025,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1039,AIRC IG-23118,Interventional,Experimental,"Radiation, Radiation",Single Group Assignment,,,,"Phase 1, Phase 2"
1040,3-2021-0026,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1041,STU-2022-0385,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Device, Procedure",Sequential Assignment,,,,"Phase 1, Phase 2"
1042,BC-P26,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1043,KOTK/2022/12550,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1044,SCHBCC-N029,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1045,PUMCH-MIRC213,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Early Phase 1
1046,A5481145,Observational,,"Drug, Drug",,Case-Only,,Non-Probability Sample,
1047,Concordance,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1048,TMS01190510,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1049,1752/20,Interventional,"No Intervention, Experimental","Radiation, Procedure, Other",Parallel Assignment,,,,Phase 2
1050,IMAP-CM,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1051,SRB_201808_163,Interventional,"Active Comparator, Experimental, No Intervention","Drug, Other",Parallel Assignment,,,,Phase 4
1052,UW16151,Observational,,"Drug, Drug, Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
1053,SMC 2020-11-051,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1054,6037248,Observational,,,,Cohort,,Non-Probability Sample,
1055,2016-A01344-47,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1056,1807187-2,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1057,Lilly-I3Y-US-I026,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1058,D8532C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1059,21-159,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1060,RG1121129,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1061,TJ-IRB20211128,Observational,,,,Case-Only,,Probability Sample,
1062,21-123,Interventional,"Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1063,UC-BCG-2103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1064,Ketogenic Diet,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
1065,20-172,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1066,CMUH108-REC1-113,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1067,ALT-P7,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1068,2019-7-Non-NSU Health,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1069,I236,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1070,131916,Observational,,,,Cohort,,Non-Probability Sample,
1071,GCO 17-1585,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1072,DRLCOLCT001,Observational,,Drug,,Cohort,,Non-Probability Sample,
1073,FNF201830,Observational,,Genetic,,Other,,Non-Probability Sample,
1074,PRO00028602,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1075,D0816C00018,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
1076,HUB-PSI-CAMAD,Interventional,"Experimental, Experimental","Drug, Behavioral",Parallel Assignment,,,,Phase 2
1077,REP0121,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1078,SBMASTER,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1079,AMCI-001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1080,Fukui-2019-1,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1081,PRO00028925,Interventional,"Other, Experimental","Other, Other",Parallel Assignment,,,,Phase 2
1082,K160913J,Interventional,Experimental,"Genetic, Biological, Other",Single Group Assignment,,,,Not Applicable
1083,N-20180090,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
1084,Genetic study and TDM,Observational,,Drug,,Cohort,,Non-Probability Sample,
1085,FDRT-BC016,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1086,RF-2016-02363686,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
1087,UPCC 10117,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1088,A231901CD,Interventional,"Experimental, Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator","Other, Other, Procedure, Other, Other, Other, Other, Other, Other",Factorial Assignment,,,,Not Applicable
1089,22/409-3611,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1090,YDPLD191016-I1-SYSU-001,Observational,,Other,,Cohort,1 Week,Probability Sample,
1091,BC-CIH-H-RWS,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1092,4-2020-1453,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1093,IRB15-1005,Interventional,"Experimental, Other, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1094,LCCC1820,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1095,GC101-21K177,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
1096,2019.046,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1097,2020-004696-41,Interventional,"No Intervention, Experimental, Experimental, Experimental, No Intervention, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1098,V3002401,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1099,2021-0768,Interventional,Experimental,"Procedure, Radiation, Procedure",Single Group Assignment,,,,Phase 2
1100,FDRT-BC008,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1101,A5481136,Observational,,"Drug, Drug",,Cohort,,Probability Sample,
1102,TILS001 trial,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1103,SYSEC-KY-KS-2022-056,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1104,S1709-101-888,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1105,ARV-471-mBC-102,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1106,BR01/02/21,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1107,MA-BC-II-020,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1108,69HCL16_0536,Observational,,Behavioral,,Other,,Non-Probability Sample,
1109,NL68820.091.19,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
1110,6010121027,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
1111,FS-1502-III1-01,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,,,,Phase 3
1112,IIT-0026,Observational,,Radiation,,Case-Only,,Non-Probability Sample,
1113,LCCC2241,Observational,,"Other, Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
1114,2020-0708,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1115,20-347,Interventional,Experimental,"Combination Product, Drug",Single Group Assignment,,,,Phase 2
1116,NCC2493,Interventional,"Active Comparator, Experimental","Drug, Radiation",Parallel Assignment,,,,Phase 3
1117,ICO 13-001,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Early Phase 1
1118,2018-A01128-47,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1119,SCBCG-006,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
1120,LRP/PegGCSF/2016/004,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
1121,GRACE,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1122,21-600,Interventional,Experimental,"Device, Device",Single Group Assignment,,,,Not Applicable
1123,114,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
1124,YLiu,Observational,,Drug,,Cohort,,Probability Sample,
1125,IIT2018-17-McArthur-TCDRT,Interventional,"Active Comparator, Experimental","Drug, Radiation, Drug, Drug",Parallel Assignment,,,,Phase 2
1126,20 KHCC 91,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
1127,SYSUCC-019,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1128,IIT-CRM2020001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1129,2018-A02191-54,Observational,,,,Cohort,,Probability Sample,
1130,2020-154,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
1131,CTO-IUSCC-0715,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1132,CLEE011ABR02,Observational,,Drug,,Cohort,,Non-Probability Sample,
1133,SP0048722,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1134,38341220.8.0000.0072,Interventional,"Active Comparator, Experimental, Experimental","Radiation, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1135,Neo-ACT,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
1136,CH-BC-059,Interventional,"Experimental, Active Comparator","Drug, Other, Genetic, Drug",Parallel Assignment,,,,Phase 3
1137,07102022_SR,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
1138,GO42784,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1139,New theory(Tamoxifen&retinoic),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Sham Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1140,145314,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,"Phase 1, Phase 2"
1141,20-505,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Radiation",Parallel Assignment,,,,Phase 2
1142,RadiaAce001,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
1143,Neo-program 2021.02.23,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
1144,ARV-471-mBC-101,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1145,275078,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1146,IIT-2017-NeoPACT,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1147,2021000247,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
1148,REaCT-70,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
1149,BTCRC-BRE16-042,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1150,TVD-101-002B,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1151,20-0140-A,Interventional,"Experimental, Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
1152,D9673R00004,Observational,,Other,,Cohort,,Non-Probability Sample,
1153,CA209-929,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Single Group Assignment,,,,Phase 2
1154,SYSEC-KY-KS-2019-099,Observational,,"Drug, Drug, Drug, Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
1155,Glnz87?,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1156,GIM24-PALBO-BP,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1157,18-115,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1158,IBISCO Trial,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
1159,NBC Che001,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1160,IC 2021-08,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1161,AI Yoga Study on Facebook - 1,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1162,6222/22.03.2017,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1163,SYSEC-KY-KS-2019-055-001,Observational,,Other,,Cohort,,Non-Probability Sample,
1164,EUBREAST-01,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1165,1216-4-011,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
1166,UPCC 15121,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1167,OMERIC-1904,Interventional,,Procedure,Single Group Assignment,,,,Not Applicable
1168,21-161,Observational,,,,Case-Control,,Non-Probability Sample,
1169,18-217,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1170,ACE-Breast-06,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1171,ONC-010,Observational,,Other,,Case-Only,6 Years,Non-Probability Sample,
1172,CHLOBREASTASP,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1173,CLEE011AFR01,Observational,,Other,,Cohort,,Non-Probability Sample,
1174,CTO-IUSCCC-0781,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Phase 2
1175,TT420X2101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
1176,201808046,Interventional,Experimental,"Radiation, Procedure",Single Group Assignment,,,,Not Applicable
1177,178-2018,Observational,,Diagnostic Test,,Cohort,5 Years,Probability Sample,
1178,OMC2018/01,Observational,,,,Cohort,,Non-Probability Sample,
1179,VersiÃ³n 4- 20/09/2020,Interventional,Other,Drug,Single Group Assignment,,,,Phase 4
1180,HS-10352-102,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 1
1181,CSPC-KAL-BC-16,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1182,REaCT-Wellness,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
1183,AB PoC 2021 RUS,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
1184,NEXT-BRCA,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1185,MedOPP167,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
1186,LPM-008,Interventional,"Other, Experimental, Experimental","Combination Product, Drug",Sequential Assignment,,,,Phase 3
1187,DATOS-20220624-ASJF-Efecto car,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1188,2019.444,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
1189,NSABP FB-13,Interventional,Experimental,"Drug, Drug, Drug, Diagnostic Test",Single Group Assignment,,,,Phase 2
1190,202207198RINB,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
1191,FZPL-â¢-303,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1192,SYSUCC 019,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1193,BCSPilot01,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1194,2014CB543202-03,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
1195,578-21-FB,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1196,1107210020,Observational,,,,Other,,Probability Sample,
1197,107CS-6,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1198,BRE 381,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1199,IRB00048455,Observational,,"Procedure, Other, Other, Other",,Cohort,,Non-Probability Sample,
1200,2022-009,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1201,CCR5654,Observational,,Other,,Other,,Non-Probability Sample,
1202,KCT 005,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1203,2022-YXZX-YX-08,Observational,,Other,,Case-Control,,Non-Probability Sample,
1204,G1T28-212,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Biological",Single Group Assignment,,,,Phase 2
1205,SCHBCC-NO28,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1206,ID-RCB 2022-A01488-35,Interventional,"No Intervention, Experimental",Device,Crossover Assignment,,,,Not Applicable
1207,PI-2021-3,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
1208,2021-KY-124-001,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1209,MA-BC-â¡-021,Interventional,"Experimental, Experimental, Experimental","Procedure, Drug, Procedure",Parallel Assignment,,,,Phase 2
1210,NCKUH SLNB,Observational,,Procedure,,Case-Only,5 Years,Non-Probability Sample,
1211,DFP22-0020,Interventional,"Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
1212,CCM 1505,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1213,PER.CIN.BN.95.III,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1214,21-5021,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1215,C4891006,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1216,2021-0840,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1217,OV-121,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1218,042110,Interventional,"Active Comparator, Other","Drug, Other",Single Group Assignment,,,,Early Phase 1
1219,BC-09638,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
1220,LB1802,Observational,,,,Case-Only,5 Years,Non-Probability Sample,
1221,2018-0601,Interventional,"Placebo Comparator, Experimental, Placebo Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1222,D967JC00002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1223,UKM14_0016,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
1224,RJBC-HFRNI,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
1225,m-VCAP1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1226,19-133,Interventional,"Experimental, Placebo Comparator",Behavioral,Crossover Assignment,,,,Not Applicable
1227,CLEE011A2206,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1228,CASE3118,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1229,2020(55),Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1230,WO40324,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Radiation, Drug",Parallel Assignment,,,,Phase 3
1231,Geneplus2020BC01,Observational,,,,Case-Only,,Non-Probability Sample,
1232,ML39208,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Phase 2
1233,18/028,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
1234,19-005860,Observational,,"Procedure, Other, Other",,Cohort,,Non-Probability Sample,
1235,A231701CD,Interventional,"Active Comparator, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
1236,FDRT-BC017,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
1237,AC699-001,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1238,2020-495,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1239,CTRIAL-IE 17-13,Interventional,Other,"Drug, Drug",Single Group Assignment,,,,Phase 1
1240,00005038,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1241,H-43432,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1242,2020-010,Observational,,Other,,Cohort,,Probability Sample,
1243,Contralateral Screening,Observational,,,,Cohort,,Non-Probability Sample,
1244,HCRN BRE18-334,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Other",Parallel Assignment,,,,Phase 2
1245,ACT16105,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1246,OSU-22013,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1247,I-3364822,Interventional,"Active Comparator, Experimental","Other, Other, Procedure, Other",Parallel Assignment,,,,Not Applicable
1248,ICO-N-2019-04,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1249,20140299,Interventional,"Experimental, Experimental","Biological, Biological",Single Group Assignment,,,,Phase 1
1250,2007-206-1145,Observational,,,,Cohort,2 Years,Non-Probability Sample,
1251,2019.629,Observational,,Other,,Cohort,,Probability Sample,
1252,CS003-BC,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Sequential Assignment,,,,Phase 2
1253,2020-005722-28,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1254,EORTC-1617-QLG-BCG,Observational,,,,Cohort,,Non-Probability Sample,
1255,MD-127-2019,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1256,2020-07-064-002,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1257,UC-BCG-2204,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
1258,PYHOPE-BC-104,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1259,TMZ-TNBC,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1260,STUDY-20-01174,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1261,SIM-1907-02-SERD-101,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1262,20-151,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1263,RJBC-SHF RNI,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
1264,YOUNGBC-17,Observational,,,,Cohort,,Non-Probability Sample,
1265,HREBA.CC-21-0429,Interventional,"Active Comparator, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
1266,Metastatic Breast Cancer,Observational,,,,Cohort,3 Years,Non-Probability Sample,
1267,UW17107,Interventional,"Experimental, Experimental","Drug, Dietary Supplement",Parallel Assignment,,,,Phase 2
1268,NL63209 041 18,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1269,KCSG BR19-15,Observational,,,,Case-Only,,Non-Probability Sample,
1270,2020-AHL-001,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
1271,SAMuhammad,Interventional,"Active Comparator, Active Comparator",Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
1272,202201100,Interventional,Experimental,"Other, Procedure",Single Group Assignment,,,,Not Applicable
1273,2019-A02195-52,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1274,ShantouCH02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1275,PekingUPH10B003,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1276,GE-280-401,Observational,,Drug,,Cohort,,Non-Probability Sample,
1277,CTMS# 19-0028,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,,,,Not Applicable
1278,NEO-01,Interventional,Experimental,Device,Sequential Assignment,,,,Not Applicable
1279,NL58040.091.16,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1280,LQ006,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1281,MCC-19-15740,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1282,K180603J,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1283,ABLE02,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1284,MCC-21-BRE-54,Interventional,Experimental,"Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1285,HUM00140468,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1286,CLEE011A3201C,Interventional,"Active Comparator, Experimental","Combination Product, Combination Product, Combination Product, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1287,2/108/7,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Not Applicable
1288,EOC202A1101,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
1289,18-2562.cc,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1290,19-586,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1291,2014CB543202-02,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
1292,CER2021,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
1293,IB 2017-05,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Phase 3
1294,On4Rehab Pilot Trial,Interventional,"Active Comparator, Experimental",Other,Parallel Assignment,,,,Not Applicable
1295,IIT-0005,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Drug",Parallel Assignment,,,,Phase 2
1296,PROTECT,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1297,MD 134/2022,Observational,,,,Cohort,,Non-Probability Sample,
1298,NCC2129,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1299,001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1300,SYSU-CSCO-2020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1301,IRB18-0970,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
1302,2019-09-023,Interventional,"Placebo Comparator, Experimental",Procedure,Single Group Assignment,,,,Not Applicable
1303,Shengjing-LCG004,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1304,A5481093,Observational,,,,Case-Control,,Probability Sample,
1305,MedOPP168,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1306,LUN_DBT_121,Observational,,Radiation,,Cohort,,Probability Sample,
1307,I239,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1308,IRB00158622,Interventional,"Active Comparator, Sham Comparator, Other","Other, Other, Other",Factorial Assignment,,,,Not Applicable
1309,RFTMBCPW,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 4
1310,s63338,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1311,2017-0071,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1312,2019/00283,Observational,,Other,,Case-Control,,Non-Probability Sample,
1313,20200628GD,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1314,ANLO-BC,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1315,SHR-A1811-III-306,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1316,REO 028,Interventional,"Active Comparator, Experimental, Experimental","Drug, Biological, Drug",Parallel Assignment,,,,Phase 2
1317,LQ007,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1318,2019-KY-049,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1319,D9268C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1320,ET17-203 DISCO,Interventional,"Experimental, Experimental, Experimental, No Intervention","Device, Behavioral",Factorial Assignment,,,,Not Applicable
1321,GO 22/41,Observational,,,,Other,,Probability Sample,
1322,07068-02,Observational,,,,Cohort,1 Day,Probability Sample,
1323,YOUNGBC-16,Observational,,,,Cohort,,Non-Probability Sample,
1324,EC/2017/0200,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1325,99mTc-DARPinG3 breast cancer,Observational,,Drug,,Cohort,,Non-Probability Sample,
1326,200277,Interventional,"Experimental, Experimental, Experimental","Drug, Device, Other",Parallel Assignment,,,,Phase 1
1327,CFT / sp123,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1328,2021-1201,Interventional,"Experimental, No Intervention",Diagnostic Test,Single Group Assignment,,,,Phase 2
1329,FDRT-BC012,Interventional,Experimental,Radiation,Single Group Assignment,,,,"Phase 1, Phase 2"
1330,99mTc- RM26,Interventional,"Experimental, Experimental",Diagnostic Test,Parallel Assignment,,,,Phase 1
1331,2103254164,Interventional,"Active Comparator, Active Comparator, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 2
1332,MA-BC-II-026,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1333,OBU-BC-II-079,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1334,BCD-178-2,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1335,YOUNGBC-24,Observational,,Drug,,Cohort,,Non-Probability Sample,
1336,SHR6390-Ib/II-201,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1337,AAAT4412,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1338,N19MIM,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 2
1339,CA209-7A8,Interventional,"Experimental, Experimental, Active Comparator","Biological, Drug, Drug",Parallel Assignment,,,,Phase 2
1340,CFT/sp123,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1341,EVER-132-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1342,KY20192081-F-1,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
1343,AC682-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1344,ATOS-Z-201,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1345,UC-0140/1711 - UCBG3-06,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 2
1346,2018-05-0155,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1347,SBU-PCWRT-BREAST,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
1348,2021.240,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1349,YOUNGBC-6,Observational,,,,Cohort,,Non-Probability Sample,
1350,HNCH-BC008,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1351,PLATO study,Interventional,Experimental,"Drug, Drug, Genetic",Single Group Assignment,,,,Phase 2
1352,PI20/596,Observational,,,,Cohort,,Non-Probability Sample,
1353,SCBCG-022,Observational,,Drug,,Cohort,,Probability Sample,
1354,RSRB00066846,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1355,KC19EESI0325,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1356,HERMIONE-10,Observational,,,,Cohort,,Probability Sample,
1357,16-007764,Interventional,Other,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
1358,18-621,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
1359,IRB-59141,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1360,STOP-BC Trial,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1361,SYSU005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1362,ZN-c5-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1363,Fudan University,Interventional,"Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 3
1364,18-8214-BO,Interventional,"Experimental, Active Comparator","Procedure, Behavioral",Parallel Assignment,,,,Not Applicable
1365,B00157,Observational,,Procedure,,Cohort,,Probability Sample,
1366,1711-048-898,Interventional,"Experimental, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
1367,HR-BLTN-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1368,2021-A03091-40,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1369,A5481166,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
1370,D081CC00012,Observational,,,,Cohort,,Non-Probability Sample,
1371,Luminal A sirt1,Observational,,,,Cohort,,Non-Probability Sample,
1372,DokuzEU.Com.Garments,Observational,,,,Other,,Non-Probability Sample,
1373,P.T.REC/012/002968,Interventional,"Active Comparator, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
1374,IIT-2021-ASSET,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1375,MC200302,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
1376,4-2020-1131,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1377,145358,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1378,UMCC 2018.016,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1379,TP.102.17.22.PAR,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1380,EFC15935,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1381,BC-NEO-IIT-SHR6390,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1382,GDWCH-001,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1383,SMC-2018-10-062,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1384,SMX 18001,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1385,A5481154,Observational,,Drug,,Cohort,,Non-Probability Sample,
1386,NRG-BR008,Interventional,"Active Comparator, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 3
1387,TEBICA002,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1388,CWCD118B12201,Interventional,"Experimental, Active Comparator, Active Comparator, Other","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1389,22-002857,Observational,,"Procedure, Procedure, Procedure, Procedure",,Cohort,,Non-Probability Sample,
1390,CALORIE,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
1391,S2010,Interventional,"Experimental, Active Comparator","Other, Procedure, Procedure, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
1392,IFOM-CPO007/2019/PO006,Observational,,Other,,Other,,Non-Probability Sample,
1393,S-detect 2019,Observational,,,,Cohort,,Probability Sample,
1394,AABCSR,Observational,,,,Cohort,,Non-Probability Sample,
1395,FMSU2017-002B,Observational,,"Device, Device",,Case-Crossover,,Probability Sample,
1396,2019-A01592-55,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1397,ABY-025-MI301,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1398,202202045MIPA,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1399,22-07025006,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1400,2019/044,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1401,B2017-11,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
1402,2022-0651,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
1403,Pro00088926,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1404,Tmab-TK006-102b,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1405,YOUNGBC-10,Observational,,,,Cohort,,Non-Probability Sample,
1406,Ahead-BC-20170323,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 2
1407,21090645,Interventional,"Experimental, Experimental, Experimental, No Intervention","Dietary Supplement, Dietary Supplement, Combination Product",Parallel Assignment,,,,Early Phase 1
1408,18-0234,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1409,20-1434.cc,Observational,,,,Cohort,,Non-Probability Sample,
1410,P20CA217199-9492018,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1411,Pro00107216,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1412,HREBA.CC 19-0363,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
1413,AHQU-2021004,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1414,H20-03123,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
1415,CSPC-KAL-AE-01,Observational,,Other,,Other,,Non-Probability Sample,
1416,SYS-C-201801-5010,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1417,SCBCG-021,Observational,,Drug,,Cohort,,Probability Sample,
1418,15-017,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
1419,ZN-c5-003,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1420,114421,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
1421,M14ABC,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1422,CLIN-52014-452,Observational,,,,Cohort,,Probability Sample,
1423,18-004803,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1424,34615/4/21,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1425,CLAG525B2101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1426,MINERVA,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
1427,LACOG 0419,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1428,CHB18.04,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1429,CSIIT-C21,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1430,BOOG 2018-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1431,AMC2020-17,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
1432,KY20222062-C-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1433,20201540,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1434,RCVDBCIIR005,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1435,STUDY00003282,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1436,IRB-2022-348,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1437,LCCC 1639,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1438,SCHBCC-N034,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
1439,2022-0431,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1440,CBYL719C1201,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1441,SYSA1802-CSP-006,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1442,201805027RSA,Observational,,Other,,Case-Only,,Probability Sample,
1443,KY2022-097-B,Observational,,Drug,,Cohort,,Non-Probability Sample,
1444,KY2019-023,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1445,MEDOPP447,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1446,GE-226-004,Interventional,"Experimental, Experimental","Drug, Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Phase 1
1447,2021P002871,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1448,CABC - Kreftfor project - SEB,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
1449,201708076,Interventional,"Experimental, Active Comparator","Other, Procedure, Behavioral, Procedure, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1450,TWT-203,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1451,CO41101,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1452,Radiodermatitistalita60,Observational,,Radiation,,Case-Only,,Non-Probability Sample,
1453,EA1183,Interventional,Experimental,"Procedure, Other, Procedure",Single Group Assignment,,,,Phase 2
1454,WO42312,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1455,MEDOPP367,Observational,,,,Cohort,,Probability Sample,
1456,YXH2022ZX02167,Observational,,Drug,,Case-Control,,Non-Probability Sample,
1457,NHP,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1458,JU 2020/1732-51,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1459,NCCH1607,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1460,NL69081.041.19,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
1461,AAAS2359,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1462,21-06023682,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1463,HSEARS20210816002,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1464,D926XC00001,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1465,PUMCH-BC500,Observational,,,,Cohort,3 Months,Non-Probability Sample,
1466,HRS-8080-I-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1467,S2020-300-01,Observational,,,,Other,,Probability Sample,
1468,99mTc-DARPinG3,Observational,,Drug,,Cohort,,Non-Probability Sample,
1469,ONA-XR-103,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1470,Soh-Med-22-05-24,Observational,,,,Other,,Probability Sample,
1471,2022-0315,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 1
1472,KCSG BR19-13,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1473,SYSEC-KY-KS-2019-054-001,Observational,,Other,,Cohort,,Non-Probability Sample,
1474,STU00216520,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Phase 3
1475,ICO-2020-25,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1476,20805,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1477,HRS-1358-I-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1478,IRFMN-BRC-7103,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1479,BL-M02D1-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1480,RJBC1901,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
1481,PELICAN-IPC 2015-016,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1482,YO41137,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Radiation, Drug",Parallel Assignment,,,,Phase 3
1483,BC2,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1484,CO40016,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1485,ADIGYN,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1486,NICSO-GINSENG,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1487,ATADEK-2018 / 9,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1488,UW22095,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1489,HREBA.CC-18-0657,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1490,NSABP FB-12,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Diagnostic Test",Single Group Assignment,,,,Phase 2
1491,4469,Interventional,Experimental,Genetic,Single Group Assignment,,,,Not Applicable
1492,RTM 2015,Observational,,Device,,Cohort,,Non-Probability Sample,
1493,Breast-Chi-2022,Observational,,Drug,,Cohort,,Non-Probability Sample,
1494,STUDY00018504,Interventional,"Experimental, Experimental, Experimental, Experimental","Procedure, Drug, Drug, Biological, Drug, Other, Drug",Parallel Assignment,,,,Phase 2
1495,38RC19.362,Observational,,Biological,,Other,,Non-Probability Sample,
1496,YOUNGBC-19,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1497,CTFSp161,Observational,,,,Other,,Non-Probability Sample,
1498,CCR5316,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1499,STUDY00000675,Interventional,Experimental,"Procedure, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 1
1500,FILBLAU1022,Interventional,"Active Comparator, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 3
1501,CBYL719C2303,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Crossover Assignment,,,,Phase 3
1502,US-MAM,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
1503,BC-IIT-SHR6390-FMTN,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1504,LV,Interventional,"Experimental, No Intervention",Biological,Factorial Assignment,,,,Phase 2
1505,CAPRICE-IPC 2020-053,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1506,P0268,Observational,,Other,,Cohort,,Non-Probability Sample,
1507,HMPL-012-SPRING-R101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1508,2107239-9,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1509,Breast PTC,Interventional,,Procedure,Single Group Assignment,,,,Not Applicable
1510,201900115B0,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
1511,2021-A02664-37,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
1512,EF 160,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1513,D20148,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1514,CBYL719C2202,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1515,PUMCH-BC503,Observational,,,,Cohort,,Non-Probability Sample,
1516,TRIO036,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1517,EG017,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1518,TIPN in China,Observational,,"Other, Other",,Case-Control,,Non-Probability Sample,
1519,2019000486,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1520,Alpha-Lipoic Acid,Interventional,"Experimental, Experimental","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1521,VICC BREP 1898,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 1
1522,07-2021/EK OUSA,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
1523,MD.22.07.674,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
1524,I241,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug, Drug",Parallel Assignment,,,,Phase 2
1525,853.4,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
1526,ShandongCHI-08,Observational,,,,Cohort,5 Years,Non-Probability Sample,
1527,173-18-CA,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1528,1400,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1529,NCC2167,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Biological, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1530,UW 18-526,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1531,H-1905-141-1035,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1532,EUBREAST-2 INDAX,Interventional,"Experimental, Experimental","Procedure, Radiation",Parallel Assignment,,,,Phase 3
1533,HRHB-CB001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Biological",Parallel Assignment,,,,"Phase 2, Phase 3"
1534,NSABP FB-14,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
1535,ADG106-T6002,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1536,1812850942,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1537,RJBC1801,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1538,UTAR- 8068/000,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
1539,SH APBI RISE,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
1540,TOL2506A,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 3
1541,852000,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Early Phase 1
1542,2019-A02500-57,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1543,JCOG1919E,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1544,AI-BMRI-S,Observational,,Diagnostic Test,,Cohort,6 Months,Non-Probability Sample,
1545,Prix Ruban Rose/2020/FF-03,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1546,SBU-SBRT-BREAST-NO-SX,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
1547,E7389-M065-401,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1548,IUSCC-0680,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1549,HCRN BRE20-468,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1550,UPCC 04119,Interventional,"Active Comparator, Active Comparator, Active Comparator, Other","Radiation, Drug, Procedure",Parallel Assignment,,,,"Phase 1, Phase 2"
1551,2021-04,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
1552,18-000718,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1553,MOST Pain,Interventional,"No Intervention, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1554,AQUAFIT-2018,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1555,Moderate Dose Omega-3,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
1556,Pro00104863,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1557,MA40,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
1558,HR-BLTN-003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1559,Velocity,Interventional,"Active Comparator, Active Comparator","Behavioral, Drug",Parallel Assignment,,,,Phase 3
1560,KN026-201,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1561,GBG105,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1562,KN026-208,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1563,RnaDx-BRV-BC- 01,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
1564,27600,Interventional,"Experimental, Other","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
1565,ZN-c5-001,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1566,2020-A00398-31,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
1567,CSIIT-C10,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1568,ICON CA209-9FN,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1569,31052019,Interventional,"Active Comparator, Other","Other, Other",Parallel Assignment,,,,Not Applicable
1570,iOM-110393,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1571,201711073,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug, Procedure, Procedure, Procedure",Sequential Assignment,,,,Phase 1
1572,L21-076,Interventional,"No Intervention, Experimental, Experimental","Device, Combination Product",Single Group Assignment,,,,"Phase 1, Phase 2"
1573,2020-007,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
1574,19-300,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
1575,RAD1901-308,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1576,LAE205INT3101,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
1577,201900180,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1578,201911047,Interventional,Experimental,"Device, Drug, Drug, Other, Other, Drug, Device, Procedure, Procedure",Single Group Assignment,,,,Phase 1
1579,CAAP CA,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1580,BCT 2102,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1581,JTU-6H-20211230001,Observational,,"Procedure, Procedure",,Cohort,1 Year,Probability Sample,
1582,OCOG-2019-RHEAL,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
1583,KY20223267-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1584,SGNTUC-016,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1585,SHEPHERD-2021-2,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
1586,GUMPTION,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1587,A5481168,Observational,,,,Cohort,,Non-Probability Sample,
1588,MA-BC-II-018,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1589,SCHBCC-N041,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1590,1401,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1591,IBIO-301,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
1592,FUSCC-T-sunflower,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1593,05022020,Observational,,,,Case-Only,,Non-Probability Sample,
1594,BTP-66732,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1595,CSIIT-C18,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
1596,2021C0102,Observational,,,,Cohort,,Non-Probability Sample,
1597,CTO-IUSCCC-0758,Observational,,"Drug, Procedure",,Case-Crossover,,Non-Probability Sample,
1598,CLOVER,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1599,LOXO-PIK-21001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
1600,SPI-GCF-104,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Biological, Biological, Drug, Drug",Sequential Assignment,,,,Phase 1
1601,HNCH-BC006,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1602,2019-0550,Interventional,Other,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1603,NL74126.091.20,Interventional,"Experimental, Experimental, Other, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
1604,ALTERBC008,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1605,IOM-050371,Interventional,"Experimental, Active Comparator","Combination Product, Combination Product",Parallel Assignment,,,,Phase 3
1606,IRB-2021-04,Interventional,"Other, No Intervention",Behavioral,Factorial Assignment,,,,Not Applicable
1607,DPMBC301,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1608,SYHX2011-001,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 1
1609,21-225,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,"Phase 1, Phase 2"
1610,KCSG-BR18-13/TR-03,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1611,ICPS002/20,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1612,21-698,Interventional,"Experimental, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
1613,20P.020,Interventional,Experimental,"Drug, Biological, Biological, Biological, Other, Other",Single Group Assignment,,,,"Phase 1, Phase 2"
1614,RJBC2001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
1615,H-2009-079-1157,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1616,GB491-005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1617,012342QM,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1618,GDWCH002(TNBC),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1619,HR-BLTN 015,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1620,HER2BRAIN,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1621,HNCH-MBC10,Interventional,"Experimental, Other","Drug, Drug",Parallel Assignment,,,,Phase 2
1622,NOGGO B3,Observational,,Other,,Case-Only,10 Years,Non-Probability Sample,
1623,IC 2020-20,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1624,2017-004909-41,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
1625,2022JC-55,Interventional,"Experimental, Sham Comparator, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
1626,ICO-2020-28,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
1627,AI-Breast-US,Observational,,Diagnostic Test,,Other,,Probability Sample,
1628,2021-0974,Interventional,"Experimental, No Intervention, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1629,HNCH-MBC12,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1630,Twisted Pink Foundation,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
1631,HORMONOVILLE,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1632,ET17-093 BreastImmune03,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1633,1910208-9,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1634,CSPC-KAL-BC-11,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1635,1503144-7,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1636,IRB00022667,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
1637,TOL2506A-EXT,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 3
1638,IKP275 / GBG91,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1639,BELIEVE@BC,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
1640,GCC 1926,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator",Radiation,Sequential Assignment,,,,Not Applicable
1641,HIFU202207,Interventional,Experimental,"Drug, Drug, Procedure, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1642,18-195,Observational,,"Device, Device",,Cohort,,Probability Sample,
1643,BO40747,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1644,KA22053,Interventional,"Experimental, Active Comparator","Other, Other",Single Group Assignment,,,,Not Applicable
1645,BOOG-2017-01,Interventional,"Other, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1646,GO39869,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
1647,2021-0532,Observational,,,,Cohort,,Probability Sample,
1648,P2100-SUR-S11,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Radiation",Parallel Assignment,,,,Phase 1
1649,BC-IIT-FMTN-SHR6390-ET,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1650,2022JC-55-1,Interventional,"Active Comparator, Sham Comparator, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
1651,XJTU1AF-CRF-2020-006,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1652,SPY LNM 01,Interventional,Experimental,"Combination Product, Combination Product",Single Group Assignment,,,,Phase 3
1653,2018-062,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1654,QUILT-3.067,Interventional,Experimental,"Drug, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,,,,"Phase 1, Phase 2"
1655,1808189-7,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1656,Version 1.0_16.08.2021,Observational,,Procedure,,Cohort,,Non-Probability Sample,
1657,17041,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1658,TSL-CM-TSL1502-â¡,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1659,82071993,Observational,,Device,,Cohort,,Probability Sample,
1660,QL1701-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1661,FAVOR,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1662,60905722.0.0000.0072,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1663,197520,Interventional,"Experimental, Experimental","Biological, Drug, Drug",Parallel Assignment,,,,Phase 2
1664,17249,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1665,Onkologikoa,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1666,ET17-057,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1667,2019-A02397-50,Observational,,Behavioral,,Case-Control,,Non-Probability Sample,
1668,21-018,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1669,ShandongCHI-20,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1670,YBCSG-22-08,Observational,,Other,,Cohort,,Probability Sample,
1671,AL-2001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1672,kazuma,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
1673,308-2017,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
1674,Pro00107615,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
1675,RSINETE,Observational,,Drug,,Cohort,,Non-Probability Sample,
1676,AC682-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1677,PRO00037175,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1678,55516,Interventional,"Experimental, Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
1679,MA-BC-II-007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1680,48347821.8.0000.5249,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
1681,200218,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1682,OBU-BC-II-086,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1683,2017 0105,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1684,MYBC,Interventional,"Placebo Comparator, Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1685,D-FR-01070-003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1686,MUKDEN01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1687,R174-A11507-17-S52,Interventional,"Experimental, Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
1688,000001,Interventional,"Experimental, Experimental",Other,Crossover Assignment,,,,Not Applicable
1689,18-240,Observational,,"Other, Behavioral",,Cohort,,Non-Probability Sample,
1690,BG01-2102,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1691,19-004343,Interventional,Experimental,Genetic,Single Group Assignment,,,,Not Applicable
1692,Shandong CHI-11,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1693,NCC2225,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1694,NCC-006461,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1695,OZM-103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1696,SCHBCC-NO27,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1697,2022/0035983,Observational,,,,Cohort,,Non-Probability Sample,
1698,2020/482,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1699,TUXEDO-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1700,CIBI375Y008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1701,NL76658.029.21,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Not Applicable
1702,SCHBCC-N032,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1703,OE861801,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
1704,1808189-8,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1705,4-2018-0765,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1706,38406,Observational,,,,Cohort,3 Months,Probability Sample,
1707,2020/134,Observational,,Procedure,,Cohort,,Probability Sample,
1708,LB,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1709,CSIIT-C34,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1710,19-886,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
1711,IEO 0834/,Observational,,,,Cohort,,Non-Probability Sample,
1712,FACILE,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1713,RP6530-2101,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1714,GEICAM/2021-08,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1715,SYHX2011-002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1716,ZDWY.XBZL.002,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
1717,D8664R00002,Observational,,,,Case-Control,,Probability Sample,
1718,BO41843,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1719,HSEARS20180509004,Interventional,"Experimental, Sham Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1720,Shandong CHI-10,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1721,erector-spinae,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1722,CHD049-17,Observational,,Other,,Cohort,,Non-Probability Sample,
1723,OnkoFit I,Interventional,"Experimental, Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
1724,103089,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1725,SHR6390-III-301,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1726,17575,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
1727,IMMU-132-09,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1728,2017-IIT-HER2-Aspire,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1729,QL1209-301,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 3
1730,17395,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 4
1731,D967RC00001,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1732,2019-A01323-54,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1733,UPCC 10119,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 2
1734,WO41554,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1735,2020-0198,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1736,UC-0109/1805,Interventional,"Other, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1737,SHR-1210-III-318,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1738,H21089,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1739,CSPC-DMS-BC-11,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1740,270-2018,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
1741,0379520202023,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1742,S63893,Interventional,"Experimental, Experimental, Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Early Phase 1
1743,KM10B,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1744,TriMix-Breast,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Sequential Assignment,,,,Phase 1
1745,19-486,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Phase 2
1746,UC-GMP-2206,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1747,SYSUCC-003,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1748,soh-Med-21-10-17,Observational,,Radiation,,Case-Control,,Probability Sample,
1749,2021-005,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Not Applicable
1750,MRG002-009,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1751,CBYL719G12301,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1752,TCF20-BRE-01,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1753,GS-US-586-6144,Interventional,"Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1754,PMC_TTAC-0001_05,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1755,EOC103A3101,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1756,CO41012,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1757,SYM013,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1758,SHR6390-III-302,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1759,HR-BLTN-016,Observational,,Other,,Cohort,2 Years,Non-Probability Sample,
1760,Pro2021000838,Interventional,"Active Comparator, No Intervention",Behavioral,Crossover Assignment,,,,Not Applicable
1761,RJBC2001,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1762,CSPC-DMS-BC-K07,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1763,SGNLVA-002,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1764,WO43919,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1765,KSVGH20-CT7-26,Observational,,Other,,Cohort,,Probability Sample,
1766,EMBRAVE-001,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
1767,I 72218,Interventional,"Experimental, Active Comparator","Other, Other, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1768,FCN-437c-III201,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1769,MCC-20899,Interventional,"Experimental, Experimental","Radiation, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1770,2021-TNBC-01,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1771,FCN-437c-III202,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1772,breast-202204,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1773,20150288,Interventional,"Experimental, Active Comparator, Active Comparator, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
1774,D9673R00005,Observational,,Other,,Other,,Non-Probability Sample,
1775,P170927J,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device",Parallel Assignment,,,,Not Applicable
1776,HBBL-01,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
1777,FDRT-BC015,Observational,,Radiation,,Cohort,,Non-Probability Sample,
1778,PCZCTP-220702-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1779,ERC-260,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1780,POL6326-009,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1781,911,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1782,IRB#18853,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
1783,EAGER-001,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1784,206010,Interventional,"Active Comparator, Experimental","Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1785,UKFC-PU-2019-01-08,Interventional,"Placebo Comparator, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Other",Parallel Assignment,,,,"Phase 1, Phase 2"
1786,2018-001705-91,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1787,KA-20007,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1788,Arise-FJ-B02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1789,SYSU-2021,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1790,SHR-A1811-II-202,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1791,REaCT-Algorithm,Observational,,,,Cohort,,Non-Probability Sample,
1792,2019-A03112-55,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
1793,017-396,Interventional,"Experimental, Experimental",Dietary Supplement,Sequential Assignment,,,,Not Applicable
1794,G1T28-213,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1795,Shengjing-LCG012,Interventional,"Experimental, Other","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1796,NK/7784/Study/249,Interventional,"Active Comparator, Experimental",Radiation,Parallel Assignment,,,,Phase 3
1797,A5481159,Observational,,"Drug, Drug",,Cohort,,Probability Sample,
1798,CL0006,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
1799,ZEN003694-004,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1800,TED15954,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1801,s2192648,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1802,UC-0140/1812,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1803,MAMA_MOVE_Gaia After Treatment,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,,,,Not Applicable
1804,GS-US-569-6172,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
1805,SunYatsenU2H-LQ5,Observational,,Drug,,Cohort,,Non-Probability Sample,
1806,HNCH-BC011,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1807,NCC3397,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Other, Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1808,IC 2020-10,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
1809,CTMX-2009-002,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1810,2021-SR-592,Observational,,,,Cohort,,Non-Probability Sample,
1811,2020-006106-23,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1812,PR351/20,Observational,,Procedure,,Cohort,3 Years,Probability Sample,
1813,HR-NeoBC-HN003,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1814,IEO 1730,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
1815,GIM23-POSTER,Observational,,Other,,Cohort,,Non-Probability Sample,
1816,17320,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
1817,15.03.2023,Observational,,"Drug, Drug, Drug",,Cohort,,Probability Sample,
1818,PALBOBIN,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1819,202103030005,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
1820,2018.451,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
1821,D8530C00002,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1822,MA-BC-II-033,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1823,17-428,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1824,NL81896.078.22,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
1825,SDX-0103,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1826,CO42177,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1827,MO39874,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 3
1828,202007016,Interventional,"Active Comparator, Experimental","Drug, Drug, Biological, Biological, Procedure, Procedure, Procedure",Parallel Assignment,,,,"Phase 1, Phase 2"
1829,B003-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
1830,DOUBLE,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1831,0000012,Observational,,"Genetic, Drug",,Cohort,,Non-Probability Sample,
1832,REaCT-5G,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
1833,STUDY00019489,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1834,CO40151,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1835,TQB2450-Ib-07,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1836,R19-149,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1837,2021/609,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
1838,BOOG-2017-02,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1839,2017-A03413-50,Observational,,Other,,Cohort,,Non-Probability Sample,
1840,AK117-203,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1841,HR-NeoBC-HN002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1842,2021-0491,Observational,,"Procedure, Other",,Case-Control,,Non-Probability Sample,
1843,2021-A02007-34,Observational,,,,Cohort,2 Years,Probability Sample,
1844,GIM26-TRASTHER,Observational,,Drug,,Other,,Non-Probability Sample,
1845,AND019-MN-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
1846,SKB264-â¢-03,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
1847,495573096,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
1848,NCR191600,Observational,,Other,,Cohort,,Non-Probability Sample,
1849,ESPB in breast cancer surgery,Interventional,"Placebo Comparator, Experimental, Experimental","Procedure, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1850,SI 475/2019,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1851,JS001-026-III-TNBC,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1852,CBYL719CIN01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 4
1853,SPORT-DS,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 1
1854,WO43571,Interventional,"Other, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1855,2020-0232,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1856,TQB2450-III-06,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1857,CASE5119,Interventional,"Active Comparator, Experimental","Dietary Supplement, Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1858,AH150201,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1859,EVER-132-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1860,99mTc-ADAPT6 in breast cancer,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1861,MOST Pain Pilot,Interventional,"No Intervention, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
1862,214-2018,Observational,,,,Cohort,5 Years,Probability Sample,
1863,TBDBreast50,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1864,BAC,Observational,,,,Cohort,,Non-Probability Sample,
1865,I237,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
1866,KarolinskaUD,Interventional,"Active Comparator, Experimental",Other,Factorial Assignment,,,,Phase 3
1867,QUILT-3.058,Interventional,Experimental,"Biological, Biological, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1868,20200225,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
1869,SCCC-03121; STU-2021-0657,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
1870,BC-Fluzoparib,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1871,NCC1969,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1872,HX008-Ib/II-TNBC-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1873,STUDY00004350,Interventional,Experimental,"Other, Other, Other, Other",Single Group Assignment,,,,Not Applicable
1874,14/2021,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1875,HNCH-MBC07,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
1876,HR-BLTN-III-NeoBC,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1877,A5481123,Observational,,,,Cohort,,Non-Probability Sample,
1878,SYSU-2022-UCAN,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1879,19-113,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Phase 1
1880,B013-301,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
1881,4CAST,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1882,811,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
1883,SHR1210-III-322,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1884,BC- T-DM1,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Not Applicable
1885,HERMIONE-7,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1886,RG1006427,Interventional,"Active Comparator, Experimental","Behavioral, Other, Behavioral, Other, Other",Parallel Assignment,,,,Phase 2
1887,22-x354,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1888,CO41863,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1889,21030,Interventional,Experimental,"Device, Other, Other",Single Group Assignment,,,,Not Applicable
1890,BAT-8001-002-CR,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug",Parallel Assignment,,,,Phase 3
1891,CBYL719A0US03T,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1892,EH20-251,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
1893,MedOPP190,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1894,Combined CTH and HT in MBC,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1895,KN046-203,Interventional,"Experimental, Experimental","Biological, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
1896,A5481095,Observational,,,,Cohort,,Non-Probability Sample,
1897,DZ2019HE001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1898,S62794,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
1899,SHR6390-SHR1020-I-101-BC,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1900,IIT2022-07-YUAN-IB-TNBC,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1901,MA-BC-II-047,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
1902,FUSCC,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Other","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1903,222.20,Interventional,"Experimental, Experimental, Experimental",Radiation,Sequential Assignment,,,,Phase 1
1904,Bioscore in breast cancer,Observational,,Other,,Cohort,,Non-Probability Sample,
1905,NCC201711008,Interventional,,Drug,Single Group Assignment,,,,Phase 2
1906,2019-0634,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1907,ShandongCHI-06,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 2
1908,275142,Observational,,Other,,Cohort,,Non-Probability Sample,
1909,NCC2474,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Device",Parallel Assignment,,,,Phase 2
1910,MK 3475-318,Interventional,"Other, Other, Other, Other, Other, Other",Drug,Single Group Assignment,,,,Early Phase 1
1911,Medical Research Institute,Interventional,"Experimental, Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
1912,MCLA-128-CL02,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1913,HNCH-HER2-MBC001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1914,P170929J,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1915,GB491-004,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
1916,MORE-T trial,Interventional,"Experimental, Active Comparator","Drug, Diagnostic Test, Procedure",Parallel Assignment,,,,Phase 2
1917,2022-A01192-41,Observational,,Behavioral,,Other,6 Months,Non-Probability Sample,
1918,IJB-LOB-2019,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1919,Cardiotoxicity study,Observational,,Drug,,Case-Control,,Non-Probability Sample,
1920,MS200647_0020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1921,262840,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1922,U025,Interventional,Experimental,"Drug, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 1
1923,KN026-205,Observational,,Drug,,Cohort,,Non-Probability Sample,
1924,Soh-Med-21_10_18,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
1925,SPH4336-301,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1926,HCB/2019/0786,Interventional,"Sham Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
1927,2019-185-AGH,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Phase 2
1928,EC2019/0127,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
1929,REaCT-OGF,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
1930,2021P002943,Observational,,,,Cohort,,Non-Probability Sample,
1931,NCI-2021-08921,Interventional,"Experimental, Active Comparator","Procedure, Drug, Other, Other, Other",Parallel Assignment,,,,Phase 2
1932,AIs with chemotherapy in MBC,Interventional,,Drug,Single Group Assignment,,,,Phase 2
1933,CTRIAL-IE 22-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1934,SIBP-01-3,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1935,20-068,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1936,19-002448,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Phase 1
1937,2022-09/2057,Observational,,Drug,,Cohort,,Probability Sample,
1938,UC Laser,Interventional,"Active Comparator, Active Comparator","Drug, Device",Parallel Assignment,,,,Not Applicable
1939,TEMPLATE,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1940,CO42867,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1941,GBG 93,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
1942,2022-0500,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
1943,IJB-LBC-NEOCHECKRAY-2018,Interventional,"Experimental, Experimental, Experimental","Drug, Radiation, Drug",Parallel Assignment,,,,Phase 2
1944,HR-MBC-HN001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1945,MCC-19803,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1946,20-130,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
1947,BG01-2001,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
1948,CBYL719CIN02,Observational,,Other,,Cohort,,Non-Probability Sample,
1949,ROGABREAST,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1950,SYSU-2021-UCAN,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Factorial Assignment,,,,Phase 3
1951,18040334,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1952,Labra-001,Interventional,"Sham Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
1953,M19-992,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
1954,2021-1122,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
1955,SYSKY-2022-105-01,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1956,CS2-19004,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
1957,CBYL719C2404,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
1958,I2I1,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1959,2019-01-064,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1960,ZhejiangCH-0709,Observational,,,,Cohort,,Non-Probability Sample,
1961,SHR-A1811-206,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1962,FOENIX-MBC2 TAS-120-201,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1963,IRB18-1178,Interventional,"Experimental, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
1964,ML43171,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
1965,UC-BCG-2011,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
1966,CSIIT-C41,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1967,MO43110,Interventional,"Other, Other, Experimental, Experimental, Other","Drug, Drug, Drug, Drug, Drug, Procedure, Radiation",Parallel Assignment,,,,Phase 3
1968,EUBREAST 3,Observational,,,,Cohort,5 Years,Probability Sample,
1969,SHR-1210-III-327,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
1970,EOC202A2102,Interventional,"Active Comparator, Active Comparator","Biological, Drug",Parallel Assignment,,,,Phase 2
1971,IEO 675,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
1972,MP-05-2021-2605,Interventional,Experimental,"Procedure, Diagnostic Test",Single Group Assignment,,,,Not Applicable
1973,7339-009,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
1974,MC1831,Interventional,Experimental,"Procedure, Procedure, Procedure, Procedure, Biological",Single Group Assignment,,,,Phase 2
1975,OSU-20380,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
1976,D933LC00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
1977,MA-BC-II-042,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
1978,2020-1190,Interventional,"Experimental, Active Comparator","Behavioral, Other, Device, Behavioral, Other, Other",Single Group Assignment,,,,Not Applicable
1979,HRS8807-I-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Device, Drug",Single Group Assignment,,,,Phase 1
1980,2019-00673; sp19Kurzeder,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
1981,BreCLIM-2018-116-31M,Interventional,"Experimental, Active Comparator","Procedure, Drug",Parallel Assignment,,,,Phase 3
1982,TQ-B3525-I-02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
1983,HKUCTR-2709,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
1984,MUKDEN5,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
1985,Prevention of neuropathy,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Device, Device, Device",Parallel Assignment,,,,Not Applicable
1986,TQB3616-II-01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
1987,s61033,Observational,,Drug,,Cohort,,Probability Sample,
1988,s17-00995,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
1989,SHR9549-I-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
1990,18/0059,Observational,,Other,,Other,,Non-Probability Sample,
1991,3-2019-0140,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
1992,IRB00109957,Interventional,"No Intervention, Active Comparator, Active Comparator","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
1993,IRB18-00912,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
1994,Shengjing-LJY03,Observational,,Drug,,Cohort,,Non-Probability Sample,
1995,0392-18-HMO,Interventional,"Active Comparator, Sham Comparator",Device,Sequential Assignment,,,,Not Applicable
1996,UW19046,Interventional,Experimental,"Drug, Diagnostic Test",Single Group Assignment,,,,Early Phase 1
1997,I 73718,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
1998,21/079,Observational,,Radiation,,Cohort,,Non-Probability Sample,
1999,2018-1133,Observational,,"Other, Other, Behavioral",,Case-Only,,Non-Probability Sample,
2000,HCB/2020/0971,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
<<<<<<< HEAD
2001,3-2019-0140,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2002,0392-18-HMO,Interventional,"Active Comparator, Sham Comparator",Device,Sequential Assignment,,,,Not Applicable
2003,22012020,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2004,FJD-LCO2-19-01,Interventional,"Experimental, Active Comparator","Device, Combination Product",Parallel Assignment,,,,Not Applicable
2005,ARIANNA (SOLTI-1502),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2006,KROG 21-07,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
=======
2001,FJD-LCO2-19-01,Interventional,"Experimental, Active Comparator","Device, Combination Product",Parallel Assignment,,,,Not Applicable
2002,MC01/05/20; IST-325 (KPT),Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2003,KROG 21-07,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 3
2004,22012020,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2005,2020-1267,Interventional,Experimental,"Procedure, Procedure, Other, Drug",Single Group Assignment,,,,Not Applicable
2006,HER2BAT,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
>>>>>>> main
2007,18291,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
2008,ARIANNA (SOLTI-1502),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2009,PROICM 2019-05 MAC,Interventional,"No Intervention, Experimental, Experimental","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2010,BLI-1401-2-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2011,R018-SABI-00193,Observational,,,,Cohort,,Non-Probability Sample,
2012,20221120,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
2013,Geriatric-CDK4/6,Observational,,Drug,,Cohort,6 Months,Non-Probability Sample,
2014,CLEAR,Interventional,Experimental,"Procedure, Radiation, Procedure",Single Group Assignment,,,,Phase 2
2015,Regina Elena,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2016,2.777.676,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,"Phase 2, Phase 3"
2017,IC 2017-06,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2018,Pro00087654,Observational,,Genetic,,Cohort,,Non-Probability Sample,
2019,IRMA,Observational,,,,Case-Only,,Non-Probability Sample,
2020,CO40115,Interventional,"Active Comparator, Experimental, Experimental, Active Comparator, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2021,111-009-F,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Phase 1
2022,2020-2-4023,Observational,,Device,,Cohort,,Non-Probability Sample,
2023,21129002,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2024,MCC-20915,Interventional,"Experimental, Experimental, Experimental","Biological, Drug, Drug, Drug, Procedure",Sequential Assignment,,,,Phase 2
2025,PMCT-IMSLNB-MIT,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2026,V2000701,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2027,University Brunswick,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2028,1605576856,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2029,3475-B49,Interventional,"Experimental, Active Comparator","Biological, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2030,2018-0287,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2031,SABO 21-01,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
2032,UW20037,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2033,20201101,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2034,ZJCH-CK19B,Interventional,"No Intervention, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
2035,69HCL21_0145,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
2036,IPI-549-03,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2037,2017-0500,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2038,APG2575XU103,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2039,BLTN-NeoBC1115,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2040,22-259,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
2041,UW18099,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
2042,17384,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2043,BL-B01D1-104,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2044,M21CSM,Interventional,Other,"Procedure, Radiation, Other",Single Group Assignment,,,,Phase 2
2045,4-2022-0600,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2046,22239,Interventional,"Experimental, Placebo Comparator","Procedure, Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 2
2047,202107015,Interventional,"Experimental, Experimental, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
2048,20171,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Not Applicable
2049,UPCC 17119,Observational,,Radiation,,Cohort,,Non-Probability Sample,
2050,HS-10352-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2051,NNG17.2,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2052,XJTU1AF-CRF-2018-001,Observational,,Other,,Cohort,,Probability Sample,
2053,I 571719,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
2054,2019-40016-06,Interventional,"Active Comparator, Other",Drug,Factorial Assignment,,,,Not Applicable
2055,IRB-52869,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2056,D9266C00001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2057,1B-21-6,Observational,,"Procedure, Other, Other, Other",,Case-Only,,Non-Probability Sample,
2058,2017/78,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
2059,ICRG0201,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2060,SHR-A1811-III-301,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2061,IRB-63041,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2062,U21-02-4401,Interventional,,Drug,Single Group Assignment,,,,Phase 2
2063,AssiutU AAHelmy,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2064,Pro00100408,Observational,,,,Cohort,,Non-Probability Sample,
2065,Polarhis,Observational,,Device,,Other,,Probability Sample,
2066,GS-US-592-6173,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2067,SCO-120-19-22,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2068,GS-US-592-6238,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2069,CBYL719C2201,Interventional,"Experimental, Placebo Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2070,TQB3616-III-01,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2071,19/218,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2072,CHANGEABLE,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2073,19-3032.cc,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2074,SCT200IITNBC,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
2075,651,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
2076,H3B-6545-J081-103,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
2077,2019-00174 Neoadj Breast Pilot,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2078,MO40628,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 2
2079,NNG17.1,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2080,STUDY00004618,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2081,19959,Interventional,"Active Comparator, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2082,AIPAC-003,Interventional,"Experimental, Experimental, Experimental, Placebo Comparator","Biological, Drug, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
2083,18-1068,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2084,SuleymanDU-SALMAN-F-001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2085,IIBSP-SIL-2017-70,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
2086,Shoulder exercise cancer,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
2087,NCI-2022-00004,Interventional,Experimental,"Drug, Dietary Supplement",Single Group Assignment,,,,"Phase 1, Phase 2"
2088,GC-627-05,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2089,LCCC 2104,Interventional,"Active Comparator, Experimental","Radiation, Drug",Parallel Assignment,,,,Phase 2
2090,2021SQGH00743,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2091,N21CPB-IRBd22-103,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2092,UPNA-CUMACA-B2022,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2093,rosuva2020,Interventional,"No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
2094,213831,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2095,Pro00109917,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2096,GCO 17-2320,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2097,32158620.0.0000.0072,Observational,,Other,,Cohort,1 Year,Probability Sample,
2098,MA-BC-II-025,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2099,CPO-NBP-2002,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2100,INT/2020/VOICE,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2101,N assisted,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2102,SYSKY-2022-024-01,Interventional,Experimental,Procedure,Sequential Assignment,,,,Not Applicable
2103,PROSOM-K,Interventional,"Other, Other, Other","Other, Drug",Parallel Assignment,,,,Not Applicable
2104,NL62441.068.17,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2105,EP0062-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
2106,LightCT-PKUPH,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2107,KY2022-044-B,Interventional,"Active Comparator, Other",Device,Parallel Assignment,,,,Not Applicable
2108,SUGBG-2021001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2109,PI2018_843_0061,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2110,2110244-11,Interventional,"Experimental, Sham Comparator, Sham Comparator",Device,Parallel Assignment,,,,Phase 4
2111,2018-09-20 Version 1.2,Observational,,Drug,,Cohort,,Probability Sample,
2112,HSM/VGH-2019-12-009CC,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2113,2021-A01550-41,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2114,2449PT,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2115,20220430GD,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2116,StrataXRT,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2117,TQB3909-Ib/II-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2118,events in breast cancer,Observational,,Drug,,Cohort,24 Months,Non-Probability Sample,
2119,"S-20200021, 19-16321",Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2120,Exo-LCR-1807,Interventional,Experimental,"Procedure, Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2121,ILLUMINE,Observational,,"Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
2122,AGO/2019/003,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
2123,C4891016,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2124,MCC-19220,Interventional,Experimental,"Diagnostic Test, Biological, Diagnostic Test",Single Group Assignment,,,,Early Phase 1
2125,2020-A01916-33,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2126,MC220902,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
2127,BR-003,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2128,2021/156064(REK),Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Phase 2
2129,MedOPP199,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2130,RECHMPL21_0680,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2131,ShengjingH 3,Observational,,Other,,Cohort,10 Years,Probability Sample,
2132,18459,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2133,PRO00030295,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2134,DBCG RT SDM,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2135,NBK 171/1/2021,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2136,NCC1787,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2137,UCI 19-145 [HS# 1459],Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2138,20923,Observational,,"Procedure, Other",,Cohort,,Non-Probability Sample,
2139,SUN-2252,Observational,,Diagnostic Test,,Cohort,3 Years,Probability Sample,
2140,18496,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Other, Other",Parallel Assignment,,,,"Phase 1, Phase 2"
2141,INT214/22,Interventional,"Placebo Comparator, Experimental",Dietary Supplement,Parallel Assignment,,,,Phase 2
2142,201906,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2143,BL-M07D1-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2144,22-250,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2145,2021-0669,Observational,,"Procedure, Procedure, Radiation",,Cohort,,Non-Probability Sample,
2146,HCI130492,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2147,E7090-J081-102,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2148,Folio No.03-2022,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2149,S63330,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2150,CA209-8H3,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2151,A171601,Interventional,Experimental,"Drug, Drug, Drug, Other, Other",Single Group Assignment,,,,Phase 2
2152,OP-1250-001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
2153,21-091,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2154,A5481122,Observational,,"Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
2155,1890-1-2019,Observational,,Drug,,Other,,Probability Sample,
2156,CARDIEJERCAN,Interventional,"No Intervention, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2157,RIBBS 2019/37,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2158,CCR5234,Interventional,"Experimental, No Intervention, Experimental, No Intervention","Other, Other",Sequential Assignment,,,,Not Applicable
2159,2574,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2160,IFG-06-2019,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
2161,439-21,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2162,VHIO20002,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
2163,H-45698,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2164,FDRT-BC010,Interventional,Experimental,Other,Single Group Assignment,,,,"Phase 1, Phase 2"
2165,D8666C00004,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2166,17-0310,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2167,OTT 17-02,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
2168,MC1835-ACCRU-BR-1701,Interventional,"Experimental, Placebo Comparator, Experimental","Biological, Biological, Other, Biological, Biological, Biological",Parallel Assignment,,,,Phase 2
2169,CCR4772,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2170,UC-BCG-2205,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2171,IEO 0837/,Observational,,Other,,Cohort,,Non-Probability Sample,
2172,PHDW-006,Observational,,,,Cohort,1 Day,Non-Probability Sample,
2173,AnhuiPH,Observational,,,,Case-Only,,Non-Probability Sample,
2174,21094,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
2175,PECP,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
2176,UPCC 11121,Observational,,Other,,Cohort,,Non-Probability Sample,
2177,11066,Interventional,"Active Comparator, Active Comparator, Active Comparator","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
2178,CBYL719A03201,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2179,S-64813,Observational,,,,Case-Only,2 Years,Non-Probability Sample,
2180,2020-0831,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
2181,SDO-006-20-01,Interventional,"Active Comparator, Active Comparator",Drug,Crossover Assignment,,,,Phase 1
2182,ASSOCIHER,Observational,,Drug,,Cohort,,Non-Probability Sample,
2183,VICC BRE 20104,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
2184,22-655,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Phase 2
2185,CL0007,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,,,,Phase 3
2186,EPTTCSM (239BRC18.0129),Observational,,,,Cohort,,Non-Probability Sample,
2187,MO39193,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2188,HSR210410,Interventional,"Other, Other, Other, Other","Drug, Drug, Radiation, Radiation",Parallel Assignment,,,,"Phase 2, Phase 3"
2189,ALTER-BC-003,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2190,"CD133, Breast Cancer",Observational,,,,Other,,Non-Probability Sample,
2191,2021-40-2343,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2192,NL67422.041.18,Interventional,Experimental,"Drug, Procedure, Drug",Single Group Assignment,,,,Phase 1
2193,AL-TNBC-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2194,300007016,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
2195,QUILT-3.057,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Biological, Biological, Biological, Biological, Biological, Biological, Drug, Biological, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2196,2021-0261,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Drug, Device, Other",Parallel Assignment,,,,Phase 3
2197,H3B-6545-G000-102,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
2198,69HCL19_0593,Observational,,Other,,Cohort,,Non-Probability Sample,
2199,NCI-2018-01581,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Drug, Procedure, Biological, Drug, Procedure, Drug, Biological, Drug, Biological",Parallel Assignment,,,,Phase 2
2200,CAR202,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2201,SIB16134,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2202,2020-11/15,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2203,20D.876,Interventional,"Active Comparator, Experimental","Other, Radiation, Procedure, Other, Other, Procedure, Other",Parallel Assignment,,,,Phase 2
2204,41494,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2205,19D.799,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2206,21-110,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2207,GM1-CIPN-202,Interventional,"Experimental, Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
2208,HSaleem,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2209,220493,Interventional,Other,Drug,Single Group Assignment,,,,Not Applicable
2210,2020-q12,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2211,1280-0022,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2212,112626,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2213,0124-18-TLV,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2214,BL2014084,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2215,20160504,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2216,RLY-2608-101,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
2217,CLEE011A2207,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2218,21050,Interventional,Experimental,"Other, Procedure, Device, Biological, Biological",Single Group Assignment,,,,Phase 4
2219,55054,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2220,PILOT 171548,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2221,22-225,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2222,ShandongCHI-04,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2223,1710018694,Interventional,Other,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2224,MC1733,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
2225,294-2018,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2226,29747,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2227,IFG-NIB-01,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2228,2022/005-OST,Observational,,Diagnostic Test,,Cohort,1 Year,Non-Probability Sample,
2229,PRESSODOU-1809,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2230,WSG-AM08,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
2231,MRG002-005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2232,HLX10-013-TNBCneo,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Sequential Assignment,,,,Phase 3
2233,INT 192/19,Interventional,"Experimental, Experimental","Dietary Supplement, Drug, Drug",Parallel Assignment,,,,Phase 2
2234,YWBC-001,Observational,,,,Case-Only,5 Years,Probability Sample,
2235,IRB-53650,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2236,VICC BRE 17107,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2237,2017-004938-28,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2238,Pro00103625,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2239,2017/01,Interventional,"Active Comparator, Placebo Comparator",Other,Parallel Assignment,,,,Phase 3
2240,G0F9119N,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
2241,NCI-2018-01519,Interventional,"Experimental, Active Comparator","Drug, Radiation",Parallel Assignment,,,,Phase 2
2242,OP_1413,Interventional,"No Intervention, Experimental",Diagnostic Test,Parallel Assignment,,,,Not Applicable
2243,2020-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2244,NCI-2022-07265,Interventional,"Experimental, Active Comparator, Experimental","Drug, Procedure, Procedure, Procedure, Drug, Procedure",Parallel Assignment,,,,Phase 2
2245,AURORA US,Observational,,"Procedure, Other",,Case-Only,,Non-Probability Sample,
2246,G1T28-208,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2247,ZZBGCART-016,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
2248,18HH4880,Observational,,Other,,Cohort,,Non-Probability Sample,
2249,21-038,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2250,STUDY00004257,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Early Phase 1
2251,IC 2020-15,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2252,09.2019.865,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2253,I-3010822,Interventional,"Experimental, Experimental","Procedure, Procedure, Drug, Procedure, Biological, Procedure, Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2254,PALBO01/2021,Observational,,Drug,,Other,,Probability Sample,
2255,UMCC 2021.056,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2256,BOOG 2019-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2257,AZV2022,Interventional,"Experimental, Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2258,RF-2016-02362383,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2259,HYPART,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2260,CLEE011AUS65,Observational,,"Drug, Drug, Drug",,Cohort,,Non-Probability Sample,
2261,UTD-1-BM-II,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
2262,IUSCC-0647,Observational,,,,Cohort,,Non-Probability Sample,
2263,SL-2020076,Observational,,Other,,Cohort,,Non-Probability Sample,
2264,2022-A00171-42,Observational,,,,Cohort,,Non-Probability Sample,
2265,2018/14-01,Interventional,"Experimental, Active Comparator",Behavioral,Crossover Assignment,,,,Not Applicable
2266,UC-0140/1814,Interventional,Other,"Drug, Other",Single Group Assignment,,,,Not Applicable
2267,NBG-19-01; SWEBCG 19-01,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2268,bakircaymzeren07,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2269,2021SCR,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
2270,Lymphedema Rehabilitation,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2271,IRB-30000320,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2272,VMA-253-18,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,,,,Not Applicable
2273,9764,Interventional,Experimental,"Drug, Drug, Other, Drug, Other, Other, Drug, Drug",Single Group Assignment,,,,Phase 4
2274,EA1211,Interventional,Experimental,"Drug, Procedure, Other, Procedure, Procedure",Single Group Assignment,,,,Phase 2
2275,11B1920N_BCS-PAIN,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2276,ShandongCHI-13,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2277,MIMIR-mTNBC,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2278,LCCC1934,Observational,,,,Cohort,,Non-Probability Sample,
2279,3-2020-0448,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2280,Pro2020001306,Interventional,Experimental,"Other, Other, Radiation, Procedure, Radiation, Other",Single Group Assignment,,,,Not Applicable
2281,17502,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2282,Pro00109777,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2283,2861/20,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Other",Factorial Assignment,,,,Phase 2
2284,GY202201,Interventional,"Experimental, Sham Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2285,WO40181,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2286,BMTN,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2287,2020-12518,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2288,20190304-01H,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2289,UKT HT03_1,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2290,30388,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2291,STUDY00146320,Interventional,"Experimental, Other",Drug,Parallel Assignment,,,,Phase 2
2292,SM-88-001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2293,2022-A00437-36,Interventional,"Experimental, Active Comparator, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
2294,2018-01-054,Observational,,Diagnostic Test,,Case-Only,5 Years,Non-Probability Sample,
2295,2.073.549,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Factorial Assignment,,,,Not Applicable
2296,2-114-18,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
2297,NCI-2020-02319,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure, Drug, Drug, Procedure",Sequential Assignment,,,,"Phase 1, Phase 2"
2298,P170407J,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
2299,QF-SC10914-203,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2300,BRAVE,Observational,,Other,,Other,,Non-Probability Sample,
2301,D926PC00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2302,NL76792.091.21,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2303,IRB00376235,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2304,HCRN BRE18-360,Interventional,Experimental,"Drug, Radiation, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2305,19-1974.cc,Interventional,"Other, Other","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
2306,H19-02480,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2307,190025,Observational,,,,Cohort,,Non-Probability Sample,
2308,HS-10342-201,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2309,IRB202000746,Interventional,"Experimental, Experimental, Other","Drug, Combination Product, Combination Product",Parallel Assignment,,,,"Phase 1, Phase 2"
2310,2020-01-mp-BUS,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2311,108818,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
2312,CBCSG041,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2313,PILHLE-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2314,WEBAPPAC,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2315,A011801,Interventional,"Active Comparator, Experimental","Biological, Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 3
2316,21-579,Interventional,"Active Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
2317,Maple Tree Exercise,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2318,ERC/2019/10/05,Interventional,"Experimental, Experimental","Procedure, Other",Parallel Assignment,,,,Not Applicable
2319,A5481151,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2320,22145,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
2321,ICS Maugeri - CE 2202,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
2322,TCHP,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
2323,19-001881,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 2
2324,STU-2020-1043,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2325,D0819C00005,Observational,,,,Cohort,,Non-Probability Sample,
2326,041-2018,Interventional,"No Intervention, Experimental",Combination Product,Parallel Assignment,,,,"Phase 2, Phase 3"
2327,RESCREEN,Interventional,"Experimental, Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2328,NCI-2019-00048,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2329,IRB-57111,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2330,2022-0959,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Single Group Assignment,,,,"Phase 2, Phase 3"
2331,I 60517,Interventional,"Active Comparator, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2332,OSU-21185,Interventional,Experimental,"Behavioral, Other, Other",Single Group Assignment,,,,Not Applicable
2333,A221803,Interventional,"Active Comparator, Experimental","Other, Device, Other, Other",Parallel Assignment,,,,Phase 3
2334,IndonesiaU2022,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2335,STUDY00003100,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
2336,FM-17-B01,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 3
2337,MC220303,Observational,,"Procedure, Procedure, Other",,Cohort,,Non-Probability Sample,
2338,STUDY00007842,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2339,STUDY00001007,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2340,20-009279,Observational,,"Procedure, Other",,Case-Only,,Non-Probability Sample,
2341,20-133,Interventional,Experimental,Procedure,Single Group Assignment,,,,Early Phase 1
2342,H19094,Interventional,"Other, Experimental","Other, Behavioral",Parallel Assignment,,,,Not Applicable
2343,KKKR-Neulasta OS-01,Observational,,,,Cohort,,Non-Probability Sample,
2344,16-185671,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2345,M18BEL,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
2346,"UPCC# 15122, IRB # 852205",Interventional,"Experimental, Experimental","Drug, Device",Sequential Assignment,,,,Phase 1
2347,HCC 20-243,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2348,Alaa_Negm_MSc_2023,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2349,SunYatsenU2H-LQ3,Interventional,"Experimental, Active Comparator, Experimental, No Intervention","Drug, Drug",Parallel Assignment,,,,Phase 2
2350,LCCC1745,Observational,,Device,,Cohort,,Non-Probability Sample,
2351,BYEC20211201,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2352,18-140,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
2353,2022-0378,Interventional,"Other, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2354,20-221,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2355,IRB-58571,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2356,BPI-1178-2019-001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2357,Organoids Breast,Observational,,Other,,Cohort,,Non-Probability Sample,
2358,PUMCH-2020-EBC,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2359,E-HHC-2016-0245,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2360,21656,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2361,UC-0140/1901,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2362,ACCRU-BR-1801,Interventional,"Active Comparator, Experimental","Drug, Biological",Parallel Assignment,,,,Phase 2
2363,HE072-CSP-002,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
2364,17-00890,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2365,2020-01,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2366,TransRosaLEE-IPC 2021-075,Interventional,Experimental,"Genetic, Genetic, Genetic, Genetic",Single Group Assignment,,,,Not Applicable
2367,2000024495,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2368,UMCC 2021.109,Interventional,"Active Comparator, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 4
2369,TROIKA,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2370,HMCC-BR22-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2371,I 1680021,Interventional,Experimental,"Biological, Procedure, Procedure, Procedure, Biological, Other",Single Group Assignment,,,,Phase 2
2372,NCC1692,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2373,0201263,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2374,19/002,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2375,CIH-TZS-20190912,Observational,,"Drug, Drug",,Case-Control,,Non-Probability Sample,
2376,NCI-2019-06461,Interventional,"Experimental, Active Comparator","Drug, Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
2377,HNCH-BC001,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2378,S-169,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Phase 1
2379,ExtremeHypofractionationBreast,Observational,,,,Cohort,,Non-Probability Sample,
2380,HCI103657,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2381,HS627-III,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2382,17782,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
2383,LQ004,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2384,KutahyaMSUcancer,Observational,,,,Cohort,,Non-Probability Sample,
2385,2021-A03166-35,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2386,AAAS9859,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2387,249571,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2388,001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2389,2022/050,Interventional,"Experimental, Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2390,BR01/01/22,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2391,POLAR-01,Observational,,Drug,,Cohort,,Non-Probability Sample,
2392,UMCC 2020.122,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2393,CA048-001,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Drug",Single Group Assignment,,,,Phase 1
2394,NCI-2022-10810,Interventional,Experimental,"Procedure, Procedure, Procedure, Drug, Procedure, Drug, Biological",Single Group Assignment,,,,Phase 1
2395,RG1004302,Interventional,Experimental,"Drug, Biological",Single Group Assignment,,,,Phase 1
2396,Pro00100093,Interventional,"Active Comparator, Active Comparator, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 2
2397,0201-21,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2398,CORE,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2399,ENZENO-C-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2400,19206,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 2
2401,NEO-R-IPC 2019-041,Observational,,Other,,Cohort,,Probability Sample,
2402,S00748-NIM,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2403,STUDY00002373,Interventional,"Experimental, Active Comparator","Device, Procedure, Other",Parallel Assignment,,,,Phase 2
2404,ATENTO19,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2405,SCHBCC-N048,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2406,3-2020-0343,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2407,KSF2-1707,Interventional,Experimental,"Procedure, Biological, Procedure",Single Group Assignment,,,,Not Applicable
2408,UW 19-045,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2409,22-074,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Other",Sequential Assignment,,,,Phase 2
2410,09.2018.,Observational,,Other,,Other,,Probability Sample,
2411,lithium and breast cancer,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 3
2412,18549,Interventional,Experimental,"Other, Behavioral, Behavioral, Other, Other",Single Group Assignment,,,,Not Applicable
2413,EGC002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2414,Multimodal Project,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2415,201710109,Interventional,"Experimental, Experimental","Drug, Biological, Device, Procedure",Parallel Assignment,,,,Phase 1
2416,2016-003518-28,Interventional,"Experimental, Active Comparator","Other, Drug, Drug",Parallel Assignment,,,,Phase 3
2417,BR01/02/19,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2418,ZLiu,Observational,,Other,,Cohort,,Probability Sample,
2419,XJLL-KY20212136,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2420,2017-073,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Phase 2
2421,CMUH107-REC3-102,Interventional,"Active Comparator, Placebo Comparator",Other,Crossover Assignment,,,,Not Applicable
2422,THALIA-01,Observational,,Drug,,Cohort,,Non-Probability Sample,
2423,C-MOT,Observational,,Other,,Cohort,,Non-Probability Sample,
2424,BC-P32,Observational,,,,Cohort,,Non-Probability Sample,
2425,HBO001,Interventional,"Experimental, Active Comparator","Procedure, Drug, Dietary Supplement",Parallel Assignment,,,,Phase 2
2426,RG1718047,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 2
2427,19-0448,Observational,,Radiation,,Cohort,5 Years,Non-Probability Sample,
2428,2020-006,Interventional,"Other, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2429,TX05-03,Interventional,"Experimental, Active Comparator","Biological, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2430,2016/65,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2431,22-490,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2432,19P.117,Interventional,Experimental,"Drug, Procedure, Other, Other",Single Group Assignment,,,,Phase 1
2433,HCRN BRE19-433,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,,,,Phase 2
2434,S2020-09,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2435,SYSKY-2022-445-01,Observational,,"Drug, Procedure, Drug, Drug",,Cohort,,Non-Probability Sample,
2436,CGAprediting,Observational,,,,Cohort,,Non-Probability Sample,
2437,J17118,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2438,EQ132-201,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
2439,UW21062,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2440,ACT16106,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2441,2018/8361/I,Interventional,Other,"Diagnostic Test, Diagnostic Test, Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2442,427 BC SDM,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2443,20210901-jiangchunling,Interventional,"Experimental, Active Comparator",Combination Product,Parallel Assignment,,,,Phase 2
2444,2023-3181,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2445,CH-BC-086,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2446,IRB00154162,Observational,,Drug,,Case-Only,,Non-Probability Sample,
2447,2020KT151,Observational,,Drug,,Cohort,,Non-Probability Sample,
2448,01,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2449,CHUV-DO-0009-CyberImmunoBreast,Interventional,"Experimental, Experimental","Radiation, Drug",Parallel Assignment,,,,Phase 2
2450,NCC3222,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2451,PEMBRACA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2452,170115,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2453,IJB-EBC-Decrescendo-2020,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 2
2454,ANG1005-CLN-07,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2455,FASCINATE-N,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2456,Manual Therapy BCS,Interventional,"Experimental, Sham Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2457,KUH5101090,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2458,17471,Interventional,Experimental,"Drug, Other, Other, Other, Drug",Single Group Assignment,,,,Phase 2
2459,BAIBU-FTR-ED-001,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2460,STUDY00018239,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
2461,NCO-21001,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2462,16-015,Interventional,"Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
2463,22-10590-BO,Observational,,,,Cohort,,Non-Probability Sample,
2464,GBG 97,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2465,DOT-1871-KIE-0120-I,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2466,IIT-2017-MM-BRST-Her2noRT,Interventional,"Experimental, No Intervention, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
2467,KaratayUHaticeTEZ,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2468,YBCSG-21-01,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2469,4-2017-1108,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2470,UniUrb_21/10.07.2019,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2471,Shengjing-LJY02,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2472,2016-6346,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2473,N19TON,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2474,Soh-Med-23-02-16,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
2475,SIMR_onc19_IIS_DAndre_Ashwaga,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Crossover Assignment,,,,Phase 2
2476,PROICM 2018-02 SKY,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2477,GRASPA-TNBC-2018-02,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2478,NCI-2016-01293,Interventional,Experimental,"Procedure, Drug, Procedure",Single Group Assignment,,,,Phase 1
2479,BOOG 2021-01 SEQUEL-Breast,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2480,2020-1138,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2481,432-17,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
2482,20170770,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2483,GATTUM -1,Observational,,,,Cohort,,Probability Sample,
2484,YX2021-070(F1),Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
2485,RI-002,Observational,,,,Cohort,,Non-Probability Sample,
2486,LCI-BRE-MTN-NIR-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2487,1B-16-11,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2488,7119-001,Interventional,Experimental,"Drug, Biological, Drug",Single Group Assignment,,,,Phase 2
2489,PRO2,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
2490,KTI-21-01,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2491,CDX-ONC-101,Interventional,"Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
2492,ICL-2022-1,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2493,1070741-1,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2494,MO42319,Interventional,"Active Comparator, Experimental","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
2495,2021-1031,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2496,MCC-19337,Interventional,"Active Comparator, Active Comparator, Experimental","Biological, Drug, Procedure",Parallel Assignment,,,,Early Phase 1
2497,18175,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2498,4090,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
2499,2021332GD,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2500,18238,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2501,21152,Interventional,"Experimental, Experimental","Drug, Other, Other, Other",Parallel Assignment,,,,Phase 1
2502,BLTN-Ig,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2503,I 62218,Interventional,Experimental,"Procedure, Procedure, Drug, Biological, Drug, Biological",Single Group Assignment,,,,Early Phase 1
2504,Pro00080769,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2505,E2019316,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Phase 4
2506,22-364,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
2507,ISK-N103,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
2508,NCI-2019-02752,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2509,STao-003,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2510,RECHMPL20_0130,Observational,,,,Cohort,,Non-Probability Sample,
2511,OSU-17122,Interventional,Experimental,"Other, Other, Other, Other, Other, Other",Single Group Assignment,,,,Not Applicable
2512,SKB264-â¡-07,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2513,LonghuaH,Interventional,"Active Comparator, Sham Comparator",Other,Parallel Assignment,,,,Not Applicable
2514,OTT 18-01,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
2515,PTC-breastNAT,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Phase 2
2516,ZL-1302-002,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2517,MCC-21-18633,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2518,Fudan-P1-201701,Interventional,"Experimental, Experimental, Experimental, Experimental","Combination Product, Combination Product, Combination Product, Combination Product",Parallel Assignment,,,,Phase 1
2519,CBYL719C2005,Observational,,Other,,Other,,Non-Probability Sample,
2520,2018-0473,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Procedure",Parallel Assignment,,,,Not Applicable
2521,BCIG,Observational,,Procedure,,Cohort,5 Years,Probability Sample,
2522,2019-0638,Interventional,Experimental,"Procedure, Other, Other, Other, Other, Other, Other, Other",Single Group Assignment,,,,Not Applicable
2523,NCC1786,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
2524,ZG-2021-002,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2525,NU 19B07,Interventional,Experimental,"Drug, Biological, Genetic",Single Group Assignment,,,,Phase 1
2526,LUT-RD-02-01,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2527,Neo-RT,Observational,,"Radiation, Drug, Procedure",,Cohort,,Non-Probability Sample,
2528,MEDOPP445,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2529,OSU-18174,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2530,ICR-CTSU/2017/10065,Interventional,"No Intervention, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2531,VICC BRE 18108,Interventional,"Experimental, Active Comparator","Dietary Supplement, Drug",Single Group Assignment,,,,Early Phase 1
2532,RIGAIN,Interventional,"Experimental, Active Comparator","Radiation, Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2533,Survey_App,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2534,DR210090_SILENCE,Interventional,"Experimental, Sham Comparator","Device, Drug, Device",Parallel Assignment,,,,Not Applicable
2535,69HCL21_0552,Observational,,Other,,Cohort,,Probability Sample,
2536,OSU-21035,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2537,19-031,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2538,20-166,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2539,INCMNSZ REF 1239,Interventional,Experimental,"Drug, Drug, Drug, Procedure, Drug",Single Group Assignment,,,,Phase 2
2540,OSU-20101,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2541,UW18063,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2542,N201912134,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2543,SAHZhejiangU---Breast,Observational,,Combination Product,,Cohort,5 Years,Non-Probability Sample,
2544,IRST174.21,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2545,PEAR-TNBC_ Protocol_v2.0,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2546,ML42876,Observational,,,,Cohort,,Non-Probability Sample,
2547,OSU-18201,Interventional,"Experimental, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
2548,H-1912-010-086,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2549,MHICC-2018-003,Observational,,"Diagnostic Test, Other",,Cohort,,Non-Probability Sample,
2550,DAN-22220205,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2551,UPCC 21118,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2552,IRB00049171,Observational,,"Biological, Procedure, Drug, Procedure",,Case-Only,,Non-Probability Sample,
2553,MA-BC-II-002,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2554,I 2612022,Interventional,Experimental,"Procedure, Procedure, Procedure, Biological, Drug, Other",Single Group Assignment,,,,Phase 2
2555,M21CAR,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2556,IFOM-CPT008/2022/PO007,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2557,RG1122380,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
2558,4070,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
2559,RG1003977,Interventional,"Experimental, Active Comparator","Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2560,2022-0239,Observational,,Drug,,Cohort,,Non-Probability Sample,
2561,20190812,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
2562,BabesBolyaiOncovox,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2563,CADPT01A12101C,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Biological, Biological",Single Group Assignment,,,,Phase 1
2564,V2011801,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2565,R.18.02.33,Interventional,"Experimental, Active Comparator","Procedure, Drug, Procedure, Procedure",Parallel Assignment,,,,Phase 3
2566,R21052,Observational,,Procedure,,Cohort,3 Years,Non-Probability Sample,
2567,Exactis-05,Observational,,Other,,Cohort,,Non-Probability Sample,
2568,MCC-19-14621,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2569,I-19-04120,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Phase 2
2570,042001,Interventional,Experimental,"Biological, Other, Other, Biological",Single Group Assignment,,,,Phase 2
2571,767/29-09-2017,Interventional,"Experimental, Placebo Comparator",Device,Parallel Assignment,,,,Not Applicable
2572,WSG-AM12,Interventional,"Experimental, Experimental, Other, Other","Drug, Drug",Crossover Assignment,,,,Phase 2
2573,STUDY00002985,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2574,CSIIT-C37,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2575,i 67518,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
2576,HCI153239,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Phase 2
2577,268-2017,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
2578,16-304,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
2579,2019-A02374-53,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2580,2022-191,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2581,NCI-2017-02320,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,,,,Phase 2
2582,GIM25-CAPT,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2583,ERC/2018/06/01,Observational,,"Behavioral, Device",,Case-Control,,Non-Probability Sample,
2584,ELA-0121,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2585,844978,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
2586,APPI2-PT-2020-AIMSS,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2587,EDP1503-101,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
2588,S2020-300,Observational,,,,Other,1 Month,Probability Sample,
2589,187519,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug, Biological, Drug, Drug",Parallel Assignment,,,,Phase 2
2590,OnerCengiz,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2591,PH-CP026,Interventional,"Placebo Comparator, Experimental","Drug, Drug, Procedure",Parallel Assignment,,,,Phase 2
2592,B1432020000025,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Crossover Assignment,,,,Not Applicable
2593,IFG-05-2019,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2594,CTP-BRST-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2595,A221801,Interventional,"Experimental, Sham Comparator","Device, Device, Other, Other",Parallel Assignment,,,,Phase 3
2596,50619,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test",,Cohort,,Probability Sample,
2597,2016-0538,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2598,2018/455,Interventional,"Experimental, Placebo Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
2599,MC2031,Interventional,Experimental,"Drug, Procedure, Drug",Single Group Assignment,,,,Early Phase 1
2600,2019-1237,Observational,,"Behavioral, Other",,Cohort,,Non-Probability Sample,
2601,9988,Interventional,"Active Comparator, Experimental","Behavioral, Other, Other, Device, Other, Other",Parallel Assignment,,,,Not Applicable
2602,TN.32.1.17.SATF,Interventional,"Experimental, Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
2603,ACT-MBC,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
2604,KN026-US-I-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2605,MC1931,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2606,CBTMMUH,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2607,20180259-01H,Interventional,"Active Comparator, Experimental, Sham Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2608,PHRI.SCHOLAR-2,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2609,2017-0502,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2610,OSU-18317,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 1
2611,e-OTCAT20,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2612,23-050,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
2613,19447,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
2614,20G.093,Interventional,Experimental,"Other, Device, Other, Other, Other",Single Group Assignment,,,,Not Applicable
2615,ANI251_BCS-PI,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2616,NCI-2019-05187,Interventional,Experimental,"Drug, Procedure, Other, Other, Radiation",Single Group Assignment,,,,Phase 1
2617,OUMK59829,Interventional,Experimental,"Drug, Drug, Drug, Drug, Procedure",Single Group Assignment,,,,Phase 2
2618,STUDY00000057,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2619,LACOG 0122,Observational,,,,Cohort,,Non-Probability Sample,
2620,239531,Interventional,"Experimental, Active Comparator","Drug, Combination Product",Parallel Assignment,,,,Phase 2
2621,Castle06(BC),Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2622,STUDY02000934_1,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2623,IFG-01-2022,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
2624,PI-0171-2020,Interventional,"Experimental, Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2625,NBC Sur001,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
2626,STU-2019-0529,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 4
2627,RG1718049,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2628,55457122.3.0000.5330,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2629,2020-A02045-34,Observational,,Other,,Cohort,,Non-Probability Sample,
2630,ESPvsPECS/AOP,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2631,MP-12-2021-2565,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
2632,NCI-2022-04956,Interventional,"Experimental, Experimental","Drug, Procedure, Procedure, Procedure, Procedure, Drug, Biological",Sequential Assignment,,,,Phase 1
2633,S1703,Interventional,"Active Comparator, Experimental","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2634,OSU-19152,Interventional,"Experimental, Active Comparator","Device, Other",Crossover Assignment,,,,Not Applicable
2635,2018-11-128,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Not Applicable
2636,OSU-20340,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Other",Parallel Assignment,,,,Early Phase 1
2637,PAXMAN,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
2638,MC210303,Interventional,Experimental,"Other, Procedure, Procedure, Device",Single Group Assignment,,,,Not Applicable
2639,NL80749.058.22 DIRECT 2,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Phase 3
2640,2020-01097,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2641,IRB-2022-329,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2642,N20ESP,Interventional,"Active Comparator, Experimental","Drug, Other",Parallel Assignment,,,,Not Applicable
2643,SMC2018-09-029-003,Observational,,Other,,Case-Only,,Non-Probability Sample,
2644,UZBRU_VHH1_3,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2645,17753,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2646,35945/10/22,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2647,2019-5382,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2648,IRB00105944,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Radiation, Drug",Single Group Assignment,,,,Phase 2
2649,IRB202201483,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2650,MC18C3,Interventional,"Experimental, Active Comparator","Other, Other, Drug",Parallel Assignment,,,,Phase 2
2651,2022-376,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2652,2019-1042,Observational,,"Procedure, Other, Other",,Cohort,,Non-Probability Sample,
2653,20-002712,Interventional,Experimental,"Other, Other, Biological",Single Group Assignment,,,,Phase 1
2654,Gabapentin RCT,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
2655,167514,Interventional,Experimental,"Drug, Biological, Drug, Drug",Single Group Assignment,,,,Phase 2
2656,FS-CY1502-Ph1-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2657,G1T48-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
2658,PH-CP032,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2659,2018-0062,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2660,URomLS-2019a,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2661,ReMig,Observational,,,,Cohort,,Probability Sample,
2662,ODO-TE-B201,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2663,EVE-CWM-01,Observational,,Other,,Case-Only,,Non-Probability Sample,
2664,MAMMoutreach,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
2665,SAFE-FORWARD,Observational,,Radiation,,Cohort,,Non-Probability Sample,
2666,20-222,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
2667,20-001275,Interventional,"Active Comparator, Experimental","Drug, Procedure, Biological",Parallel Assignment,,,,Phase 2
2668,2018-8984,Observational,,Device,,Case-Only,,Probability Sample,
2669,OSU-22083,Interventional,Experimental,"Procedure, Other, Procedure, Other",Single Group Assignment,,,,Not Applicable
2670,CF22200A,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2671,2018-0550,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2672,3543,Interventional,"Active Comparator, Active Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
2673,EstroTEP COMPARE,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2674,230/HÄÄÄ-ÄHYD,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2675,2020-0715,Interventional,Experimental,"Drug, Drug, Drug, Drug, Biological, Biological",Single Group Assignment,,,,Phase 2
2676,NCI-2019-06088,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Procedure, Drug, Radiation",Parallel Assignment,,,,Phase 2
2677,MA-BC-II-037,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2678,A5481152,Observational,,Drug,,Cohort,,Non-Probability Sample,
2679,LCZ696ABM001.001,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 4
2680,2018-0127,Interventional,"Experimental, No Intervention","Drug, Procedure, Procedure",Parallel Assignment,,,,Early Phase 1
2681,S2007,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
2682,19-004024,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2683,ANG-002,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
2684,115300-20-52703,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2685,MC1635,Interventional,"Experimental, Experimental","Radiation, Other, Radiation",Parallel Assignment,,,,Phase 2
2686,IIT2019-21-Basho-TOPAZ,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2687,81603703,Interventional,"Experimental, Sham Comparator, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
2688,38RC20.120,Observational,,,,Case-Only,1 Day,Non-Probability Sample,
2689,BTCRC BRE15-024,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2690,2021-375,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2691,3474028/2019,Interventional,"Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2692,2020-0245,Interventional,Experimental,"Drug, Biological, Radiation",Single Group Assignment,,,,Phase 1
2693,18-000427,Interventional,Experimental,"Biological, Biological, Biological",Single Group Assignment,,,,Phase 1
2694,CASE11119,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2695,ZLYNXM202014,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2696,19.07,Interventional,Experimental,Other,Single Group Assignment,,,,"Phase 1, Phase 2"
2697,REaCT-Low Risk HER-2,Interventional,"Active Comparator, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 3
2698,D19160,Observational,,Other,,Cohort,,Non-Probability Sample,
2699,PRO00035701,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2700,REaCT-CHRONO,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
2701,Acu-CIPN,Interventional,"Active Comparator, Experimental","Procedure, Drug",Parallel Assignment,,,,Not Applicable
2702,202104085,Interventional,"Experimental, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
2703,ZL-MG-BC-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2704,P170104J,Interventional,Other,Drug,Single Group Assignment,,,,Phase 2
2705,Pro00104214,Interventional,"Experimental, Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2706,CLEE011AIT01,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 3
2707,MedOPP150,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2708,ODO-TE-B202,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2709,IO Panel,Observational,,Other,,Case-Control,,Probability Sample,
2710,Study00146761,Interventional,"Experimental, Other",Drug,Parallel Assignment,,,,Early Phase 1
2711,17-546,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2712,DRACARYS,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2713,PA18-1077,Observational,,Other,,Cohort,,Non-Probability Sample,
2714,RIPH2_BREYSSE_ETAPH,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2715,I 60217,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2716,21-001819,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Drug, Drug, Drug, Biological, Other, Drug, Biological, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2717,ARC-2 (AB928CSP0002),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2718,IRB00076577,Observational,,"Biological, Biological",,Cohort,,Probability Sample,
2719,RJ-101-RCT-001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Early Phase 1
2720,KEK 2021-D0051,Observational,,,,Case-Control,,Non-Probability Sample,
2721,SCHBCC-N046,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2722,2021-1151-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
2723,Aqua POLO-IPC 2019-028,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2724,OSU-20408,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
2725,21D.625,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
2726,TNBC-NEO,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
2727,RD19/125787,Observational,,Other,,Cohort,,Probability Sample,
2728,13/21,Interventional,"Active Comparator, Sham Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
2729,NCI-2017-01960,Interventional,Experimental,"Drug, Other",Sequential Assignment,,,,Phase 1
2730,2020-01,Interventional,"Experimental, Other","Radiation, Other",Parallel Assignment,,,,Not Applicable
2731,USB_22 Trial,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2732,YOUNGBC-12,Observational,,,,Cohort,,Non-Probability Sample,
2733,CSIIT-C25,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
2734,SAKK 95/17,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2735,2018-A01019-46,Interventional,"Active Comparator, Sham Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
2736,Fisioterapia en Linfedema,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2737,2019-0752,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2738,STUDY00003705,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2739,CL 2775,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 4
2740,STUDY00003782,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2741,X9001194,Observational,,Drug,,Cohort,,Non-Probability Sample,
2742,UEM QuirÃ³n,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
2743,MUST-02-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2744,IB2022-04,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2745,D5336C00001,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2746,CE 193/17,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
2747,IRAS 314460,Interventional,Other,Procedure,Single Group Assignment,,,,Phase 2
2748,UPCC12118,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 1
2749,LCCC 1716,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2750,YL202-INT-101-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2751,227/KEPK/IX/2022,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
2752,OFA,Interventional,"Experimental, Sham Comparator","Procedure, Drug, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2753,STUDY00021243,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2754,HNCH-2022KY59,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2755,Prevention of radiodermatitis,Interventional,"Placebo Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
2756,EXERT-BC,Observational,,Other,,Other,3 Months,Non-Probability Sample,
2757,D3614C00001,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2758,AH150202-1,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
2759,yifeng,Observational,,Other,,Cohort,,Non-Probability Sample,
2760,MEC-2021-0829,Observational,,Other,,Cohort,,Non-Probability Sample,
2761,YOUNGBC-23,Observational,,Drug,,Cohort,,Non-Probability Sample,
2762,D8530C00007,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
2763,NEODOC-2021668610-165,Observational,,Device,,Case-Only,,Non-Probability Sample,
2764,21-194,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
2765,Exactis-03,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2766,MedOPP100,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2767,SYSU003-2020,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2768,MS201922_0010,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2769,HR-BLTN-III-MBC-C,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2770,MC1892,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Phase 2
2771,ZWI-ZW25-202,Interventional,Experimental,"Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
2772,MC1734,Interventional,"Experimental, Experimental","Drug, Procedure",Parallel Assignment,,,,Phase 2
2773,UW20058,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Not Applicable
2774,DokuzEUBanuNihan,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
2775,202207200MIPB,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2776,00055029,Observational,,,,Cohort,,Non-Probability Sample,
2777,2019COIMBRA001,Interventional,"Other, Other","Procedure, Procedure",Parallel Assignment,,,,Phase 2
2778,TADANAC,Observational,,Procedure,,Other,,Non-Probability Sample,
2779,C4391002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
2780,CPH-2022-10-MHS-2,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2781,HCRN BRE17-141,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2782,YOUNGBC-11,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2783,C4891018,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2784,P-2020-246,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2785,YOUNGBC-18,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2786,SHR-1210-APTN-IIT-TNBC,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2787,FMUUH-BC-2201,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
2788,PF008,Observational,,Drug,,Case-Only,,Non-Probability Sample,
2789,20-153,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2790,OBU-BC-II-024,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2791,328717,Interventional,"Placebo Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2792,2066383,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2793,2021-5644,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2794,MC1935,Interventional,"Experimental, Experimental","Radiation, Other, Radiation",Parallel Assignment,,,,Phase 2
2795,19F.265,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
2796,201901698B0,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2797,2,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2798,2018-0477,Observational,,"Behavioral, Other",,Cohort,,Non-Probability Sample,
2799,MedOPP253,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2800,S-20180117,Interventional,"Experimental, Placebo Comparator","Procedure, Procedure, Procedure, Biological, Procedure",Parallel Assignment,,,,Phase 2
2801,BZ01/17,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2802,712,Observational,,"Other, Other, Other",,Cohort,10 Days,Probability Sample,
2803,RC48-C006,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Crossover Assignment,,,,"Phase 2, Phase 3"
2804,KGYY-001,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
2805,1808852902,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2806,UHaiArtBC,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2807,16381,Interventional,"Active Comparator, Active Comparator, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2808,NL67059.068.18,Interventional,"No Intervention, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
2809,WHUH-BC-001,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2810,ALRN-6924-1-05,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2811,202301160RINA,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2812,IRB00223131,Interventional,"Experimental, Active Comparator","Drug, Behavioral",Sequential Assignment,,,,Phase 2
2813,202111198,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2814,Shengjing-LCG003,Interventional,"Other, Other","Drug, Drug",Parallel Assignment,,,,Phase 4
2815,AHQU-2022002,Interventional,"Experimental, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2816,IC 2019-04,Interventional,"Placebo Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2817,STU00201961B,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2818,2-107-05-079,Interventional,"Experimental, No Intervention",Combination Product,Parallel Assignment,,,,Not Applicable
2819,2001272738,Observational,,Procedure,,Cohort,,Non-Probability Sample,
2820,2018/781,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2821,2012-090-1182,Interventional,"Experimental, Other","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
2822,IRB00054587,Interventional,"Experimental, Active Comparator","Other, Drug",Parallel Assignment,,,,Early Phase 1
2823,VSN-18-199,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
2824,2022YF035-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2825,22-544,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2826,2019-06-027,Observational,,,,Cohort,3 Years,Non-Probability Sample,
2827,MRI in response assesment,Observational,,Device,,Other,,Non-Probability Sample,
2828,021-013772,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2829,GCO 15-1783,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2830,1191/2018,Interventional,"Active Comparator, Placebo Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2831,NCI-2017-01119,Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Drug, Procedure, Drug, Biological, Other, Other, Biological",Parallel Assignment,,,,Phase 3
2832,UAB 1794,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2833,19-5080,Observational,,,,Cohort,,Probability Sample,
2834,METIS,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2835,IUSCC-0616 (1709077419),Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2836,H1901940,Observational,,"Procedure, Radiation",,Cohort,10 Years,Non-Probability Sample,
2837,APA-PG1,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2838,26778919.3.0000.0072,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2839,HSM/VGH-2017-01-011AC,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2840,H2207-207-1346,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2841,CRM-BRE-002,Interventional,"Experimental, Active Comparator, No Intervention","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2842,BC-TATOO-2020,Interventional,Other,Drug,Single Group Assignment,,,,Not Applicable
2843,ICO-N-2018-03,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2844,20190511,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
2845,RG1121659,Interventional,Experimental,"Procedure, Drug, Other",Single Group Assignment,,,,Phase 4
2846,17-AKD-186,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2847,Immuno2020-01,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2848,BGB-A317-ZW25-101,Interventional,"Experimental, Experimental","Biological, Drug, Biological, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2849,STUDY00011444,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2850,TQB3616-â¢-02,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2851,ATOX-2018,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2852,A5481150,Observational,,,,Cohort,,Non-Probability Sample,
2853,SHAW001,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2854,CETC 002,Observational,,"Radiation, Drug",,Cohort,,Non-Probability Sample,
2855,71306642-5/24,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2856,2021-0077,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2857,SYSA1501-CSP-005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2858,00031569,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
2859,1028595,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2860,QoLMa,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2861,CTPR-0015,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
2862,FZPL-Ib-105,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2863,TDM of TAM,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2864,STUDY20110029,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Phase 4
2865,ECP 250 - 15/16,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
2866,CTR20220630,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2867,2022-001,Observational,,Other,,Cohort,,Probability Sample,
2868,REC 22/WA/0164,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2869,2019DEPO-TRIGGER001,Interventional,"Experimental, Active Comparator","Drug, Procedure, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2870,OSU-16288,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2871,20.478.486,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2872,829400,Observational,,,,Other,,Non-Probability Sample,
2873,J16146,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
2874,2022-A02337-36,Interventional,"No Intervention, Experimental",Other,Crossover Assignment,,,,Not Applicable
2875,STUDY00001721,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2876,H19017,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
2877,1100903,Interventional,"Experimental, Experimental, Experimental","Device, Drug",Parallel Assignment,,,,Not Applicable
2878,LAAVA2,Interventional,"Active Comparator, Placebo Comparator","Device, Device",Crossover Assignment,,,,Not Applicable
2879,BXu-1839,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2880,NABP201801,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2881,RG1121642,Interventional,Experimental,"Biological, Biological, Drug",Single Group Assignment,,,,Phase 1
2882,C-plus-Pairs,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2883,URomLS_4,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2884,46.20 PAR ComEt CBM,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2885,012418QM,Interventional,"Other, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2886,R_ReLoCC,Observational,,,,Cohort,5 Years,Non-Probability Sample,
2887,2020466,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2888,2021-0031,Interventional,Experimental,"Procedure, Procedure, Other, Other",Single Group Assignment,,,,Not Applicable
2889,SYM011,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2890,16-0040-02,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2891,2022-008,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
2892,X4P-001-201,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
2893,2017-0479,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2894,SYSU-2022-01,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
2895,SAKK 21/18,Interventional,"Experimental, Active Comparator","Drug, Other, Other",Parallel Assignment,,,,Phase 3
2896,HelouEl,Observational,,Procedure,,Cohort,1 Day,Non-Probability Sample,
2897,2018/827,Observational,,,,Cohort,,Non-Probability Sample,
2898,RWS-PEGCSF,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2899,736-19,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
2900,198411013011,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2901,AP1907-50101,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
2902,YOUNGBC-13,Observational,,Drug,,Cohort,,Non-Probability Sample,
2903,2021-19,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2904,A5481170,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
2905,RLY-5836-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
2906,BRI-ROL-001,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
2907,RP-PG-1214-20016,Interventional,"Experimental, Active Comparator","Other, Other",Sequential Assignment,,,,Not Applicable
2908,220287,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2909,PI17/01687,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2910,BCP-25,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Phase 3
2911,20210312/2,Interventional,"Experimental, Active Comparator","Device, Drug",Parallel Assignment,,,,Not Applicable
2912,2018-1518,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
2913,EUBREAST-4,Observational,,,,Cohort,,Probability Sample,
2914,UCI 18-79 [HS# 2020-5660],Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
2915,ePOST,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
2916,URCC16070,Interventional,"Experimental, Experimental, Experimental","Drug, Other, Drug, Drug, Other, Drug, Other",Parallel Assignment,,,,Phase 3
2917,Shengjing-LJY06,Interventional,"Experimental, Experimental, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2918,Pro00105104,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
2919,202210064DIPD,Interventional,"Experimental, Placebo Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
2920,PERT.21.001,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,,,,Phase 3
2921,HCI140278,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2922,MedOPP068,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
2923,69HCL17_0480,Observational,,Other,,Other,,Non-Probability Sample,
2924,KCT003,Interventional,"Experimental, Active Comparator",Device,Crossover Assignment,,,,Not Applicable
2925,SILMET_0107665,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
2926,S-20180134,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
2927,241379,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2928,A5481158,Observational,,Drug,,Cohort,,Non-Probability Sample,
2929,2021/270,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2930,202109031MIPD,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2931,00048814,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
2932,JD-LK-2022-136-01,Interventional,Experimental,"Drug, Radiation, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
2933,2017/12-SBO-GHMG,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2934,WSG-NIS04 / PROOFS,Observational,,,,Cohort,10 Years,Non-Probability Sample,
2935,LYT-100-2020-01,Interventional,"Experimental, Placebo Comparator, Experimental, Placebo Comparator, Experimental, Placebo Comparator, Experimental, Placebo Comparator","Drug, Other, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2936,SCHBCC-N023,Observational,,"Procedure, Procedure",,Cohort,24 Months,Non-Probability Sample,
2937,2017-0328,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
2938,2179 CE,Interventional,"Experimental, Experimental, Other","Other, Radiation",Parallel Assignment,,,,Not Applicable
2939,Pro00117242,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2940,MC1937,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
2941,2018-A03054-51,Observational,,Other,,Cohort,,Non-Probability Sample,
2942,US-003,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
2943,7119-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
2944,21-169,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Device, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
2945,2018-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2946,12345,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
2947,GLSI-21-01,Interventional,"Placebo Comparator, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 3
2948,A221702,Interventional,"Active Comparator, Experimental","Drug, Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 3
2949,22-006606,Interventional,Experimental,Device,Single Group Assignment,,,,Early Phase 1
2950,CAPRICE,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2951,CT/2019/CANFLAX,Interventional,"Experimental, Experimental","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
2952,20-754,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
2953,URomLS-2019,Interventional,"Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
2954,mavis20023,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
2955,2021-01-075,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
2956,HiFi-APBI,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
2957,Self-compassion FCR,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
2958,20-010751,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
2959,IJB-BC-TDM1BM-2016,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2960,1B-15-6,Interventional,"Experimental, Experimental, Active Comparator","Other, Behavioral, Behavioral, Other, Device, Other, Other",Parallel Assignment,,,,Not Applicable
2961,P018,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
2962,CBYL719H12301,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
2963,QUILT 2021-1,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2964,2020-10/850,Observational,,Diagnostic Test,,Other,8 Months,Probability Sample,
2965,IEO 0758/,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
2966,MC18C1,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,,,,Phase 1
2967,GN19ON381,Observational,,,,Case-Control,,Probability Sample,
2968,2021/03,Observational,,Other,,Cohort,,Non-Probability Sample,
2969,WSG-AM11,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
2970,2018-0528,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
2971,1024489,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
2972,OBI-822-011,Interventional,"Experimental, Active Comparator","Biological, Device, Other",Parallel Assignment,,,,Phase 3
2973,CCR 5006,Observational,,,,Case-Control,,Probability Sample,
2974,ICO-N-2018-12,Observational,,Other,,Cohort,,Non-Probability Sample,
2975,20180349,Observational,,,,Cohort,,Non-Probability Sample,
2976,MSCW2019,Interventional,"Active Comparator, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2977,H-18016600,Observational,,,,Cohort,,Non-Probability Sample,
2978,2020-12-044-012,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
2979,IJB-PRINTEMPS-2022,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
<<<<<<< HEAD
2980,2020-12-044-012,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
2981,c5ZTCN100,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
2982,Ref. 070/2018,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2983,HNCH-BC009,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2984,ICO_UCC_202001,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2985,CRO-2019-26,Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2986,19-578,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
2987,A211601,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
2988,LCCC1921,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2989,182113,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2990,AP2205-5015,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
2991,YM111146EF,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
2992,2018-172,Observational,,Dietary Supplement,,Case-Only,,Non-Probability Sample,
2993,EC /2018/0996,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
2994,19-008929,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Not Applicable
2995,22-4004,Observational,,"Other, Other",,Cohort,1 Year,Non-Probability Sample,
2996,CD07_TNBC,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
2997,2021-04031,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
2998,STU-2019-0769,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
2999,F16J16000620002,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3000,PSCI 21-045,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
3001,CD07_TNBC,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3002,F16J16000620002,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3003,NUR20-0124CRYO,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3004,32551/09/2018,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3005,AAAS3402,Observational,,Device,,Cohort,,Probability Sample,
3006,2017-1535,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3007,HUM00208684,Observational,,Drug,,Cohort,,Non-Probability Sample,
3008,12341234,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
=======
2980,NIS07075,Observational,,Drug,,Cohort,,Non-Probability Sample,
2981,HNCH-BC009,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
2982,c5ZTCN100,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
2983,CRO-2019-26,Interventional,"Experimental, Active Comparator","Drug, Procedure, Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2984,YM111146EF,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
2985,AP2205-5015,Interventional,"Experimental, Experimental, Active Comparator","Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
2986,182113,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2987,LCCC1921,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
2988,EC /2018/0996,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
2989,ICO_UCC_202001,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
2990,19-008929,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Not Applicable
2991,2018-172,Observational,,Dietary Supplement,,Case-Only,,Non-Probability Sample,
2992,19-578,Interventional,"Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
2993,Ref. 070/2018,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
2994,2021-04031,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
2995,A211601,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
2996,PSCI 21-045,Interventional,"Experimental, Other","Behavioral, Other",Parallel Assignment,,,,Not Applicable
2997,22-4004,Observational,,"Other, Other",,Cohort,1 Year,Non-Probability Sample,
2998,AC-TMSQ-2018,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
2999,STU-2019-0769,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3000,R-2021-3203-005,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
3001,R-2021-3203-005,Interventional,"Experimental, Active Comparator",Radiation,Parallel Assignment,,,,Not Applicable
3002,32551/09/2018,Interventional,"Placebo Comparator, Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3003,AC-TMSQ-2018,Interventional,"Experimental, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3004,HUM00208684,Observational,,Drug,,Cohort,,Non-Probability Sample,
3005,CADEX-0001,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3006,AAAS3402,Observational,,Device,,Cohort,,Probability Sample,
3007,2017-1535,Interventional,"Experimental, Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3008,NUR20-0124CRYO,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
>>>>>>> main
3009,Mepitel RCT,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Phase 3
3010,ShandongCHI-07,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3011,D8532C00005,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3012,CADEX-0001,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3013,ELIPSE (SOLTI-1905),Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3014,VI-ISRP-026,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3015,5652-18-SMC,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3016,Ä°boelif22,Observational,,,,Case-Control,,Non-Probability Sample,
3017,FEMAL,Interventional,"Experimental, Placebo Comparator",Other,Single Group Assignment,,,,Not Applicable
3018,20-30638,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
3019,R.20.11.1099,Interventional,Experimental,"Diagnostic Test, Procedure, Diagnostic Test, Procedure",Single Group Assignment,,,,Not Applicable
3020,IRB00074154,Interventional,"Experimental, Active Comparator","Drug, Dietary Supplement, Other",Parallel Assignment,,,,Phase 2
3021,SMC 2021-05-045,Observational,,Radiation,,Cohort,2 Years,Non-Probability Sample,
3022,SamsunU,Observational,,Other,,Cohort,1 Year,Probability Sample,
3023,ShandongCHI-18,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
3024,JWCI OBCS WITH IORT,Interventional,Other,"Radiation, Procedure",Single Group Assignment,,,,Not Applicable
3025,AAAT8915,Interventional,"Experimental, Other","Other, Device",Parallel Assignment,,,,Not Applicable
3026,20-513,Interventional,Experimental,Radiation,Single Group Assignment,,,,Early Phase 1
3027,IRB00313835,Interventional,"Active Comparator, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3028,HE-202012,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
3029,NCC201804007,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
3030,110.01-2016-GES-0001,Observational,,"Device, Device",,Cohort,30 Months,Non-Probability Sample,
3031,PREVENT,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3032,QL-KPTB-150,Interventional,"Active Comparator, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
3033,REaCT-Hot Flashes Pilot,Interventional,Other,Other,Single Group Assignment,,,,Phase 4
3034,IRB00081356,Observational,,Drug,,Cohort,,Probability Sample,
3035,VIL-HEQ-17-014,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
3036,COMPLEMENT,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3037,DHLI-BC/OC-BE-001,Interventional,"Active Comparator, Experimental",Drug,Crossover Assignment,,,,Phase 1
3038,GS18/107321,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3039,2019-003825-56,Interventional,Other,"Drug, Drug",Single Group Assignment,,,,Phase 4
3040,80252,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3041,Exo-LCR,Interventional,Experimental,"Procedure, Procedure, Biological",Single Group Assignment,,,,Not Applicable
3042,MCC-19117,Interventional,"Active Comparator, Active Comparator","Biological, Biological",Parallel Assignment,,,,Phase 2
3043,EA1181,Interventional,"Experimental, Experimental","Drug, Procedure, Procedure, Drug, Drug, Biological, Radiation, Biological, Biological",Parallel Assignment,,,,Phase 2
3044,PAL-ZJCC-02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3045,GCO 18-1832,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3046,DS_v01,Observational,,Drug,,Cohort,,Probability Sample,
3047,T06/024/21,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3048,ES,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3049,Study00145121,Interventional,"Experimental, Other",Drug,Parallel Assignment,,,,Early Phase 1
3050,STU 042018-083,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3051,AcuBreast 2020,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3052,4-2020-1093,Observational,,Procedure,,Cohort,,Probability Sample,
3053,A012103,Interventional,"Active Comparator, Experimental","Biological, Other, Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 3
3054,HREBA.CC-22-0128,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3055,A191901,Interventional,"Experimental, Experimental, Experimental, Active Comparator","Other, Other, Behavioral, Other, Other, Other",Parallel Assignment,,,,Phase 3
3056,VICCBRE2257,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Procedure, Procedure, Biological",Parallel Assignment,,,,Phase 2
3057,HCI69515,Interventional,Experimental,"Drug, Drug, Diagnostic Test",Single Group Assignment,,,,Phase 2
3058,TX05-03E,Interventional,"Experimental, Active Comparator, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 3
3059,2019/639,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3060,GBG 107,Observational,,,,Cohort,10 Years,Probability Sample,
3061,CE-MRI&CESM in breast lesions,Observational,,Device,,Case-Only,,Non-Probability Sample,
3062,PBCST,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3063,NEODOC- 2021668610-221,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3064,9785-CL-0018,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3065,2021-03165,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
3066,IRB202202679,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3067,Arise-FJ-B102,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3068,453190,Interventional,"Experimental, Other","Drug, Behavioral",Parallel Assignment,,,,Phase 4
3069,RenJiH-2018-038,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3070,202110124,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3071,18-003544,Interventional,Other,"Diagnostic Test, Drug",Single Group Assignment,,,,Early Phase 1
3072,MCC-21262,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3073,CKRC2021-CCV,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3074,BEXMET,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3075,PICC One Day 01 (ET15-123),Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
3076,IRB00049061,Interventional,"Experimental, Active Comparator","Procedure, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3077,CP-13-001,Observational,,Device,,Case-Only,,Probability Sample,
3078,SOLTI-1710,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Early Phase 1
3079,IJB-SYNERGY-012017,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3080,IRB00046759,Interventional,"Experimental, Active Comparator","Other, Other, Device",Parallel Assignment,,,,Not Applicable
3081,18947,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3082,2021-A03027-34,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3083,IRB-44367,Interventional,Experimental,"Device, Other",Single Group Assignment,,,,Not Applicable
3084,NEPA-17-05,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3085,I3Y-MC-B009,Observational,,Other,,Other,104 Weeks,Non-Probability Sample,
3086,SHR6390-III-303,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3087,17/222,Observational,,"Other, Other",,Other,,Non-Probability Sample,
3088,2022-761,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
3089,JCL2020,Interventional,Other,"Drug, Radiation",Single Group Assignment,,,,"Phase 1, Phase 2"
3090,19-302,Interventional,Experimental,"Other, Device, Diagnostic Test",Single Group Assignment,,,,Not Applicable
3091,BFH-BC,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3092,RT 1901,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
3093,MC1732,Interventional,Experimental,Radiation,Single Group Assignment,,,,Phase 2
3094,ET19-084 - CICA-RT,Interventional,"Experimental, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 3
3095,A5481160,Observational,,Drug,,Cohort,,Non-Probability Sample,
3096,21623,Interventional,"Experimental, Experimental","Other, Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3097,CASE10116,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3098,2021/271,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3099,CASE5Y21,Interventional,"Active Comparator, Active Comparator","Device, Other, Other",Parallel Assignment,,,,Not Applicable
3100,University in Zielona Gora,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3101,T148/2020,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3102,ICO-2019-16,Observational,,,,Cohort,,Non-Probability Sample,
3103,ISI dV SP - NSM-01,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3104,ATOPE18,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3105,ChungnamNU.J1,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3106,EC/2017/1261,Interventional,"Active Comparator, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
3107,M21REO,Observational,,"Procedure, Procedure, Procedure",,Cohort,,Non-Probability Sample,
3108,EORTC-2129-BCG,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3109,22-001501,Observational,,"Procedure, Other",,Cohort,,Non-Probability Sample,
3110,NCI-2021-11793,Interventional,Experimental,"Drug, Drug, Procedure, Procedure, Procedure, Procedure",Single Group Assignment,,,,Phase 1
3111,ET19-283,Observational,,,,Cohort,,Non-Probability Sample,
3112,2019-4433,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3113,THERMOEDEME,Interventional,"Active Comparator, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3114,C3621001,Interventional,"Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
3115,LSB-12345,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3116,108511,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3117,202101421A0,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3118,960-CSP-USA_DenseBreasts_USS1,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3119,PROICM 2018-09 BSA,Observational,,Radiation,,Other,,Non-Probability Sample,
3120,211521,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3121,BC-P30(FZQ),Interventional,"Experimental, Other","Device, Drug",Parallel Assignment,,,,Not Applicable
3122,2017-0672,Interventional,"Experimental, Experimental","Biological, Biological, Biological, Drug, Drug, Biological, Biological, Other, Other",Parallel Assignment,,,,Phase 2
3123,2019-4432,Observational,,,,Cohort,,Non-Probability Sample,
3124,22-508,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
3125,NCC2021-0335,Observational,,,,Cohort,,Probability Sample,
3126,LET,Observational,,Drug,,Cohort,2 Years,Non-Probability Sample,
3127,Pectoral nerve block in breast,Interventional,"Active Comparator, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3128,TNBC,Observational,,,,Case-Control,,Non-Probability Sample,
3129,NU 18B05,Interventional,Experimental,"Drug, Procedure, Other",Single Group Assignment,,,,Phase 2
3130,20476,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3131,ICRCTSU/2019/10068,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
3132,EU001,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
3133,2018-63,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
3134,2020-06245,Observational,,"Procedure, Procedure, Procedure",,Cohort,,Non-Probability Sample,
3135,18-168,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3136,2021-A01407-34,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Not Applicable
3137,soh-Med-21-02-05,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3138,CIMPAX BREAST,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3139,18D.003,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Other, Other, Behavioral, Other",Parallel Assignment,,,,Phase 2
3140,YOUNGBC-20,Observational,,,,Cohort,,Non-Probability Sample,
3141,20-002505,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3142,XianganHXiamenU,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3143,YOUNGBC-21,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
3144,201900572,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3145,MEDOPP459,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3146,MedOPP485,Interventional,"No Intervention, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
3147,09.2019.866,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3148,A5481128,Observational,,,,Cohort,,Non-Probability Sample,
3149,YOUNGBC-3,Observational,,,,Cohort,,Non-Probability Sample,
3150,020-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3151,YOUNGBC-14,Observational,,,,Cohort,,Non-Probability Sample,
3152,LQiao,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
3153,2021157,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3154,2020-KY-051,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
3155,YOUNGBC-25,Observational,,,,Cohort,,Non-Probability Sample,
3156,BC-09374,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3157,Shengjing-LCG011,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3158,2021-02902,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3159,GCO 19-0477,Interventional,Experimental,"Drug, Drug, Radiation, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3160,202100318,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
3161,19-458,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3162,S1904,Interventional,"Active Comparator, Experimental","Behavioral, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3163,Seno_Ex_MAC 003,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3164,E2018210,Observational,,"Procedure, Procedure, Radiation",,Cohort,2 Years,Non-Probability Sample,
3165,CL(3204),Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3166,211-2018,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
3167,AAAO1760,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3168,J17120,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3169,1712078374,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
3170,D17168,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3171,ShandongCHI-14,Observational,,Drug,,Cohort,,Non-Probability Sample,
3172,2020-KY-007,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3173,DELFINO trial,Interventional,"No Intervention, No Intervention, Active Comparator",Drug,Parallel Assignment,,,,Phase 3
3174,PRISMA,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3175,3125001,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
3176,ShandongCHI-16,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3177,ERAS-ABR,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3178,ProFertil,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3179,MEDOPP240,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3180,TQB3616-I-0001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3181,BreastIls-1605,Observational,,,,Cohort,,Non-Probability Sample,
3182,7964,Observational,,,,Case-Only,,Non-Probability Sample,
3183,18-00309,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3184,2005P002282,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
3185,2023-9333,Interventional,"Other, Other, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3186,STUDY00020501,Interventional,"Experimental, Active Comparator","Other, Other, Behavioral",Parallel Assignment,,,,Not Applicable
3187,[2016]124,Interventional,"Placebo Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3188,IIT2018-04-MCARTHUR-NEOHP,Interventional,"Active Comparator, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3189,MCP Study,Interventional,"Other, Other, Other","Diagnostic Test, Diagnostic Test, Diagnostic Test",Factorial Assignment,,,,Not Applicable
3190,STUDY00000194,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,,,,Phase 1
3191,mastectomy coverage formula 20,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
3192,KC19EEDT0031,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3193,SIB2232,Interventional,"Other, Other","Other, Other",Single Group Assignment,,,,Not Applicable
3194,22-008,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3195,1807188-16,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3196,OSU-20429,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Other, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3197,2020/295,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3198,SunYatsenU2H-LQ4,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3199,Phaon1,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Procedure, Procedure, Procedure",Parallel Assignment,,,,Phase 2
3200,SUGBG-2021002,Interventional,"Other, Other","Drug, Combination Product",Parallel Assignment,,,,Not Applicable
3201,S2018-2450-0001,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3202,IIT-0016,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device, Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
3203,N.sativavsRID BreastCancerpt.,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3204,00130272,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3205,URCC-18007,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other, Other",Parallel Assignment,,,,Phase 3
3206,jcl2020-2 breast cancer,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3207,OP-1250-003,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3208,38285020.8.0000.0072,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3209,17-001546,Observational,,Other,,Cohort,,Probability Sample,
3210,TMP-0315-2018,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3211,21-3117.cc,Interventional,Experimental,"Drug, Drug, Radiation, Drug",Single Group Assignment,,,,Phase 2
3212,IRB00103558,Interventional,"Experimental, Active Comparator","Other, Behavioral",Parallel Assignment,,,,Not Applicable
3213,ICOnnectat-BC,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3214,20-028,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3215,C3441038,Observational,,Drug,,Case-Only,,Non-Probability Sample,
3216,2,Interventional,"Experimental, Other","Device, Other",Parallel Assignment,,,,Not Applicable
3217,STU-2022-0091,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3218,ICO-2021-36,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3219,2021-0048-B,Interventional,"Placebo Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3220,Breastblock,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3221,OMS-I141 (KEYNOTE-890),Interventional,"Experimental, Experimental","Biological, Biological, Device, Drug",Parallel Assignment,,,,Phase 2
3222,L424,Observational,,Other,,Other,,Non-Probability Sample,
3223,BHP0111,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3224,18-001926,Interventional,"Experimental, Experimental","Dietary Supplement, Behavioral, Other",Parallel Assignment,,,,Not Applicable
3225,20CX6399,Observational,,Device,,Other,,Non-Probability Sample,
3226,REDHEMOPACH,Interventional,"Other, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3227,PMC_TTAC-0001_06 / KEYNOTE-C14,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3228,INSPIRE-001,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3229,STUDY00149312,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3230,IIT2021-10-Giuliano-OmitRT,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3231,VICCBRE2256,Interventional,"Active Comparator, Experimental","Drug, Other, Other",Parallel Assignment,,,,Phase 2
3232,Patient reported outcome,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3233,EAZ171,Interventional,"Experimental, Experimental","Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 2
3234,2017/62,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3235,17-001864,Interventional,Experimental,"Device, Procedure",Single Group Assignment,,,,Early Phase 1
3236,SCHBCC-N031,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3237,20429001,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3238,2000020335,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3239,KN026-CHN-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3240,Pro00103527,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3241,21-374,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3242,CBCRP 23AB-1400,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3243,EJERDIETLINF,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3244,MC02/04/19,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3245,22-5074,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3246,STUDY00018789,Interventional,"Experimental, Active Comparator","Drug, Other, Other, Drug, Drug",Parallel Assignment,,,,Not Applicable
3247,SCHBCC-SOAPET,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3248,3212,Observational,,Other,,Cohort,,Non-Probability Sample,
3249,ATADEK-2022/08/20,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3250,2018-06,Observational,,Other,,Cohort,,Non-Probability Sample,
3251,OBU-BC-â¡-077,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3252,RG1005296,Interventional,Experimental,"Biological, Drug, Biological, Biological",Single Group Assignment,,,,Phase 2
3253,B7391012,Observational,,Drug,,Case-Only,,Probability Sample,
3254,ONCO-FIRE,Observational,,Other,,Cohort,,Non-Probability Sample,
3255,2021-01534,Observational,,Diagnostic Test,,Cohort,2 Years,Non-Probability Sample,
3256,RD19/123502,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Crossover Assignment,,,,Not Applicable
3257,091-19,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3258,PR139/21,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3259,2021.341,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3260,17-361,Interventional,"Other, Experimental, Other","Behavioral, Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
3261,PPMP_INO,Observational,,,,Cohort,,Probability Sample,
3262,Overcome project,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3263,DS8201-A-A103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3264,Xiangan Hospital of XMU,Observational,,Drug,,Other,,Non-Probability Sample,
3265,OBU-BJ-BB-BC-II-007,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3266,NU 21B01,Interventional,Experimental,"Procedure, Device",Single Group Assignment,,,,Phase 2
3267,COOL-CLIN-2022-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3268,110.01-2018-GES-0001,Observational,,Device,,Cohort,,Non-Probability Sample,
3269,NURS-IIR-IUSCCC-0748,Observational,,Behavioral,,Case-Only,,Non-Probability Sample,
3270,2020-1243,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3271,OSU-19085,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,,,,Phase 1
3272,SYSUCC-012,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3273,UUBreast01,Interventional,"Experimental, Active Comparator","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Phase 3
3274,IMPACTT,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3275,1/2020,Observational,,"Genetic, Other",,Cohort,5 Years,Non-Probability Sample,
3276,CBBCT2018CIH,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3277,30-225 ex 17/18,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3278,ITSligo SG,Interventional,"Experimental, Active Comparator","Other, Procedure, Device",Parallel Assignment,,,,Not Applicable
3279,STUDY00003067,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3280,PROICM 2019-02 PRA,Interventional,"Experimental, Other","Other, Drug",Parallel Assignment,,,,Phase 2
3281,850366,Interventional,"Experimental, Experimental, Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3282,060021-HMO-CTIL,Observational,,,,Cohort,,Non-Probability Sample,
3283,2018/13,Interventional,"Experimental, Other, Experimental, Other","Drug, Procedure",Parallel Assignment,,,,"Phase 1, Phase 2"
3284,A095053,Interventional,"No Intervention, Active Comparator, Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3285,MC210301,Observational,,"Procedure, Other",,Cohort,,Non-Probability Sample,
3286,202302077,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3287,Yunwei Wei 2019-09-12,Observational,,Drug,,Case-Control,,Probability Sample,
3288,2.510.081,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3289,K170702J,Observational,,Other,,Cohort,,Probability Sample,
3290,GX-I7-CA-006,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3291,R17137,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3292,2021-395,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3293,IC 2018-09,Interventional,"Other, Other, Other, Other, Other, Other","Behavioral, Behavioral, Other, Other",Sequential Assignment,,,,Not Applicable
3294,NeoCAT,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3295,AAAR9515,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Device, Device, Device",Sequential Assignment,,,,Not Applicable
3296,2019-01395CE3508,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3297,RG1007463,Interventional,Experimental,"Drug, Drug, Drug, Biological, Biological",Single Group Assignment,,,,"Phase 1, Phase 2"
3298,PA191001001,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3299,18070604,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
3300,1613494-3,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
3301,2021198-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
3302,PROTOCOL-M7-037,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3303,201801105,Interventional,Experimental,"Procedure, Drug, Procedure, Drug, Drug",Single Group Assignment,,,,Early Phase 1
3304,202004120MINB,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3305,CHIR-05-IMTAD,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
3306,EAQ201,Observational,,Other,,Cohort,,Non-Probability Sample,
3307,STUDY00001356,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3308,PANTHERA,Observational,,,,Case-Only,3 Years,Non-Probability Sample,
3309,IC 2020-04,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
3310,Remimazolam_recovery,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
3311,BIOC-046,Observational,,Device,,Cohort,,Non-Probability Sample,
3312,RECHMPL21_0525,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3313,2022037,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3314,Q122-2001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3315,S64410,Interventional,Other,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
3316,MC1689,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug, Drug, Other, Biological, Biological, Biological, Procedure, Biological, Drug, Other, Biological",Single Group Assignment,,,,Phase 1
3317,2017C0165,Observational,,,,Case-Only,,Non-Probability Sample,
3318,2017-0301,Interventional,"Experimental, Active Comparator","Radiation, Other",Parallel Assignment,,,,Phase 2
3319,S59396,Interventional,"Experimental, Active Comparator, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3320,1105/18,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3321,RFID,Observational,,"Device, Device",,Case-Control,,Probability Sample,
3322,SP11631,Interventional,"Experimental, Active Comparator",Biological,Parallel Assignment,,,,Phase 3
3323,EKNZ 2015-026,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3324,5505,Observational,,Diagnostic Test,,Other,,Non-Probability Sample,
3325,H-37314,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
3326,852666,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
3327,Three birds with one stone,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3328,XZP-3287-1001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3329,I 56617,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3330,TAK-676-1003,Interventional,Experimental,"Drug, Drug, Radiation",Sequential Assignment,,,,Phase 1
3331,STUDY00022229,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3332,CR108557,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
3333,UPCC 25920,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,"Phase 1, Phase 2"
3334,MEDOPP243,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3335,4901,Interventional,,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3336,22-269,Interventional,"Experimental, Active Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3337,2016-051-000001- 1731,Observational,,,,Case-Control,,Non-Probability Sample,
3338,Yvonne Wengstrom,Interventional,"Experimental, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3339,4-2019-0795,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3340,20180569-01H,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3341,None yet,Observational,,Device,,Cohort,,Non-Probability Sample,
3342,REaCT-Hold BMA,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3343,2020-0761,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
3344,202005217,Interventional,"Experimental, Active Comparator, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3345,Abbreviated Breast MRI,Observational,,Radiation,,Case-Crossover,,Probability Sample,
3346,SBI-CIP 20-002,Interventional,"Placebo Comparator, Experimental","Drug, Device, Drug",Sequential Assignment,,,,Phase 3
3347,DS8201-A-U106,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3348,A2018-002,Interventional,Other,Drug,Single Group Assignment,,,,Phase 4
3349,STUDY00016221,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
3350,2669,Observational,,,,Cohort,,Probability Sample,
3351,PR275/20,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3352,X-PACT 101,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
3353,SHF-WBI,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3354,MCC-20257,Observational,,"Behavioral, Behavioral",,Case-Only,,Non-Probability Sample,
3355,19-07020531,Interventional,Other,Radiation,Single Group Assignment,,,,Phase 2
3356,DS8201-A-U105,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3357,NAUTILUS study,Interventional,"Experimental, Other","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3358,BrUOG 387,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3359,Instituto Nacional do CÃ¢ncer,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3360,HP-LY-CL-2063,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3361,2008222-12,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Phase 3
3362,2019-0837-002,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3363,9785,Observational,,"Device, Device",,Cohort,,Non-Probability Sample,
3364,BCP24,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3365,IRB00083573,Interventional,Experimental,"Drug, Diagnostic Test, Diagnostic Test, Other, Behavioral",Single Group Assignment,,,,Early Phase 1
3366,CCR5199,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
3367,HVST-HEMO-20,Interventional,"Experimental, Other","Device, Other",Parallel Assignment,,,,Phase 4
3368,1708018471,Observational,,,,Other,,Non-Probability Sample,
3369,APBI Registry,Observational,,Radiation,,Cohort,,Non-Probability Sample,
3370,STUDY00019979,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3371,109489,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3372,IIT2019-14-SHIRAZIP-SWEAT,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Early Phase 1
3373,SGNTUC-019,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
3374,EORTC-1984-BCG,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3375,H-43277,Interventional,"Experimental, Experimental","Device, Device, Other",Crossover Assignment,,,,Not Applicable
3376,Oncolact2020,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3377,OE20/2020,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3378,GNC-035-101ï¼V1.1ï¼,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3379,2022-0880,Interventional,"Experimental, Experimental","Radiation, Other",Single Group Assignment,,,,Phase 3
3380,ABCB1 in Paclitaxel Neuropathy,Observational,,Genetic,,Cohort,,Non-Probability Sample,
3381,ACT16432,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3382,AAAT8817,Interventional,"Experimental, Other","Behavioral, Other",Single Group Assignment,,,,Not Applicable
3383,19-07020533,Interventional,"Experimental, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
3384,PSIBBR,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3385,THRIVORSBH-01,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3386,20190516,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
3387,RECHMPL20_0614,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3388,RD19/121361,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Not Applicable
3389,BRAVEHeartV1,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3390,R/19.08.578,Interventional,Experimental,Procedure,Single Group Assignment,,,,Phase 1
3391,DHP107_Bioimaging,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3392,18-5029,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3393,201902048MINC,Interventional,"Active Comparator, Experimental","Drug, Radiation",Parallel Assignment,,,,Phase 3
3394,050811,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3395,0594,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
3396,APHP201173,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3397,2019-001,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3398,19-315,Observational,,,,Cohort,,Non-Probability Sample,
3399,2022P000354,Interventional,"Experimental, Experimental, No Intervention, No Intervention","Other, Other",Crossover Assignment,,,,Not Applicable
3400,UMCC 2019.125,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Phase 2
3401,SB-2101,Observational,,,,Cohort,,Probability Sample,
3402,00001137,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3403,2017/2805,Observational,,"Other, Other, Other",,Other,,Non-Probability Sample,
3404,C3661001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 2
3405,4-2020-0430,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3406,N16PRB,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
3407,CASE10119,Interventional,Experimental,"Other, Behavioral",Single Group Assignment,,,,Not Applicable
3408,21-012300,Interventional,Experimental,"Other, Behavioral",Single Group Assignment,,,,Not Applicable
3409,Breast MRI,Observational,,Device,,Case-Only,,Non-Probability Sample,
3410,KY-Q-2021-182,Interventional,"Experimental, No Intervention",Behavioral,Single Group Assignment,,,,Not Applicable
3411,DOLPHIN,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
3412,METC20-099,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3413,D8534C00001,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3414,NUV-422-03,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3415,CLEE011ARU01,Observational,,"Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
3416,FIS-APBI-2019-02,Observational,,,,Case-Only,,Non-Probability Sample,
3417,17/0774,Observational,,,,Cohort,,Non-Probability Sample,
3418,OSU-18094,Interventional,Experimental,"Procedure, Procedure, Other",Single Group Assignment,,,,Not Applicable
3419,21-3100.cc,Observational,,,,Cohort,,Probability Sample,
3420,10840098-604.01.01-E.184,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3421,Breast Cancer Chemotherapy,Interventional,Experimental,"Procedure, Procedure, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Drug",Single Group Assignment,,,,Not Applicable
3422,STUDY02001039,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3423,CSCS,Interventional,"Experimental, Active Comparator","Other, Other",Sequential Assignment,,,,Not Applicable
3424,2020/6422,Interventional,"Experimental, Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Phase 4
3425,2022-0150,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,,,,Phase 2
3426,2007-0003,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3427,2-028-22,Observational,,Other,,Case-Only,,Non-Probability Sample,
3428,GEN-602-CT-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3429,CASE2119,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3430,STUDY00000228,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3431,PRESIONA20,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3432,IPAC,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3433,CTMS# 18-0135,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
3434,3734,Observational,,,,Cohort,,Non-Probability Sample,
3435,6077,Observational,,,,Other,,Non-Probability Sample,
3436,2022LS100,Observational,,,,Cohort,,Non-Probability Sample,
3437,STX-478-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3438,18-486,Interventional,"Active Comparator, Experimental","Radiation, Drug",Parallel Assignment,,,,Phase 2
3439,20-124,Interventional,"Experimental, Placebo Comparator, Experimental","Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 2
3440,2019-02661,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
3441,110181,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3442,IRB-55153,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3443,GS3,Observational,,Other,,Cohort,,Non-Probability Sample,
3444,20953,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3445,QT MG PRE Phase 1,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
3446,MC1932,Interventional,"Experimental, Experimental, Active Comparator",Drug,Parallel Assignment,,,,Phase 2
3447,2018-A011828-47,Observational,,,,Cohort,,Non-Probability Sample,
3448,EXPLLN21-01,Interventional,Experimental,Diagnostic Test,Parallel Assignment,,,,Not Applicable
3449,22-457,Interventional,Experimental,"Drug, Radiation",Single Group Assignment,,,,Early Phase 1
3450,GW10029,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
3451,GCC1950,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
3452,2020-0501,Observational,,"Procedure, Other, Procedure, Other",,Cohort,,Non-Probability Sample,
3453,Erector block after mastectomy,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3454,2021-0025,Interventional,Experimental,"Procedure, Procedure, Drug, Other",Single Group Assignment,,,,Not Applicable
3455,HCI148669,Interventional,Experimental,Device,Single Group Assignment,,,,Early Phase 1
3456,CBYL719CKR01,Observational,,Other,,Cohort,,Non-Probability Sample,
3457,21/59848,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3458,221-005,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
3459,228012,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 4
3460,RECHMPL20_0005-UF7919,Observational,,,,Cohort,,Non-Probability Sample,
3461,INT31/19,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3462,P.T.REC/012/002615,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3463,Telerehab CH Usability,Observational,,Other,,Other,,Non-Probability Sample,
3464,ICO-N-2018-15,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3465,B00394,Interventional,Other,Radiation,Single Group Assignment,,,,Not Applicable
3466,CKMW-1801,Interventional,"Experimental, No Intervention",Behavioral,Crossover Assignment,,,,Not Applicable
3467,EGC101,Interventional,"Experimental, Active Comparator, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3468,69HCL20_1018,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3469,300.08-2018-Samsungmedison-S,Interventional,"Active Comparator, Experimental, Experimental","Device, Device, Device, Procedure",Crossover Assignment,,,,Not Applicable
3470,ICO-A-2020-10,Interventional,"Other, Other","Device, Device",Crossover Assignment,,,,Not Applicable
3471,INT157/17,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3472,13155,Interventional,"Experimental, Active Comparator","Procedure, Device, Other",Parallel Assignment,,,,Not Applicable
3473,IRB20-0528,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3474,BO40933,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3475,2018-0345-1105,Observational,,,,Other,,Non-Probability Sample,
3476,NL67696.068.18,Interventional,"Active Comparator, Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3477,UW17032,Interventional,Experimental,Device,Single Group Assignment,,,,Phase 2
3478,MedOPP321,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3479,RECHMPL21_0379,Observational,,,,Cohort,,Non-Probability Sample,
3480,2017-8737,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3481,AP2204-50104,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Procedure, Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3482,IRB-53132,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3483,5160378,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
3484,R.21.11.1523,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Phase 2
3485,CYP003,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3486,315581,Interventional,"Active Comparator, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
3487,2022000438,Observational,,Device,,Case-Only,,Non-Probability Sample,
3488,CTB in Breast surgery,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3489,RS1307/20,Observational,,Other,,Cohort,24 Months,Non-Probability Sample,
3490,H-18041465,Observational,,,,Cohort,,Non-Probability Sample,
3491,RIS42756,Interventional,"Experimental, Experimental, Experimental, Experimental, No Intervention","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3492,YH32367-101,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
3493,18-294,Observational,,"Behavioral, Behavioral",,Case-Control,,Non-Probability Sample,
3494,2021.127,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3495,2020-0974,Observational,,Other,,Case-Control,,Non-Probability Sample,
3496,HP-00088085,Observational,,Radiation,,Cohort,1 Year,Probability Sample,
3497,ShantouCH,Interventional,Experimental,Drug,Single Group Assignment,,,,Not Applicable
3498,HYACOM,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Sequential Assignment,,,,Not Applicable
3499,NL82061.096.22,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3500,36264PR116/2/23,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Not Applicable
3501,MCC-20335,Observational,,"Device, Device",,Case-Only,,Non-Probability Sample,
3502,00101494,Interventional,"Other, Other, Other",Behavioral,Sequential Assignment,,,,Not Applicable
3503,ETK00-2020-0103,Interventional,"Experimental, Experimental, Other","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3504,DIVA-001,Interventional,"Experimental, Placebo Comparator",Device,Parallel Assignment,,,,Not Applicable
3505,PRO00030436,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Other, Other",Single Group Assignment,,,,Not Applicable
3506,JS2021-6-1,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
3507,20180335,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3508,DRBX201901/PRO,Interventional,"Experimental, Active Comparator",Drug,Crossover Assignment,,,,Not Applicable
3509,21-04,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3510,A221505,Interventional,"Active Comparator, Experimental","Radiation, Other, Other, Other, Radiation",Parallel Assignment,,,,Phase 3
3511,UC-0107/1803,Interventional,"Active Comparator, Experimental","Radiation, Other",Parallel Assignment,,,,Not Applicable
3512,SHS-An-1-2022,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
3513,R01CA249419,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3514,STU 072016-058,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Early Phase 1
3515,DS1103-074,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3516,NEUROTOX,Observational,,Drug,,Case-Only,,Probability Sample,
3517,Biofeedback_based_music,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
3518,IRB-21-28,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3519,BREAST-Pyrotinib,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3520,ELEGANT - ET18-262,Observational,,"Device, Device",,Cohort,,Non-Probability Sample,
3521,A5481065,Observational,,,,Ecologic or Community,,Probability Sample,
3522,L19-065,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3523,HP-00068503,Observational,,Other,,Case-Control,,Probability Sample,
3524,TQB211-III-01,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
3525,AP2110-30111,Interventional,"No Intervention, Experimental, Experimental","Procedure, Procedure",Sequential Assignment,,,,Not Applicable
3526,IRB202101449,Interventional,"Sham Comparator, Experimental",Device,Parallel Assignment,,,,Not Applicable
3527,NL72808.068.20,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3528,IIT2021-01-Shiao-CSF1Ri,Interventional,Experimental,"Drug, Radiation, Drug",Single Group Assignment,,,,Phase 2
3529,R17096,Observational,,Other,,Case-Only,,Non-Probability Sample,
3530,WHITE TEA,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3531,2017/15,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Not Applicable
3532,A222101,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Other, Other, Drug",Parallel Assignment,,,,Phase 2
3533,AP2014-50103,Interventional,"Experimental, Experimental, No Intervention","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3534,DMT-2015.002,Observational,,Device,,Case-Control,,Probability Sample,
3535,21-318,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3536,KY2019,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3537,S61864,Observational,,Device,,Cohort,,Non-Probability Sample,
3538,IRAS 283017,Observational,,Procedure,,Cohort,,Probability Sample,
3539,BXU572940,Interventional,"Active Comparator, Experimental",Drug,Crossover Assignment,,,,Phase 1
3540,62/19-06-18,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3541,ZUH-MICB-UMPR,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
3542,20/WS/0110,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3543,RG1007834,Interventional,Experimental,"Drug, Procedure, Procedure, Drug, Procedure, Procedure, Other",Single Group Assignment,,,,Phase 2
3544,KCT001,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3545,HE641269,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3546,AIUR trial,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3547,S-20200094,Interventional,"Other, Other","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
3548,ATADEK 2021-14/18,Interventional,"No Intervention, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
3549,LBS-CA-PTL-033,Observational,,Diagnostic Test,,Other,6 Weeks,Non-Probability Sample,
3550,19-665,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Radiation,Parallel Assignment,,,,Not Applicable
3551,RECHMPL18_0244,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3552,TBio-4101-001,Interventional,"Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,Phase 1
3553,UCCS19102,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3554,UCCS20127,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3555,U21-08-4519,Observational,,,,Case-Only,,Probability Sample,
3556,RCB: 2022-A01349-34,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3557,211820931,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3558,CTC-SMMiL-E-1901,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3559,LCI-BRE-VITD-001,Interventional,"Experimental, Active Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3560,CLEE011A2412B,Interventional,Other,"Drug, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
3561,PB-2020-01,Observational,,"Drug, Drug, Procedure, Procedure",,Cohort,,Non-Probability Sample,
3562,OX2022-203-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3563,2018-0561,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3564,IRB00180383,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3565,ID-RCB: 2018-A03356-49,Interventional,"Experimental, Experimental, Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
3566,2011684,Interventional,"Other, Experimental, Active Comparator","Device, Device, Device",Parallel Assignment,,,,Not Applicable
3567,2021/058,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3568,CDK-002-101,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
3569,SAPB for MRM 2.0,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3570,2020_16,Observational,,,,Cohort,,Non-Probability Sample,
3571,TJ107001STM202,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
3572,2015C0090,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3573,Study-21-00112,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3574,2020-013-00US3,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3575,NeuroMod-PCCI,Interventional,"Experimental, Sham Comparator","Device, Device, Behavioral",Parallel Assignment,,,,Not Applicable
3576,D8530C00004,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Radiation, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3577,19-5250.0,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3578,STU 2019-1099,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Early Phase 1
3579,2020.253 NL72539.029.20,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3580,A5481173,Interventional,"Other, Experimental, Other, Other","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3581,RCT Pristina 2/TR,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3582,2021-0568-001,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
3583,STUDY00143316,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
3584,2019P001434-1,Observational,,,,Other,,Non-Probability Sample,
3585,19-238,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
3586,FDRT-BC007,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
3587,IRMA,Observational,,Other,,Cohort,,Non-Probability Sample,
3588,PMPS 1,Observational,,,,Case-Control,,Probability Sample,
3589,2004-219-1119,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3590,2000031319,Observational,,"Other, Other, Device, Other, Other",,Cohort,,Probability Sample,
3591,DS1062-A-J101,Interventional,"Experimental, Experimental","Drug, Drug, Other",Sequential Assignment,,,,Phase 1
3592,CMUH110-REC1-122,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3593,IIT-ePRO,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Phase 3
3594,ICO-2020-22,Observational,,,,Cohort,,Non-Probability Sample,
3595,22-091,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3596,UTK-IRB-22-07195,Interventional,"Experimental, Other","Other, Device",Parallel Assignment,,,,Not Applicable
3597,ERC#2020-3379-10190,Observational,,Other,,Case-Only,,Non-Probability Sample,
3598,PROICM 2018-07 BPR,Interventional,"Other, Other, Other, Other",Other,Factorial Assignment,,,,Not Applicable
3599,5271,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
3600,ZG01012019,Interventional,"Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3601,PO18091,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3602,22-197,Interventional,"Active Comparator, Placebo Comparator","Procedure, Other",Parallel Assignment,,,,Phase 2
3603,21-055,Observational,,"Diagnostic Test, Behavioral",,Cohort,,Non-Probability Sample,
3604,1955K,Observational,,"Procedure, Procedure",,Case-Control,,Non-Probability Sample,
3605,20-5111,Interventional,"Experimental, Other",Other,Parallel Assignment,,,,Not Applicable
3606,PROICM 2020-06 BIO,Interventional,"Experimental, Experimental, No Intervention","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3607,IRB-46373,Interventional,"Active Comparator, Experimental","Procedure, Radiation",Parallel Assignment,,,,Not Applicable
3608,UPCC 21220,Observational,,Other,,Cohort,1 Year,Non-Probability Sample,
3609,2019_NOV_CP_001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3610,DEGENCA,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3611,IRB-2022- 1451,Interventional,"Placebo Comparator, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
3612,ASO.RianGen.22.02,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3613,19-00222,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3614,C4431001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Diagnostic Test",Sequential Assignment,,,,Phase 1
3615,M336,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3616,MAGREES,Observational,,,,Cohort,,Non-Probability Sample,
3617,KIA 2018/155,Interventional,"No Intervention, Experimental",Procedure,Crossover Assignment,,,,Not Applicable
3618,B-1206-158-005,Interventional,"Experimental, Active Comparator","Biological, Biological",Parallel Assignment,,,,Not Applicable
3619,190311,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3620,20-021,Interventional,"Experimental, Active Comparator","Procedure, Procedure, Other, Other",Parallel Assignment,,,,Phase 3
3621,202200395A3,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3622,PECS in Breast Cancer Surgery,Interventional,"Placebo Comparator, Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3623,HREBA.CC-19-0354,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
3624,Analgesia in breast surgey,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3625,159-2019,Interventional,"No Intervention, Experimental",Device,Sequential Assignment,,,,Not Applicable
3626,9778,Observational,,"Diagnostic Test, Other",,Cohort,,Non-Probability Sample,
3627,LCCC1920,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3628,MCC-19650,Interventional,"Active Comparator, Active Comparator, Experimental, Experimental",Biological,Single Group Assignment,,,,Phase 2
3629,2018-05-0009,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3630,DCIS Cryo,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
3631,STU00214745,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
3632,ENTheR,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3633,Michal Nissim 2,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3634,IUSCC-0533,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3635,Version 1.1.6,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3636,GALENO 1,Interventional,"Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3637,MMSTD1Pecs2,Interventional,"Other, Other","Procedure, Procedure, Other",Parallel Assignment,,,,Not Applicable
3638,875329,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3639,ST-067-001,Interventional,"Experimental, Experimental",Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
3640,H-40045,Interventional,"No Intervention, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3641,SYSKY-2023-122-02,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3642,TRV-002,Observational,,,,Cohort,,Non-Probability Sample,
3643,KOU KAEK 2018/487,Interventional,"Experimental, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
3644,TREM-1,Interventional,"Other, Other, No Intervention, No Intervention, No Intervention",Biological,Parallel Assignment,,,,Not Applicable
3645,RC31/17/0335,Interventional,"Other, Other","Device, Device",Crossover Assignment,,,,Not Applicable
3646,201912245RINB,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3647,KND-QX-CXXT,Observational,,Device,,Cohort,,Non-Probability Sample,
3648,ALTERTASTE,Observational,,Drug,,Cohort,,Non-Probability Sample,
3649,CUT_DN_02,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3650,Pro00052823,Observational,,Device,,Case-Only,,Non-Probability Sample,
3651,PKUPH10B001,Interventional,"Active Comparator, Experimental",Combination Product,Parallel Assignment,,,,Early Phase 1
3652,19.58/ONCO19.08,Interventional,"Active Comparator, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3653,CCS1477-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3654,CO-338-098,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3655,CIRCADIAN,Observational,,,,Cohort,,Non-Probability Sample,
3656,UBP-A103-HER2,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator","Biological, Biological",Sequential Assignment,,,,Phase 1
3657,UMCC 2021.071,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3658,Pro00040035,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
3659,18-6047,Interventional,"Experimental, Experimental",Radiation,Single Group Assignment,,,,Not Applicable
3660,Real-HER2,Observational,,,,Cohort,,Non-Probability Sample,
3661,PI2018068,Interventional,"Experimental, Experimental",Behavioral,Crossover Assignment,,,,Not Applicable
3662,Metimedi-202,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3663,CBCSG-040,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3664,NUV-422-02,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3665,UBT 2022-01,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3666,2020-A01534-35,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3667,181367,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3668,PRO00041443,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3669,19SM5221,Observational,,Device,,Other,,Non-Probability Sample,
3670,METCZ20190024,Interventional,"No Intervention, Experimental",Device,Single Group Assignment,,,,Not Applicable
3671,22-01024342,Interventional,"Active Comparator, Active Comparator",Radiation,Parallel Assignment,,,,Phase 3
3672,PUMA-NER-9501,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3673,SY-5609-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3674,MCC-20487,Interventional,"Experimental, Experimental, Experimental, Experimental","Radiation, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3675,DWI breast cancer,Observational,,Device,,Cohort,,Non-Probability Sample,
3676,2022/73,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3677,TBMZ-Radio-boron gel,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3678,0141-19-RMB,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3679,BT5528-100,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3680,2021P000209,Observational,,,,Cohort,,Non-Probability Sample,
3681,REaCT-TEMPO,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
3682,SYSKY-2022-117-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3683,IRB 22-211,Observational,,Other,,Cohort,18 Months,Non-Probability Sample,
3684,PROT-P2-024,Interventional,"Other, Other",Device,Parallel Assignment,,,,Not Applicable
3685,2022-0454,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3686,Pro00101109,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3687,22-071,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Phase 3
3688,ZL-2306-006,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3689,OTT-15-02,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3690,CONFIDENCE-01,Observational,,Device,,Other,2 Years,Probability Sample,
3691,K 2020-9716,Interventional,Experimental,"Diagnostic Test, Diagnostic Test",Single Group Assignment,,,,Phase 2
3692,NCC20180327,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Not Applicable
3693,3121_MATFIH22,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3694,Modi-1-001,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Device",Parallel Assignment,,,,"Phase 1, Phase 2"
3695,20-437,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3696,16-01,Interventional,Experimental,"Radiation, Drug",Single Group Assignment,,,,"Phase 2, Phase 3"
3697,IEO 1002/,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3698,3271,Interventional,Experimental,"Radiation, Radiation",Single Group Assignment,,,,Not Applicable
3699,21-559,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3700,LCCC2139,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3701,NK-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3702,1903399639,Interventional,Experimental,"Diagnostic Test, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3703,18-00684,Observational,,"Diagnostic Test, Diagnostic Test",,Cohort,,Non-Probability Sample,
3704,MCC-19-15167,Interventional,"No Intervention, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
3705,CASE5117,Interventional,"Active Comparator, Experimental, Active Comparator","Device, Device, Other",Parallel Assignment,,,,Not Applicable
3706,CASE10117,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3707,Medipol Hospital 18,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3708,18-431,Interventional,"Experimental, Active Comparator","Radiation, Drug",Parallel Assignment,,,,Phase 2
3709,SPI-POZ-203,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
3710,STUDY21070030,Interventional,Experimental,"Device, Drug",Single Group Assignment,,,,Phase 4
3711,E2018124,Interventional,"No Intervention, Experimental, Experimental",Drug,Parallel Assignment,,,,Not Applicable
3712,2140-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3713,2019(S073),Observational,,Device,,Case-Only,,Non-Probability Sample,
3714,21-288,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3715,OSU-21198,Observational,,Other,,Cohort,,Non-Probability Sample,
3716,RadOnc,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3717,INX-315-01,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3718,JSKN003-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
3719,20-275,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 1
3720,018-781,Observational,,,,Cohort,,Non-Probability Sample,
3721,IGAR-TO-007,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3722,Laser LabCorp #001,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3723,2020-04936,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3724,NCC2962,Observational,,Device,,Other,,Probability Sample,
3725,IRB-50877,Interventional,Experimental,"Drug, Device",Single Group Assignment,,,,Early Phase 1
3726,PER-19-04,Interventional,"No Intervention, Experimental",Device,Parallel Assignment,,,,Not Applicable
3727,KL166-I-01-CTP,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
3728,PROTOCOL-P2-054,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3729,254-18,Interventional,"Active Comparator, Active Comparator, Active Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3730,B076201420067,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,,,,Not Applicable
3731,MIP-2019-001,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3732,21051,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3733,DE-17-17,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3734,CLINP-001013,Observational,,Device,,Other,,Non-Probability Sample,
3735,201701045,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Phase 1
3736,E20210210,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3737,ICO-2021-05,Observational,,Procedure,,Cohort,,Non-Probability Sample,
3738,735CLD Rev.04,Observational,,Device,,Cohort,,Non-Probability Sample,
3739,CLP-0004,Observational,,"Other, Other, Other, Other, Other",,Cohort,,Non-Probability Sample,
3740,EMC-0124-18,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3741,LYL797-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3742,2834,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Not Applicable
3743,APHP220816,Observational,,Other,,Cohort,,Non-Probability Sample,
3744,IC 2021 07,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
3745,GEN1B-01,Interventional,"Active Comparator, Active Comparator","Device, Device",Sequential Assignment,,,,Not Applicable
3746,GOG-8023,Observational,,"Other, Other, Other, Genetic, Other, Genetic",,Cohort,,Non-Probability Sample,
3747,IIT2018-25-MITA-NEOBREADS,Interventional,Experimental,"Other, Drug",Single Group Assignment,,,,Phase 1
3748,2020-00493,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
3749,20210817-01H,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3750,CIRB Ref. No: 2019/2090,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3751,20295,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3752,TO-TAS0728-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
3753,124.03-2017-GES-0005,Interventional,Other,"Device, Device",Single Group Assignment,,,,Not Applicable
3754,IIT2018-21-AMERSI-BREADS,Interventional,"Experimental, Active Comparator","Other, Drug",Parallel Assignment,,,,Phase 2
3755,PSG SOMAVAC,Observational,,Device,,Case-Only,,Non-Probability Sample,
3756,FMSU2017-003,Observational,,"Device, Device",,Case-Crossover,,Non-Probability Sample,
3757,3-2021-0468,Interventional,"Experimental, Placebo Comparator","Procedure, Other",Parallel Assignment,,,,Not Applicable
3758,IB 2019-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3759,2022-010,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3760,Reader-02 Study,Interventional,"Active Comparator, Experimental","Device, Device, Device",Sequential Assignment,,,,Not Applicable
3761,20-03,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3762,YWBC-002,Interventional,"Experimental, Experimental, Experimental, No Intervention","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3763,PER-19-03,Observational,,Device,,Cohort,,Probability Sample,
3764,2019-1176,Interventional,"Experimental, Active Comparator","Other, Other, Procedure, Other, Other",Parallel Assignment,,,,Not Applicable
3765,2018-4107,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
3766,2021-0290,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Phase 2
3767,0180910/16,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Not Applicable
3768,ETNA-CRCI,Observational,,Device,,Cohort,,Probability Sample,
3769,INTRUSION,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3770,2019-A00121-56,Observational,,Other,,Cohort,26 Months,Non-Probability Sample,
3771,2018-9409,Observational,,,,Cohort,5 Years,Non-Probability Sample,
3772,R.22.09.1830,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
3773,SCOUT2021,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3774,PROICM 2019-07 PRE,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3775,2022-A01940-43,Interventional,"Placebo Comparator, Experimental","Drug, Other",Parallel Assignment,,,,Phase 2
3776,Reader-01,Interventional,"Active Comparator, Experimental","Device, Device, Device",Sequential Assignment,,,,Not Applicable
3777,2020-0980,Observational,,Other,,Case-Only,,Non-Probability Sample,
3778,STUDY00025461,Interventional,"Experimental, Active Comparator","Other, Behavioral, Other",Parallel Assignment,,,,Not Applicable
3779,19D.203,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
3780,BCD-178-1,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
3781,2019P003607-11,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
3782,SHR6390-I-114,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
3783,19-005445,Observational,,,,Cohort,,Non-Probability Sample,
3784,2204MDJ,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3785,mastectomy regional anesthesia,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 3
3786,PECS 2019,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 4
3787,R-2017/UEM11,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other",Crossover Assignment,,,,Not Applicable
3788,IBIO-302,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 1
3789,LAE203CN2101,Interventional,"Active Comparator, Active Comparator, Active Comparator, Placebo Comparator","Combination Product, Combination Product, Combination Product, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3790,SN132D CSP final version 6.0,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3791,2022-1151,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3792,2020-3,Observational,,,,Case-Crossover,,Non-Probability Sample,
3793,CIRB Ref. No: 2017/3139,Observational,,,,Cohort,,Non-Probability Sample,
3794,LCCC1754,Observational,,,,Cohort,32 Years,Non-Probability Sample,
3795,Tomosymthesis,Observational,,,,Case-Only,,Probability Sample,
3796,NINTAU,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3797,BCA-AI,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3798,21-002713,Interventional,Experimental,"Other, Procedure",Single Group Assignment,,,,Early Phase 1
3799,LIVFOU-930411,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure, Procedure, Drug, Device",Parallel Assignment,,,,Not Applicable
3800,21-BI-1607-01,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3801,20-378,Interventional,"Experimental, Experimental",Other,Sequential Assignment,,,,Not Applicable
3802,2019-A0872-55,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3803,CAAA504A12101,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Early Phase 1
3804,20190701041GH,Observational,,,,Cohort,1 Year,Non-Probability Sample,
3805,D6900C00001,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3806,HNCH-BC004,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3807,CMUH106-REC2-117,Observational,,Procedure,,Case-Control,,Probability Sample,
3808,20200491,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3809,2019-06214,Observational,,,,Case-Control,,Non-Probability Sample,
3810,PRO2021-1428,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
3811,ZN-A-1041-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3812,HCC 21-265,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3813,HNCH-BC007,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
3814,2020-0498,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Other, Other",Parallel Assignment,,,,Not Applicable
3815,NBE-002-01,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3816,1B-22-2,Interventional,"Experimental, Experimental","Biological, Drug, Radiation, Biological",Sequential Assignment,,,,Phase 1
3817,PROT002 - Test Plan 01 Rev A,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3818,Gen 2 - 01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3819,PROT001,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3820,MW05-2020-CP301,Interventional,"Experimental, Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
3821,BYON5667.002,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3822,UZBRU_VHH2_1,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3823,v24-9-2017,Observational,,Behavioral,,Case-Control,5 Years,Non-Probability Sample,
3824,19-007547,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3825,Pro00092817,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3826,Pro00112215,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3827,Ageing-NIO,Observational,,"Procedure, Procedure, Procedure, Procedure, Procedure, Procedure",,Cohort,,Probability Sample,
3828,5R44CA203608,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Not Applicable
3829,M16-573,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
3830,ACROPOLI (SOLTI-1904),Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3831,NL52329.075.15,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3832,DPCVC,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3833,AAAT2490,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Other, Other, Other, Other",Factorial Assignment,,,,Not Applicable
3834,0S-20-6,Observational,,Other,,Case-Only,,Non-Probability Sample,
3835,SRNSM,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
3836,CMP-001-009,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
3837,SS-SP01-201904,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3838,5890-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Biological, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
3839,H19-03343,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3840,BPI-2358-106 phase 3,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Drug",Parallel Assignment,,,,Phase 3
3841,EK 1623/2020,Interventional,"Other, Other","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3842,TRX518-004,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
3843,20200110,Interventional,"Sham Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
3844,ASPB vs ESBP for mastectomy,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3845,2018-01,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3846,TYKM1602101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3847,BrUOG 351,Interventional,Experimental,"Radiation, Procedure",Single Group Assignment,,,,Not Applicable
3848,PI-3958,Observational,,Drug,,Case-Control,,Non-Probability Sample,
3849,KL264-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3850,Medipol Hospital 26,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Not Applicable
3851,NeoVAB,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
3852,16-136,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
3853,SGN228-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3854,1612017795,Interventional,"No Intervention, Experimental, Experimental",Other,Single Group Assignment,,,,Not Applicable
3855,7902-005,Interventional,"Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,Phase 2
3856,UUBreast02,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 3
3857,2021-0842,Interventional,Experimental,Device,Single Group Assignment,,,,Early Phase 1
3858,GN19HS442,Interventional,"Experimental, Active Comparator","Other, Other",Crossover Assignment,,,,Not Applicable
3859,06-2020/1,Observational,,"Other, Other, Other",,Case-Only,,Non-Probability Sample,
3860,MCC-21622,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Biological",Sequential Assignment,,,,Phase 1
3861,SIBP-03-01,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3862,IRB00047335,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Early Phase 1
3863,217510,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
3864,RIN20230039,Interventional,"Experimental, Experimental",Behavioral,Sequential Assignment,,,,Not Applicable
3865,4-2019-0834,Observational,,Procedure,,Case-Control,,Non-Probability Sample,
3866,UI/EC/20/0275,Interventional,"Active Comparator, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 4
3867,AB-201-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3868,IOM-040369,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
3869,233,Interventional,"Active Comparator, Sham Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
3870,TQB3616-I-02,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 1
3871,MAR-BAS-18-005,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
3872,107709,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3873,20-1456,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3874,UTN: U1111-1278-1680,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3875,19-104,Interventional,"Active Comparator, Active Comparator, Placebo Comparator",Other,Parallel Assignment,,,,Not Applicable
3876,MASCT-I-1003,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
3877,REC/RCR&AHS/22/0511,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
3878,18-264,Interventional,"Experimental, No Intervention",Behavioral,Crossover Assignment,,,,Not Applicable
3879,KY20202093-F-1,Interventional,,Drug,Single Group Assignment,,,,Early Phase 1
3880,P050001 TiLOOPÂ® Bra Pocket,Observational,,Device,,Cohort,,Non-Probability Sample,
3881,2021-0262,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3882,262180,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
3883,H18-02014,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3884,IRB19-2074,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
3885,TG1819ONC,Interventional,Experimental,"Biological, Biological, Biological, Biological, Biological, Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
3886,STUDY00018917,Interventional,"No Intervention, Experimental",Combination Product,Parallel Assignment,,,,Not Applicable
3887,STUDY00002789,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3888,S66520,Interventional,"Active Comparator, Active Comparator, Sham Comparator",Device,Parallel Assignment,,,,Not Applicable
3889,P.T.REC/012/002677,Interventional,"Active Comparator, Sham Comparator","Device, Other",Crossover Assignment,,,,Not Applicable
3890,ISPY-P1.01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3891,NCI-2017-01921,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other",Parallel Assignment,,,,Phase 1
3892,"2016-051-000001, 1835",Interventional,"Other, Other",Behavioral,Parallel Assignment,,,,Not Applicable
3893,CF21163B,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3894,D-FR-01072-002,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3895,Breast-Nektaria,Interventional,"Active Comparator, Sham Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3896,1413727,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3897,1049/2018,Observational,,"Device, Other",,Cohort,,Non-Probability Sample,
3898,20200426,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
3899,VALO-001,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3900,IMU R204/2017,Interventional,"Active Comparator, Active Comparator, Active Comparator","Dietary Supplement, Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
3901,LCCC1915,Interventional,"Experimental, Experimental, Experimental","Drug, Device",Single Group Assignment,,,,Phase 2
3902,RiphahIU Shafaq,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3903,CRX100-001,Interventional,Experimental,Biological,Sequential Assignment,,,,Phase 1
3904,HREBA.CC-20-0077,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3905,TST-9-H,Interventional,"Experimental, Active Comparator","Biological, Drug",Parallel Assignment,,,,Phase 1
3906,OCOG-2022-RAPID2,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Phase 3
3907,20181004,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3908,18-571,Interventional,"Other, Other","Other, Other",Sequential Assignment,,,,Not Applicable
3909,R19-159,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3910,2018B0521,Interventional,"Experimental, Placebo Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
3911,287482,Interventional,"Placebo Comparator, Active Comparator","Drug, Other",Parallel Assignment,,,,Phase 4
3912,HR-BLTN-DDI-07,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3913,201612723,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3914,2012285106,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
3915,AWS,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
3916,2022-0328,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
3917,20/007-E_TFM,Interventional,"Experimental, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
3918,0352-2189,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
3919,HCI128055,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3920,180097,Interventional,Experimental,"Drug, Device",Single Group Assignment,,,,Phase 2
3921,190134,Interventional,"Experimental, Active Comparator, Active Comparator","Biological, Biological, Biological",Sequential Assignment,,,,Phase 1
3922,TH1902-CTR-0001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
3923,18112,Interventional,Experimental,"Procedure, Drug, Other, Procedure",Single Group Assignment,,,,Early Phase 1
3924,KY20172047-1,Interventional,Experimental,Procedure,Single Group Assignment,,,,Phase 1
3925,BREAST HEMATOMA,Observational,,Device,,Other,,Non-Probability Sample,
3926,mRNA-2752-P101,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
3927,1380800-R,Interventional,"Active Comparator, Experimental, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3928,7621,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3929,TomBakerCC,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
3930,SVIFT Nodal Trial,Interventional,"Active Comparator, Other",Radiation,Factorial Assignment,,,,Not Applicable
3931,CASE1Z21,Interventional,"No Intervention, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
3932,IRB00075787,Interventional,Experimental,"Other, Other",Single Group Assignment,,,,Not Applicable
3933,HB-AT-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3934,ART4215C001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3935,D161100000816006,Observational,,,,Cohort,,Probability Sample,
3936,Duke-NUS,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
3937,226947,Observational,,Other,,Other,,Non-Probability Sample,
3938,SKNA pilot,Interventional,"Active Comparator, No Intervention",Drug,Parallel Assignment,,,,Not Applicable
3939,IIT2018-05-ASHER-IMPROV2,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
3940,OU-SCC Virtual Reality,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
3941,2020-A03205-34,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3942,OPERA2,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
3943,201907039,Interventional,"Experimental, Placebo Comparator","Drug, Drug, Drug, Drug, Procedure, Procedure",Parallel Assignment,,,,Phase 2
3944,TaiHao BR-USCAD VT 20-249,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Crossover Assignment,,,,Not Applicable
3945,UMCC 2021.004,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
3946,UPMREB 2021-140-01,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Phase 2
3947,15/LO/1038 BRACELET,Observational,,,,Cohort,,Non-Probability Sample,
3948,KS01,Interventional,"Active Comparator, Active Comparator",Drug,Parallel Assignment,,,,Phase 4
3949,MS-268-2019,Interventional,"Experimental, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3950,BoCCE,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3951,875329B,Interventional,"Experimental, Experimental","Device, Device",Single Group Assignment,,,,Not Applicable
3952,MS-536-2021,Interventional,"Experimental, Experimental, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3953,Gyn F-Chem,Interventional,"Experimental, Experimental, Placebo Comparator",Other,Parallel Assignment,,,,Not Applicable
3954,PROICM 2019-06 COH,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
3955,NCCH1905,Observational,,Genetic,,Cohort,,Probability Sample,
3956,D3614C00004,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
3957,1449,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
3958,RocuMAST,Observational,,Drug,,Cohort,,Probability Sample,
3959,CHD22_0002,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3960,CLINP-001001,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
3961,1920306,Observational,,Other,,Cohort,,Non-Probability Sample,
3962,17-VIN-0855,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,,,,Phase 1
3963,2022-01423-01,Observational,,"Procedure, Procedure, Procedure, Procedure",,Case-Control,,Non-Probability Sample,
3964,2019-0557,Interventional,Experimental,Diagnostic Test,Sequential Assignment,,,,Early Phase 1
3965,Breast 2019,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
3966,D0817C00098,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 3
3967,2017-377,Interventional,"Active Comparator, Sham Comparator","Other, Device",Crossover Assignment,,,,Not Applicable
3968,IZKSZ3_188408 / 1,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3969,2018-94,Interventional,"Active Comparator, Active Comparator, Other","Device, Other, Other",Crossover Assignment,,,,Not Applicable
3970,ORIN1001-C1,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
3971,UMCC 2020.041,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3972,H-42207 GAIL-N,Interventional,"Experimental, Experimental",Genetic,Single Group Assignment,,,,Phase 1
3973,Esogu Anesthesia,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
3974,TED16925,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
3975,Telerehab CH Feasibility,Interventional,"Experimental, Sham Comparator","Device, Other",Parallel Assignment,,,,Not Applicable
3976,RPC006,Interventional,"Other, Placebo Comparator, Active Comparator, Other, Placebo Comparator, Active Comparator, Other, Placebo Comparator, Active Comparator","Dietary Supplement, Drug, Drug",Parallel Assignment,,,,Phase 2
3977,BEX15859,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
3978,waitingroom,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
3979,CP-10-001,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
3980,REB16-1463,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,"Phase 2, Phase 3"
3981,UF-STO-ETG-003,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3982,UMCC 2020.157,Interventional,"Experimental, Active Comparator","Other, Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
3983,OnkoFit II,Interventional,"Experimental, Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
3984,R7075-ONC-2009,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
3985,CART-TnMUC1-01,Interventional,"Experimental, Experimental","Biological, Drug, Drug",Sequential Assignment,,,,Phase 1
3986,PT06-01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
3987,2019/2944,Interventional,,Procedure,Single Group Assignment,,,,Not Applicable
3988,SPI-POZ-501,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
3989,LCB-1801-001,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
3990,PECS vs SAP,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
3991,2020-000495-37,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Early Phase 1
3992,2018-0175,Interventional,"Experimental, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 2
3993,2021-082,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
3994,012018CONTROL,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
3995,18232,Observational,,,,Cohort,,Non-Probability Sample,
3996,R19258,Interventional,"Experimental, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
3997,2020/03FEV/065,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Other","Device, Other",Parallel Assignment,,,,Not Applicable
3998,2012-001-108,Interventional,"No Intervention, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 4
3999,HREC/74777/Alfred-2021,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4000,7905,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
4001,ARX788-1711,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4002,69HCL18_0492,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4003,BB-1701-101,Interventional,"Other, Experimental, Experimental, Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
4004,D9720C00001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4005,XuanWuH-NK,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4006,FPX-01-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Biological, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4007,RAPA-201-STP-01,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4008,HC-404-FCP-2011,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4009,assuitu faculty of medicine,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
4010,STUDY00015358,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4011,ONCX-NAV-G201,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Biological",Parallel Assignment,,,,Phase 2
4012,CRUKD/22/002,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4013,042201,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4014,DCC-2036-01-004,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4015,NM1F-T1-01,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4016,213409,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4017,ICO-2020-06,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4018,OMO-103-01,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4019,849679,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4020,UC-0101/1709,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4021,4-2020-0165,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
4022,ZN-A-1041-101-US,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4023,UW21084,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4024,IRB#56402,Observational,,Other,,Cohort,,Non-Probability Sample,
4025,TAEK-VAC-HerBy-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
4026,C4161001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4027,MORAb-202-G000-201,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4028,18-27025,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
4029,APHP210583,Observational,,Other,,Cohort,,Probability Sample,
4030,19-652,Interventional,"Active Comparator, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4031,BESTa,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
4032,SOLTI-1804,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4033,M19-037,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4034,2020-00256; ch18Weber4,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4035,OSU-21313,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,,,,Not Applicable
4036,AN0025S0103,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4037,202202104,Observational,,Other,,Other,,Non-Probability Sample,
4038,Medipol Hospital 9,Interventional,"Active Comparator, Active Comparator, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
4039,69HCL18_0369,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4040,2019/629,Observational,,Device,,Cohort,,Non-Probability Sample,
4041,200023,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4042,RB-vs-RG-BCS,Observational,,"Procedure, Procedure",,Cohort,,Non-Probability Sample,
4043,CHANCES-IPC 2021-008,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4044,17-694,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4045,SLS17-201/MK3475-770,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4046,AP2207-30110,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Procedure, Procedure, Procedure, Drug",Parallel Assignment,,,,Not Applicable
4047,2015-KAEK-64-22-09,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4048,FZPL-â¢-301-OC,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4049,2022-0329,Interventional,"Other, Other","Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
4050,CLODIS,Interventional,"Experimental, Active Comparator","Device, Procedure",Parallel Assignment,,,,Phase 3
4051,KE-0254/92/2018,Interventional,"Placebo Comparator, Experimental, Sham Comparator","Procedure, Procedure, Procedure, Procedure, Drug, Drug",Parallel Assignment,,,,Phase 4
4052,2019-001982-34,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Drug, Other",Parallel Assignment,,,,Phase 3
4053,G423 Multi TP,Interventional,,Other,Single Group Assignment,,,,Not Applicable
4054,201803061RIND,Interventional,"Active Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4055,192004,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,Phase 1
4056,RIPH3-RNI18/NEUROTAX,Observational,,Other,,Cohort,,Probability Sample,
4057,22339,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug, Drug, Other",Parallel Assignment,,,,Early Phase 1
4058,TAS2940-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4059,Bio2738,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4060,20252,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4061,2021-PrMa-RWiberg,Observational,,,,Cohort,,Non-Probability Sample,
4062,STM-IRB-22B-001,Interventional,"Experimental, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
4063,69HCL20_0346,Observational,,Other,,Case-Control,,Non-Probability Sample,
4064,21-5539,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4065,2018-1361,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Sequential Assignment,,,,Not Applicable
4066,MC1713,Interventional,Experimental,"Biological, Biological, Procedure",Single Group Assignment,,,,Phase 1
4067,HREBA.CC-18-0028,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
4068,E-SN@P PROJECT-IPC 2017-029,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4069,PASCA,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4070,H-49731,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4071,BrUOG 390,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4072,EC/2018/0315,Interventional,"Other, Other, Other, Other, Other, Other, Other, Other, Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4073,CIMS-2019-01,Interventional,"No Intervention, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4074,XL102-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4075,Dnr 2019-04151,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4076,2021-001624-17,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4077,GCO 21-0012,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4078,2018-0004,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4079,TJ-IRB20211129,Observational,,,,Other,2 Years,Non-Probability Sample,
4080,823981A,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4081,NIT-110 (KEYNOTE PNA60),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4082,69HCL19_0731,Observational,,Other,,Cohort,,Non-Probability Sample,
4083,BT-001.01,Interventional,"Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4084,EAQ161CD,Observational,,Other,,Ecologic or Community,,Non-Probability Sample,
4085,Pro00106186,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4086,G-5097-2019,Observational,,,,Case-Only,,Non-Probability Sample,
4087,Laser treatment,Interventional,"Active Comparator, Sham Comparator, Active Comparator, Sham Comparator, Active Comparator, Sham Comparator, Active Comparator, Sham Comparator","Procedure, Device, Device",Parallel Assignment,,,,Not Applicable
4088,NIMAO/2016/PC-01,Observational,,Other,,Case-Only,,Non-Probability Sample,
4089,IIT-2021-CANINE,Observational,,Biological,,Case-Only,,Probability Sample,
4090,PROICM 2017-05 BAL,Interventional,"Other, Other",Biological,Parallel Assignment,,,,Not Applicable
4091,Breast Biopsy,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4092,GOP,Interventional,"No Intervention, Experimental",Drug,Parallel Assignment,,,,Phase 2
4093,2018P000084,Observational,,"Procedure, Device",,Cohort,,Non-Probability Sample,
4094,IRB00167074,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4095,NIP IT!,Observational,,,,Cohort,,Non-Probability Sample,
4096,CDKY709A12101C,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4097,IRB#21-001169,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4098,PRO 1676,Observational,,Other,,Other,,Probability Sample,
4099,Pro00102260,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4100,19829,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4101,00011271,Interventional,Experimental,"Behavioral, Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4102,CE3220.,Interventional,"Active Comparator, Experimental","Device, Other",Parallel Assignment,,,,"Phase 1, Phase 2"
4103,METCZ20220056,Interventional,"Experimental, No Intervention",Device,Single Group Assignment,,,,Not Applicable
4104,RC31/17/0350,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4105,19-179,Interventional,"Experimental, Sham Comparator, Other","Other, Other, Other",Parallel Assignment,,,,Phase 2
4106,180276,Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
4107,213353,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4108,ebeddows,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4109,IFCT-1703,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4110,69HCL17_0642,Observational,,Other,,Case-Only,,Non-Probability Sample,
4111,CS001-SA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4112,MSK8/22,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4113,JAB-2485-1001,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4114,BA3021-001,Interventional,"Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,"Phase 1, Phase 2"
4115,PVMEDCT202201,Observational,,Device,,Cohort,,Probability Sample,
4116,2020-05-001B,Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4117,PRT2527-01,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4118,13104,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4119,RECHMPL22_0024,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4120,21-369,Interventional,"Experimental, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4121,120134,Interventional,"Experimental, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
4122,Pro00078230,Interventional,"Active Comparator, Experimental","Procedure, Procedure, Drug, Drug, Drug",Parallel Assignment,,,,Not Applicable
4123,18-000948,Interventional,"Experimental, Placebo Comparator","Dietary Supplement, Other",Parallel Assignment,,,,Not Applicable
4124,20-08,Interventional,"Other, Other",Device,Single Group Assignment,,,,Not Applicable
4125,AP2001-50504,Interventional,"Active Comparator, Active Comparator",Other,Parallel Assignment,,,,Not Applicable
4126,FMBSURECS/30042019/Ali,Interventional,"Active Comparator, Active Comparator",Procedure,Parallel Assignment,,,,Not Applicable
4127,21-192,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4128,SBT6290-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4129,SAHZhejiangU 123,Observational,,,,Cohort,,Non-Probability Sample,
4130,CRYO for Mastectomy (DoD),Interventional,"Active Comparator, Sham Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4131,FMASUMD45/2021,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,"Phase 2, Phase 3"
4132,PT3465,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4133,Lishui Peoples Hospital,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4134,HAN2014005-CT02,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4135,SHEBA-19-6136-RS-CTIL,Interventional,"Active Comparator, Active Comparator",Combination Product,Sequential Assignment,,,,Phase 1
4136,GS-US-417-5937,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4137,2021/01159,Interventional,Experimental,"Device, Device, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4138,SOGUG-2016-A-IEC(PRO)-12,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4139,CCR5653,Observational,,,,Cohort,,Non-Probability Sample,
4140,PPP005-Ph2/3-01,Interventional,"Experimental, Placebo Comparator","Radiation, Radiation",Parallel Assignment,,,,Phase 2
4141,AAAS9968,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4142,METCZ2019016,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4143,1190532,Observational,,Other,,Cohort,,Probability Sample,
4144,HSL 2016-83,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4145,IMM2902-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4146,NOX66-005,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Radiation",Sequential Assignment,,,,"Phase 1, Phase 2"
4147,CCR5063,Interventional,Experimental,"Behavioral, Behavioral",Single Group Assignment,,,,Not Applicable
4148,BGB-3111-108,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4149,2020/14MAI/273,Interventional,"Active Comparator, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4150,B4T2-PRC-IIT-001,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4151,PROACTIVE,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
4152,2017-02028,Observational,,Device,,Cohort,,Probability Sample,
4153,JS001-PMS-CO1,Observational,,Drug,,Other,,Non-Probability Sample,
4154,875351,Interventional,Experimental,Other,Single Group Assignment,,,,Phase 2
4155,CX-839-011,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4156,Pro00037562,Observational,,,,Cohort,,Non-Probability Sample,
4157,16-010491,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4158,INT17676,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4159,829785,Observational,,Other,,Cohort,,Non-Probability Sample,
4160,ESG401-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4161,GS-US-382-1587,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4162,20221202,Interventional,"Experimental, Experimental, No Intervention","Radiation, Procedure",Parallel Assignment,,,,Not Applicable
4163,KSCM-CRD-001,Interventional,"Other, Experimental","Device, Other",Parallel Assignment,,,,Not Applicable
4164,201707042,Interventional,"Experimental, Experimental",Device,Sequential Assignment,,,,Not Applicable
4165,201810102MINC,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
4166,IRB 20-488,Observational,,,,Cohort,,Non-Probability Sample,
4167,1237087,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4168,P.T.REC/012/003747,Interventional,"Experimental, Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4169,GIHSYSU-26,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4170,GO-1,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug, Device",Single Group Assignment,,,,Phase 1
4171,BRCA-ACP.2022,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4172,20,Observational,,Other,,Case-Only,,Non-Probability Sample,
4173,JK08.1.01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4174,NC762-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4175,PARPA-293-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4176,INT 36/18,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4177,17237,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4178,209514,Observational,,"Procedure, Procedure, Procedure, Procedure, Other",,Cohort,,Probability Sample,
4179,MER-XMT-2056-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4180,Klotho _ LRP-6 _ GC,Observational,,Other,,Cohort,,Non-Probability Sample,
4181,ZL-2306-912 ALTER-OC-02,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4182,CEP1:4/2016,Interventional,"Experimental, No Intervention",Dietary Supplement,Parallel Assignment,,,,Not Applicable
4183,Chemobrain Study,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4184,XB002-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4185,KlusPharma,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4186,AJIRB-MED-THE-18-236,Interventional,"Experimental, Experimental","Biological, Biological",Single Group Assignment,,,,"Phase 1, Phase 2"
4187,20/PR/0222,Observational,,Genetic,,Cohort,,Probability Sample,
4188,JTU-6H-20210227001,Interventional,"Experimental, Active Comparator","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
4189,69HCL22_0275,Interventional,Other,Biological,Single Group Assignment,,,,Not Applicable
4190,REPLAMOD,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4191,BTC-HER2,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4192,CASE2117,Interventional,"Active Comparator, Active Comparator, Experimental","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4193,GOUDET 2018,Observational,,Other,,Cohort,,Non-Probability Sample,
4194,H-38855,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4195,FF-2018-084,Observational,,Procedure,,Cohort,2 Years,Probability Sample,
4196,2018-03,Observational,,,,Case-Control,,Probability Sample,
4197,4-2019-0648,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4198,TG-iConquerFear,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4199,P2101,Observational,,Diagnostic Test,,Cohort,10 Years,Non-Probability Sample,
4200,TCM-padia001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4201,GO43860,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4202,C/35/2017,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4203,2018-003115-21,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4204,EC29,Interventional,"Placebo Comparator, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4205,2021/117,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4206,Health consortium maresme,Interventional,"Experimental, No Intervention",Other,Sequential Assignment,,,,Not Applicable
4207,HS-10502-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4208,STUDY00023183,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4209,201903142,Observational,,,,Cohort,,Non-Probability Sample,
4210,DCC-2036-01-003,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4211,E-19-3943,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4212,CASE6118,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4213,MCART-006,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4214,PRO1184-001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4215,ONC-392-001,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4216,2021-04840,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
4217,BPI-2358-105 phase 3,Interventional,"Active Comparator, Experimental","Drug, Drug, Other, Other",Parallel Assignment,,,,Phase 3
4218,HCC 20-064,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4219,E-19-773,Interventional,"Experimental, Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
4220,STUDY00003387,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
4221,MCART-002,Interventional,Experimental,Biological,Single Group Assignment,,,,Early Phase 1
4222,SBT6050-201,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4223,ARRAY-818-103,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4224,Niraparib-5001,Observational,,,,Cohort,,Non-Probability Sample,
4225,LINDA,Observational,,Device,,Cohort,,Probability Sample,
4226,MC210302,Interventional,Experimental,"Procedure, Procedure, Drug, Procedure",Single Group Assignment,,,,Early Phase 1
4227,QSPainRelief-patientCNS,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Other",Single Group Assignment,,,,Not Applicable
4228,CARTIER,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4229,The Swedish DIRECT study,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4230,CKAF156A2104,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Combination Product, Drug, Drug, Drug, Combination Product",Sequential Assignment,,,,Phase 1
4231,B3271007,Observational,,Drug,,Case-Only,,Probability Sample,
4232,Elasto Trial,Interventional,"Active Comparator, Active Comparator","Diagnostic Test, Diagnostic Test",Sequential Assignment,,,,Not Applicable
4233,Soh-Med-22-09-01,Observational,,Device,,Case-Only,,Probability Sample,
4234,N201810002,Interventional,"Other, Experimental, Experimental",Dietary Supplement,Parallel Assignment,,,,Not Applicable
4235,MastoVit150,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
4236,CASE1219,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4237,OCOG-2021-ELISA,Observational,,,,Cohort,,Probability Sample,
4238,CHIRCOLREC-IPC 2018-017,Observational,,Other,,Cohort,,Non-Probability Sample,
4239,RELI/19/Der-Rdt/001,Interventional,"Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4240,GS-US-467-5643,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4241,PRO00031416,Interventional,"Experimental, Other",Behavioral,Parallel Assignment,,,,Not Applicable
4242,7635,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 2
4243,VAC for HPV,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4244,ONCB-006-19F,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4245,70781,Interventional,"Active Comparator, Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4246,1407426,Interventional,"Other, Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4247,PRS-343-PCS_08_18,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4248,NL72939.078.20,Interventional,"Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4249,HCI105691,Interventional,"Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Phase 2
4250,49/20 b,Observational,,Radiation,,Case-Control,,Probability Sample,
4251,AP2007-50104,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4252,PRO00032593,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4253,H00020209,Interventional,"Active Comparator, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
4254,ROR2103,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
4255,BG01-2002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4256,Rhomboid,Interventional,"Experimental, Experimental, Sham Comparator","Procedure, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4257,KY-2021-012,Observational,,Drug,,Other,1 Year,Non-Probability Sample,
4258,49/20,Observational,,Radiation,,Case-Control,,Probability Sample,
4259,GC101 TIL-ST-01,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
4260,IM014-032,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 1
4261,CEEGOG EX-02,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4262,93 /1801/2021,Interventional,"Active Comparator, Placebo Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4263,2020-3627-1407,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4264,OTH267,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4265,Pro00054854,Observational,,Drug,,Cohort,,Non-Probability Sample,
4266,MF 22-02,Interventional,"Active Comparator, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4267,2019-0989,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
4268,UCSD IIT 150729,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4269,P.T.REC/012/003464,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4270,BPX603-201A,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4271,KEEP-G 07,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4272,2021-0611,Interventional,"Other, Other, Other","Drug, Drug",Single Group Assignment,,,,Phase 2
4273,13022260-300-180785,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4274,INCB 123667-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4275,ICO-2020-19,Interventional,"Experimental, Experimental, Experimental",Procedure,Parallel Assignment,,,,Not Applicable
4276,CRUKD/21/004- Treatment Arm 4,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 2, Phase 3"
4277,NU22-09-00539,Interventional,Experimental,"Diagnostic Test, Diagnostic Test, Procedure",Single Group Assignment,,,,Not Applicable
4278,2019-A03336-51,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
4279,09.2020.125,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4280,ANAE-341-19,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4281,01-2/141 27,Interventional,"Active Comparator, Active Comparator, Active Comparator",Diagnostic Test,Parallel Assignment,,,,Not Applicable
4282,KF2019#1,Interventional,"Placebo Comparator, Active Comparator","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4283,Vein-project,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4284,thoracic sympathectomy,Interventional,"Experimental, Active Comparator","Procedure, Drug",Parallel Assignment,,,,Not Applicable
4285,20-240,Interventional,"Experimental, Experimental","Radiation, Drug, Other",Parallel Assignment,,,,Phase 2
4286,Debio 1143-106,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4287,457,Interventional,Other,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4288,D8410C00001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4289,229510,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4290,38RC17.291,Observational,,Other,,Case-Control,,Non-Probability Sample,
4291,034-2020,Observational,,,,Cohort,,Non-Probability Sample,
4292,Estim Breast,Interventional,"Experimental, Placebo Comparator","Device, Procedure",Single Group Assignment,,,,Not Applicable
4293,228-17-EP,Observational,,,,Cohort,,Non-Probability Sample,
4294,YS-RVON-001,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4295,RG1006143,Interventional,Experimental,"Other, Other, Other",Single Group Assignment,,,,Not Applicable
4296,ZL-2306-914,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4297,2019-8890,Observational,,Device,,Case-Only,,Non-Probability Sample,
4298,2021-KY-073,Observational,,Procedure,,Cohort,,Probability Sample,
4299,SNK01-102,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4300,C4551001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4301,ONT-380-011,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4302,KCSG-ST18-20,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4303,HCC 20-117,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4304,EXGEFATU,Observational,,Genetic,,Cohort,,Probability Sample,
4305,HEM-ONCO-013,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4306,FESPET,Observational,,Diagnostic Test,,Case-Only,,Non-Probability Sample,
4307,22-501,Interventional,"Experimental, No Intervention, Experimental, Experimental","Other, Other",Factorial Assignment,,,,Not Applicable
4308,STUDY00002021,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4309,OLATRA,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4310,ELVN-002-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4311,FN-1501-UP1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4312,ILYAD1_2019,Observational,,Other,,Ecologic or Community,,Non-Probability Sample,
4313,RBN-2397-19-001,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4314,STUDY00000334,Interventional,"Other, No Intervention",Device,Single Group Assignment,,,,Not Applicable
4315,OPT-IN Research Protocol,Interventional,,Other,Single Group Assignment,,,,Not Applicable
4316,2017-A02018-45,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4317,919/2020/Oss/IOR,Observational,,"Other, Other",,Case-Control,4 Years,Non-Probability Sample,
4318,CX-5461-04,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4319,MC16C2,Interventional,"Experimental, Placebo Comparator","Drug, Other, Other, Other",Crossover Assignment,,,,Early Phase 1
4320,NL75863.068.21,Interventional,"Experimental, Experimental",Device,Parallel Assignment,,,,Not Applicable
4321,20-009,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4322,PUMCH-NM-11/041,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4323,ISU104-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,Phase 1
4324,BR/2019/487,Interventional,"No Intervention, Other, Other",Other,Parallel Assignment,,,,Not Applicable
4325,ATADEK/2022.11,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4326,60116787-020/34123,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4327,BARBEN 2020,Observational,,"Biological, Other",,Cohort,,Non-Probability Sample,
4328,CHUB-Hystocor,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
4329,BLU-222-1101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4330,Soh-Med-22-09-16,Observational,,,,Other,5 Months,Non-Probability Sample,
4331,Shengjing-LJY05,Observational,,Other,,Cohort,,Probability Sample,
4332,CHUBX 2015/17,Interventional,"Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4333,1766419-7,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4334,NUV-868-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4335,436,Interventional,"Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4336,200155,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4337,2021-BRV-004,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4338,PREDICT,Observational,,,,Case-Only,,Non-Probability Sample,
4339,EJC001,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,"Phase 1, Phase 2"
4340,CHU-426,Observational,,Other,,Cohort,,Non-Probability Sample,
4341,PHOX-CLI_001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4342,NICSO,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4343,BJK-Z-F18HN-202010-YZGK,Interventional,"Experimental, Active Comparator","Drug, Drug",Crossover Assignment,,,,Phase 3
4344,A-ER-109-415,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4345,2-107-05-162,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 4
4346,IRAS307166,Observational,,Device,,Cohort,,Non-Probability Sample,
4347,20.60-onco20.07,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4348,YBCSG-21-04,Interventional,"Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4349,SamanRostambeigi,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4350,20190131,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4351,999916161,Observational,,,,Other,,Non-Probability Sample,
4352,IRB00038262,Interventional,"Other, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator, Active Comparator","Drug, Device, Other, Other",Factorial Assignment,,,,"Phase 2, Phase 3"
4353,IRB00095260,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4354,TapeK_Gesso_ABM_PSO,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
4355,29BRC18-0005 (VinMetAtezo),Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4356,1000-1,Observational,,Device,,Cohort,,Non-Probability Sample,
4357,OPTIMUM,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4358,R-17-360,Observational,,Radiation,,Cohort,,Non-Probability Sample,
4359,2017-003582-10,Interventional,Experimental,"Drug, Drug, Radiation",Single Group Assignment,,,,Phase 2
4360,BIC4VMR,Observational,,"Other, Other, Other",,Other,,Non-Probability Sample,
4361,2017_43,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4362,4397,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4363,00000001,Interventional,"Experimental, Other",Combination Product,Parallel Assignment,,,,Not Applicable
4364,IRB-2019-118,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
4365,RGC-1501-001,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4366,19CX5601,Observational,,,,Other,,Probability Sample,
4367,20-03021615,Interventional,"Other, Other","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
4368,210026,Interventional,"Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4369,702576,Interventional,"Experimental, Placebo Comparator",Drug,Parallel Assignment,,,,Phase 4
4370,MT-5111_001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4371,APHP180576,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4372,2020-1255,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4373,RC2022_prg.15,Interventional,"Experimental, Active Comparator","Dietary Supplement, Dietary Supplement",Parallel Assignment,,,,Not Applicable
4374,IEO 1740,Observational,,,,Other,,Probability Sample,
4375,UW 19-436,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4376,EDGE 000339,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4377,METCZ20210156,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4378,2000031462,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4379,METCZ20210103,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4380,2017/184 HP,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
4381,20-002000,Interventional,Experimental,"Behavioral, Other, Other, Other",Single Group Assignment,,,,Not Applicable
4382,18.068,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Phase 3
4383,Soh-Med-22-03-01,Observational,,,,Other,,Non-Probability Sample,
4384,2020-3547,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Other",Crossover Assignment,,,,Not Applicable
4385,CTM-N2D,Interventional,Experimental,Biological,Sequential Assignment,,,,Phase 1
4386,IMT-009-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4387,B.30.2.ATA.0.01.00/1/6,Interventional,"Experimental, Active Comparator","Drug, Device, Drug, Drug",Parallel Assignment,,,,Phase 4
4388,SYSKY-2022-019-02,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4389,2019-02Obs-CHRMT,Observational,,,,Cohort,,Non-Probability Sample,
4390,CHGH-IRB:(864)110-10,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4391,PROT-CI2021,Interventional,"Experimental, Experimental, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4392,CP-MGC018-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4393,RTX-224-01,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4394,2021-A01625-36,Interventional,Other,Device,Single Group Assignment,,,,Not Applicable
4395,SGNB7H4V-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4396,ShuangHoH,Observational,,Device,,Cohort,,Non-Probability Sample,
4397,P130935,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4398,2000029793,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4399,794/2020/Farm/IOR,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4400,CMUH109-REC2-101,Observational,,,,Cohort,,Probability Sample,
4401,RNI 2021 LEBRETON 3 (EVIGE),Observational,,,,Case-Control,,Probability Sample,
4402,SBNK-YJ-2020-016-02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4403,ThirdMMUb,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
4404,2693-CL-0307,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
4405,2020NZKY-062-01,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4406,2021-13614,Interventional,"Experimental, Experimental, No Intervention","Device, Device",Parallel Assignment,,,,Not Applicable
4407,MER-XMT-1660-1,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4408,no: P.T.REC/012/002774,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4409,SBNK-YJ-2019-006-02,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4410,1648/2019,Observational,,Drug,,Cohort,6 Months,Non-Probability Sample,
4411,2020/900/88,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4412,DF1001-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4413,STUDY00000224,Interventional,"Experimental, Active Comparator, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4414,2693-CL-0304,Interventional,"Experimental, Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4415,ZUH-ITP-MBCS,Interventional,"Experimental, Experimental",Drug,Crossover Assignment,,,,Phase 4
4416,1 TP2AH000076-01-00,Interventional,"Experimental, Sham Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4417,21-007867,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4418,Masters thesis,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4419,22072,Observational,,Drug,,Cohort,,Non-Probability Sample,
4420,CPI-006-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4421,HKG-KZ-PRAD-103,Observational,,,,Case-Control,,Probability Sample,
4422,RG1001812,Interventional,Experimental,"Dietary Supplement, Procedure, Other",Single Group Assignment,,,,Not Applicable
4423,25922,Interventional,Experimental,Other,Sequential Assignment,,,,Not Applicable
4424,2693-CL-0305,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4425,PET/CT in malignancy,Observational,,Radiation,,Cohort,,Probability Sample,
4426,2021-A01570-41,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4427,2693-CL-0302,Interventional,"Experimental, Experimental, Placebo Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
4428,2693-CL-0301,Interventional,"Placebo Comparator, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 3
4429,AssiutNT,Observational,,"Behavioral, Procedure",,Case-Only,,Probability Sample,
4430,PUMCH-NM-RR,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Early Phase 1
4431,HKG-Bng-HCC-100,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
4432,IX-2021-DS-LEARN,Observational,,,,Cohort,,Non-Probability Sample,
4433,1-1-7-05-114,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
4434,Pro00101102,Observational,,Other,,Cohort,,Non-Probability Sample,
4435,ALXN2040-HV-102,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4436,NL66650.041.18,Observational,,Radiation,,Cohort,2 Years,Non-Probability Sample,
4437,21083,Interventional,Experimental,Other,Sequential Assignment,,,,Not Applicable
4438,NCI-2020-01206,Interventional,Experimental,"Procedure, Procedure, Procedure, Procedure, Biological",Single Group Assignment,,,,Phase 1
4439,STUDY00144314,Interventional,"Active Comparator, Experimental",Behavioral,Single Group Assignment,,,,Not Applicable
4440,19-068,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4441,69HCL21_0409,Interventional,"Experimental, Active Comparator","Other, Other, Other, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
4442,HALO Dx 001,Observational,,Other,,Cohort,,Non-Probability Sample,
4443,D8532C00003,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 1
4444,UC-0107/1603,Interventional,"Experimental, No Intervention",Radiation,Parallel Assignment,,,,Not Applicable
4445,AK_2021_HP,Interventional,Experimental,"Drug, Drug, Procedure",Single Group Assignment,,,,Phase 2
4446,C4391001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Combination Product, Combination Product, Drug, Combination Product",Sequential Assignment,,,,Phase 1
4447,ICO-2020-14,Interventional,"Active Comparator, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Drug",Parallel Assignment,,,,Not Applicable
4448,20-2458.cc,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4449,844554,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,"Phase 1, Phase 2"
4450,GCT1047-01,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4451,659/2017BO1,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Radiation, Diagnostic Test",Single Group Assignment,,,,Not Applicable
4452,SYSU_AI01,Observational,,,,Cohort,2 Years,Non-Probability Sample,
4453,HSC-SPH-20-1117,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4454,XL092-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4455,B2017-113R,Observational,,Diagnostic Test,,Case-Control,3 Years,Non-Probability Sample,
4456,PH-FAPGA-01/22,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
4457,GCT1029-01,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4458,FPA150-001,Interventional,Experimental,"Biological, Biological",Single Group Assignment,,,,Early Phase 1
4459,STU-2019-0522,Observational,,,,Cohort,,Probability Sample,
4460,HEALED_CPS3,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4461,PJ-KS-KY-2019-134,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
4462,PY314-1-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4463,LAUMCRH.YJ1.16/Jul/2019,Interventional,"Active Comparator, Experimental",Drug,Parallel Assignment,,,,Phase 4
4464,DMT-2019.002,Observational,,Device,,Case-Control,,Probability Sample,
4465,DMT-2019.001,Observational,,Device,,Case-Control,,Probability Sample,
4466,AD10,Observational,,Diagnostic Test,,Case-Control,1 Month,Probability Sample,
4467,CASE7Y16,Observational,,Device,,Cohort,,Probability Sample,
4468,1474/19,Interventional,"Active Comparator, Sham Comparator","Procedure, Procedure, Other",Parallel Assignment,,,,Phase 2
4469,CNZV930X2101,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other, Drug",Parallel Assignment,,,,Phase 1
4470,TirolGESUND,Interventional,"Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4471,R20-3896L,Interventional,"Experimental, Sham Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4472,69HCL19_0992,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
4473,201805930,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4474,12345,Interventional,"Placebo Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4475,2018-0075,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 2
4476,LOCAL/2020/DR-01,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
4477,IRB-300003680,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Early Phase 1
4478,HSC-MS-16-0467,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4479,PJ-KS-KY-2019-135,Observational,,,,Cohort,,Non-Probability Sample,
4480,2021/03-12,Interventional,"Active Comparator, No Intervention",Procedure,Crossover Assignment,,,,Not Applicable
4481,D0817R00010,Observational,,,,Cohort,,Non-Probability Sample,
4482,201610,Observational,,,,Case-Control,,Non-Probability Sample,
4483,VAR-2021-12,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4484,WVU010518,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Not Applicable
4485,NUSMart NM,Interventional,"No Intervention, Experimental, Experimental","Behavioral, Behavioral",Crossover Assignment,,,,Not Applicable
4486,XmAb22841-01,Interventional,"Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
4487,PREDAPT,Observational,,Diagnostic Test,,Case-Only,,Probability Sample,
4488,SC103,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4489,ACE1702-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4490,RP12146-2101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4491,RG1005815,Interventional,"Active Comparator, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4492,HH-PRT-0001,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4493,MP01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4494,AD07,Observational,,Diagnostic Test,,Case-Control,1 Month,Probability Sample,
4495,5688,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
4496,RG1005140,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
4497,BT8009-100,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4498,HN20190929,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4499,STUDY00018000,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral, Other, Other",Parallel Assignment,,,,Not Applicable
4500,00003543,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4501,OSU-19199,Interventional,Experimental,"Procedure, Other, Device",Single Group Assignment,,,,Not Applicable
4502,KB-0742-1001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4503,GQ1001X2101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4504,21820,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4505,NL 70691.091.19,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4506,ORM-5029-01-001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4507,NCI-2017-01232,Interventional,Experimental,"Drug, Other, Other, Drug",Single Group Assignment,,,,Phase 1
4508,PRT3645-01,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4509,123glioma,Observational,,,,Cohort,,Non-Probability Sample,
4510,HMBD-002-V4C26-01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4511,NCH04-2020,Observational,,"Radiation, Diagnostic Test",,Case-Control,,Non-Probability Sample,
4512,BakircayU/D208,Observational,,,,Cohort,,Non-Probability Sample,
4513,RG1121550,Interventional,Experimental,"Other, Other, Behavioral",Single Group Assignment,,,,Not Applicable
4514,KYL[2020091],Interventional,"Experimental, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4515,TJ004309STM103,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4516,AP1904-50102,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 4
4517,GCT1044-01,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4518,SZMC-0216-22,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4519,7465-CL-202,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4520,ELU-FRÎ±-1,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4521,IMP7068 - 101,Interventional,Other,Drug,Sequential Assignment,,,,Phase 1
4522,D0818R00008,Observational,,Other,,Cohort,,Non-Probability Sample,
4523,2000028592,Observational,,,,Cohort,,Non-Probability Sample,
4524,D17062,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4525,SGNPDL1V-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4526,22/006-P,Observational,,,,Other,1 Month,Non-Probability Sample,
4527,SAIL-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 4
4528,101,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
4529,PREFER,Observational,,Diagnostic Test,,Cohort,2 Years,Probability Sample,
4530,ASN004-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4531,C3881001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4532,TT420X1103,Interventional,"Experimental, Experimental, Experimental","Drug, Combination Product",Parallel Assignment,,,,"Phase 1, Phase 2"
4533,RP2-001-18,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
4534,M18HAR,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4535,8259,Observational,,,,Cohort,,Probability Sample,
4536,20-458,Observational,,Other,,Cohort,,Non-Probability Sample,
4537,STUDY00020679,Interventional,Experimental,"Procedure, Procedure, Biological, Drug, Biological, Biological, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Other",Single Group Assignment,,,,Phase 2
4538,M20COM,Observational,,Other,,Cohort,10 Years,Non-Probability Sample,
4539,21-508,Interventional,"Experimental, Experimental, Experimental","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4540,CPG-01-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4541,TJCC-LC-20190108,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 4
4542,2000026840,Interventional,Experimental,"Drug, Drug, Combination Product",Single Group Assignment,,,,Phase 2
4543,S1714,Observational,,"Drug, Other, Other",,Cohort,,Non-Probability Sample,
4544,2020/2706,Observational,,,,Cohort,,Probability Sample,
4545,INCB 106385-102,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4546,GCT1046-01,Interventional,"Experimental, Experimental","Biological, Biological, Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4547,127-CL-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Combination Product, Combination Product",Sequential Assignment,,,,Phase 1
4548,Pro00077309,Observational,,,,Ecologic or Community,,Non-Probability Sample,
4549,KY1044-CT01,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4550,UAB30,Interventional,"Active Comparator, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4551,MCC-20086,Interventional,"No Intervention, Experimental, No Intervention",Behavioral,Sequential Assignment,,,,Not Applicable
4552,Oncoplastic breast surgeries,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4553,105909,Observational,,,,Cohort,,Probability Sample,
4554,XmAb20717-01,Interventional,Experimental,Biological,Sequential Assignment,,,,Phase 1
4555,PBC017,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4556,19ON033,Observational,,"Behavioral, Procedure, Procedure",,Case-Control,,Non-Probability Sample,
4557,Parameters of resistence,Observational,,Drug,,Cohort,3 Months,Probability Sample,
4558,NCI-2017-01979,Interventional,Experimental,"Drug, Biological, Other, Biological, Other",Single Group Assignment,,,,"Phase 1, Phase 2"
4559,NCI-2018-01375,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4560,Pro20170001392,Interventional,Experimental,"Other, Biological",Single Group Assignment,,,,Phase 2
4561,A005D-E01-201,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4562,A212102,Observational,,"Other, Procedure",,Case-Control,,Non-Probability Sample,
4563,TAP_Sett17,Interventional,"Experimental, No Intervention",Device,Parallel Assignment,,,,Not Applicable
4564,CPO-100-US-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4565,IRB00058758,Observational,,"Other, Other, Other",,Cohort,,Probability Sample,
4566,20-117,Interventional,"Experimental, Experimental, Other","Radiation, Radiation, Other, Other",Parallel Assignment,,,,Phase 2
4567,19-002006,Interventional,Experimental,"Procedure, Other, Other, Other",Single Group Assignment,,,,Early Phase 1
4568,Plasticity Longitudinal cANcer,Interventional,"Experimental, Experimental, Experimental",Biological,Parallel Assignment,,,,Not Applicable
4569,2021-025,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4570,ATRC-101-A01,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug",Sequential Assignment,,,,Phase 1
4571,ST101-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4572,190143,Interventional,Experimental,"Drug, Drug, Drug, Biological",Single Group Assignment,,,,Phase 2
4573,CYT-0851-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4574,MC210102,Interventional,Experimental,"Drug, Biological, Biological, Biological",Single Group Assignment,,,,Phase 1
4575,17573,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4576,NCI-2020-13883,Interventional,Experimental,"Drug, Biological",Single Group Assignment,,,,Phase 1
4577,TT00420CN04,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4578,ONCR-177-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological",Parallel Assignment,,,,Phase 1
4579,SGNSTNV-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4580,2021-0299,Interventional,"Experimental, Experimental","Biological, Drug, Drug, Procedure",Parallel Assignment,,,,Phase 1
4581,SKL27969C001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4582,ACE-Pan tumor-02,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4583,HCC 20-266,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4584,2019-0239,Observational,,"Other, Other, Other",,Cohort,,Non-Probability Sample,
4585,D9090C00003,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4586,FT500-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4587,17364,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4588,180043,Observational,,,,Cohort,,Non-Probability Sample,
4589,NCI-2020-06906,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 2
4590,INT 48/21,Observational,,Other,,Case-Control,,Probability Sample,
4591,IDE161-001,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4592,AK2018_1,Interventional,Experimental,"Drug, Other",Single Group Assignment,,,,Phase 1
4593,FT536-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Combination Product, Drug",Sequential Assignment,,,,Phase 1
4594,STUDY00000719,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Sequential Assignment,,,,Not Applicable
4595,DV001,Observational,,"Diagnostic Test, Behavioral",,Cohort,,Probability Sample,
4596,JZP712-201,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4597,TMPS-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4598,CancerDyads,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4599,IIBSP-ECV-2019-103,Observational,,,,Case-Control,,Non-Probability Sample,
4600,CCI-2003,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4601,00000441,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4602,SGNB6A-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4603,MLB-PK-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
4604,XmAb23104-01,Interventional,"Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,Phase 1
4605,2020-0439,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4606,CYH33-G102,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4607,20-410,Interventional,"Experimental, Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4608,202101,Interventional,"Experimental, Other","Behavioral, Device",Crossover Assignment,,,,Not Applicable
4609,NB-ND021 (NM21-1480)-101,Interventional,Experimental,Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4610,SBT6050-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4611,17-262-01,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4612,UC-IMM-2101,Interventional,"Experimental, No Intervention",Drug,Parallel Assignment,,,,Phase 3
4613,ADCT-301-103,Interventional,"Experimental, Experimental, Experimental","Drug, Biological",Sequential Assignment,,,,Phase 1
4614,170177,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 2
4615,TPST-1120-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4616,180032,Interventional,"Experimental, Experimental","Biological, Biological, Biological",Sequential Assignment,,,,Phase 1
4617,VICC SUPP 2112,Interventional,"Experimental, Experimental, Active Comparator","Other, Other, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4618,IB2022-03,Interventional,"Experimental, No Intervention",Other,Sequential Assignment,,,,Not Applicable
4619,PR148/21,Interventional,"Experimental, Active Comparator","Radiation, Procedure",Parallel Assignment,,,,Not Applicable
4620,A9001502,Interventional,Other,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
4621,2020-117,Interventional,"Other, Other, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4622,NCI-2020-05428,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4623,2021-0175,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4624,CCT303-406-mST01,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4625,6B-20-1,Interventional,Experimental,"Procedure, Drug, Procedure, Procedure",Single Group Assignment,,,,Early Phase 1
4626,NRG-BN009,Interventional,"Experimental, Active Comparator","Drug, Other, Other, Radiation, Radiation",Parallel Assignment,,,,Phase 3
4627,TCR2-21-01,Interventional,Experimental,"Biological, Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4628,2018-01,Observational,,Other,,Cohort,,Non-Probability Sample,
4629,NCI-2020-05956,Interventional,Experimental,"Procedure, Drug, Procedure, Procedure, Biological",Single Group Assignment,,,,Phase 1
4630,Pro9646,Observational,,"Other, Other, Other, Other",,Case-Control,,Non-Probability Sample,
4631,CA052-002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4632,IMX-110-001,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4633,IIR 17-127,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4634,WPH 2201,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4635,IRB20-0462,Interventional,"No Intervention, Experimental",Other,Parallel Assignment,,,,Not Applicable
4636,XmAb808-01,Interventional,Experimental,"Biological, Biological",Sequential Assignment,,,,Phase 1
4637,2019-1091,Interventional,Experimental,"Drug, Drug, Other",Single Group Assignment,,,,"Phase 1, Phase 2"
4638,INT156-19,Observational,,Drug,,Cohort,,Non-Probability Sample,
4639,02-MX-003,Observational,,Diagnostic Test,,Cohort,,Probability Sample,
4640,VAR-2022-04,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4641,Phase 1 SV-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4642,NYPC ERC# 2019-002,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, No Intervention",Radiation,Single Group Assignment,,,,Not Applicable
4643,TTX-080-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4644,P.T.REC/012/003744,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4645,P.T.REC/012/004199,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4646,Doaa Atef,Interventional,"Active Comparator, Active Comparator","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4647,09.2018.466,Observational,,Diagnostic Test,,Other,,Probability Sample,
4648,0752-20-HMO,Interventional,Experimental,"Drug, Drug, Biological, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4649,OCEL-01,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Single Group Assignment,,,,"Phase 1, Phase 2"
4650,ILBS-VASMPCa-103,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4651,NuTide:303,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4652,IC 2020-11_ALCINA4,Interventional,"Other, Other, Other, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4653,AMT-151-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4654,MDNA11-01,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4655,SGNTGT-001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4656,PT199X1101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4657,GB1275-1101 (KEYNOTE-A36),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4658,IB2022-02,Observational,,,,Cohort,,Non-Probability Sample,
4659,INCAGN 2385-101,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4660,IB 2017-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4661,INCAGN 2390-101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4662,NU04,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4663,STUDY00001436,Interventional,"Experimental, Active Comparator","Behavioral, Other",Parallel Assignment,,,,Not Applicable
4664,20430,Interventional,"Active Comparator, Experimental, Experimental","Other, Other, Other, Procedure, Other",Parallel Assignment,,,,Not Applicable
4665,STUDY00015588,Interventional,Experimental,"Drug, Drug, Drug, Biological, Drug, Procedure, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Biological, Biological, Drug, Other, Drug, Drug, Drug, Drug, Drug, Drug, Biological, Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4666,IRB00092505,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Sequential Assignment,,,,Not Applicable
4667,NX-1607-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4668,GLP-CDK-1009,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4669,0S-17-4,Observational,,"Other, Other",,Case-Only,,Non-Probability Sample,
4670,Teleclub_cam,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,,,,Not Applicable
4671,AS-IRB-BM-17056,Observational,,,,Cohort,4 Years,Probability Sample,
4672,HZDH20-002,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 1
4673,Pro00100029,Interventional,"No Intervention, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
4674,2022-0712,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Factorial Assignment,,,,Not Applicable
4675,2018-0439,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4676,CR109080,Interventional,Experimental,"Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4677,GIMI-IRB-20004,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4678,2020-0079-E,Interventional,"Experimental, Other","Other, Behavioral",Parallel Assignment,,,,Not Applicable
4679,EOC317X1101,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4680,IRB00056774,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4681,EAQ202,Interventional,"Other, Other",Other,Parallel Assignment,,,,Early Phase 1
4682,SYNERGY-AI,Observational,,Other,,Cohort,36 Months,Non-Probability Sample,
4683,V937-013,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4684,10000045,Interventional,Experimental,"Drug, Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
4685,19-006717,Interventional,Experimental,"Procedure, Other",Single Group Assignment,,,,Not Applicable
4686,ATLAS-101,Interventional,Experimental,"Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4687,19-151,Interventional,"No Intervention, Active Comparator",Behavioral,Parallel Assignment,,,,Not Applicable
4688,21-00715,Interventional,"Active Comparator, Active Comparator, Placebo Comparator","Drug, Drug, Other",Parallel Assignment,,,,Phase 3
4689,TAC01-HER2-03,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4690,UW17009,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Radiation",Single Group Assignment,,,,Early Phase 1
4691,UMCC 2021.076,Interventional,"Active Comparator, Experimental, Experimental","Other, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4692,H19-04010,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4693,F/N-R19-3893L,Interventional,"Experimental, Placebo Comparator","Drug, Other",Parallel Assignment,,,,Phase 2
4694,CRUKD/21/005,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4695,Adela-EDMRD-001,Observational,,,,Case-Control,,Non-Probability Sample,
4696,YXLL-KY-2022(057),Interventional,"Active Comparator, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4697,ISI dV Xi-NSM,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4698,16712,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4699,HREBA.CC-20-0098,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4700,IPO/PI134,Interventional,"Experimental, Experimental, Other","Behavioral, Behavioral, Other",Parallel Assignment,,,,Not Applicable
4701,IMM2520-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4702,Cancer Genetic Counseling.PSI,Observational,,Other,,Cohort,,Non-Probability Sample,
4703,OM-GRPR-02,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4704,17493,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4705,LOXO-IDH-20002,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4706,1623168,Interventional,"Active Comparator, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4707,1,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4708,11190071,Observational,,,,Cohort,3 Months,Non-Probability Sample,
4709,PACT-0101,Interventional,"Experimental, Experimental, Experimental","Biological, Biological, Biological",Sequential Assignment,,,,Phase 1
4710,PROICM 2021-05 SER,Interventional,Experimental,Diagnostic Test,Single Group Assignment,,,,Not Applicable
4711,IRB-300002068,Interventional,"Experimental, Experimental, Experimental","Behavioral, Other, Other, Other",Parallel Assignment,,,,Not Applicable
4712,0000-0001-5580-7256,Interventional,"Experimental, No Intervention",Other,Crossover Assignment,,,,Not Applicable
4713,2017-0319,Interventional,Experimental,"Procedure, Procedure, Radiation, Radiation, Procedure, Procedure",Single Group Assignment,,,,Phase 1
4714,TRV-003,Observational,,,,Cohort,,Probability Sample,
4715,ATOS-016R,Interventional,"Placebo Comparator, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
4716,HSP70CTC,Observational,,Diagnostic Test,,Cohort,3 Months,Probability Sample,
4717,Pro00104093,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4718,VNC-236-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4719,Metabolic Cancer 001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
4720,19-000756,Interventional,Experimental,"Procedure, Radiation, Radiation, Procedure, Radiation",Single Group Assignment,,,,Early Phase 1
4721,7339-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4722,2018-001744-62,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
4723,20-533,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4724,D9950C00001,Interventional,"Experimental, Experimental","Drug, Biological",Sequential Assignment,,,,Phase 1
4725,19-011472,Interventional,Experimental,"Procedure, Other, Other, Other",Single Group Assignment,,,,Phase 1
4726,7684A-005,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4727,2017-0719,Interventional,Experimental,"Drug, Biological, Drug",Single Group Assignment,,,,Phase 1
4728,1801,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4729,MOHCCN-O,Observational,,,,Cohort,,Non-Probability Sample,
4730,STU00209558,Observational,,Device,,Cohort,,Non-Probability Sample,
4731,IJB-IRAES-2020,Interventional,,Drug,Single Group Assignment,,,,Phase 2
4732,IRB00229163,Interventional,"Other, Other, Other","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4733,ON-1002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4734,SGN47M-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4735,TP-CA-001,Observational,,Other,,Cohort,,Non-Probability Sample,
4736,P-MUC1C-ALLO1-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Drug",Sequential Assignment,,,,Phase 1
4737,NTI1GSA,Interventional,"Experimental, Experimental, Experimental","Biological, Drug",Sequential Assignment,,,,Phase 1
4738,FT538-102,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Combination Product, Combination Product",Sequential Assignment,,,,Phase 1
4739,CBX-12-101,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4740,OHSN-REB#20170381-01H,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4741,H-43405 VISTA,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4742,QUILT-2.025,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4743,ZZTIL-012,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4744,202211038RINA,Observational,,,,Case-Control,5 Years,Non-Probability Sample,
4745,20201421,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4746,YSCH-01-0000,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
4747,SNB101P01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4748,1224/2018,Interventional,"Active Comparator, Active Comparator",Device,Parallel Assignment,,,,Not Applicable
4749,438-IO-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4750,831-IO-101,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Single Group Assignment,,,,Phase 1
4751,BHP0120,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Phase 2
4752,CDX527-01,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4753,HREBA.CC-22-0196,Observational,,,,Family-Based,,Non-Probability Sample,
4754,Meet-URO 12,Interventional,"Experimental, Other","Drug, Other",Parallel Assignment,,,,Phase 2
4755,NC318-01,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4756,STR-004-001,Interventional,"Other, Other, Other, Other, Other","Drug, Drug, Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
4757,Pro00103249,Interventional,"Experimental, Active Comparator",Behavioral,Crossover Assignment,,,,Not Applicable
4758,21850,Interventional,"Experimental, Experimental, Experimental, Experimental","Device, Drug, Drug",Parallel Assignment,,,,Phase 1
4759,180049,Interventional,"Experimental, Experimental","Drug, Drug, Drug, Biological, Drug",Parallel Assignment,,,,Phase 2
4760,ARC-5 (AB928CSP0005),Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4761,201809177,Interventional,"Experimental, Active Comparator",Device,Parallel Assignment,,,,Phase 2
4762,2020-2110,Interventional,"Active Comparator, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4763,AVS4TL - 0921,Observational,,,,Other,,Probability Sample,
4764,IIT2020-24-SHIRAZIP-BURN,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4765,PY159-2-01,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4766,C3651010,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Sequential Assignment,,,,Phase 1
4767,Palliach,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4768,DPM401,Observational,,,,Cohort,,Non-Probability Sample,
4769,BR-DTX-OS-401,Observational,,,,Cohort,,Non-Probability Sample,
4770,TAK-500-1001,Interventional,"Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4771,PRT1419-02,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4772,IIT2020-13-GRESHAM-ELLY,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4773,2018-0663,Interventional,Experimental,"Procedure, Drug",Single Group Assignment,,,,Phase 1
4774,APHP190973,Observational,,Behavioral,,Cohort,,Non-Probability Sample,
4775,C3441037,Interventional,"Experimental, Experimental","Drug, Drug, Drug",Crossover Assignment,,,,Phase 1
4776,CE 07-14-2020,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
4777,ELVCAP-001-01,Interventional,"Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4778,143631,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4779,202100484,Observational,,Procedure,,Cohort,,Probability Sample,
4780,ZZITICI-004,Interventional,"Experimental, Active Comparator",Drug,Parallel Assignment,,,,"Phase 2, Phase 3"
4781,QBS-72S-1001,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4782,2440LM-002,Interventional,"Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,Phase 1
4783,MX-011-219,Observational,,,,Cohort,,Non-Probability Sample,
4784,DB-1303-O-1001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4785,VISTA-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4786,ZZICI3-015,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4787,ALS-6000-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4788,AA1809,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4789,PMV-586-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4790,R231-A14057,Observational,,Genetic,,Other,6 Months,Non-Probability Sample,
4791,AMXT1501-102,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4792,201909133,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4793,ROOT,Observational,,"Diagnostic Test, Drug, Other",,Cohort,5 Years,Non-Probability Sample,
4794,FPI-1966-101,Interventional,"Experimental, Experimental","Drug, Drug, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4795,MYCT001,Observational,,,,Case-Only,,Non-Probability Sample,
4796,JAB-3312-1002,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4797,707-IO-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Factorial Assignment,,,,"Phase 1, Phase 2"
4798,UW18101,Interventional,Experimental,Dietary Supplement,Single Group Assignment,,,,Phase 3
4799,JAB-3312-1001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4800,PAL-E602-001,Interventional,"Experimental, Experimental, Experimental, Experimental","Biological, Biological",Sequential Assignment,,,,"Phase 1, Phase 2"
4801,340-74,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4802,PRO17070414,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4803,MAPreminder1,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4804,MFLeong,Interventional,"Experimental, Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4805,1100,Interventional,Experimental,"Drug, Radiation, Drug, Drug",Sequential Assignment,,,,Phase 1
4806,MAPinitial,Interventional,"Experimental, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4807,MAPreminder2,Interventional,"No Intervention, Experimental, Experimental, Experimental","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4808,G190165,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4809,JSKN003-102,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4810,RAIN-3202,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4811,05-2019,Observational,,Other,,Cohort,,Non-Probability Sample,
4812,56160922.7.3001.5274,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4813,PN #1082409C,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
4814,A222001,Interventional,"Experimental, Experimental, Placebo Comparator, Placebo Comparator","Drug, Drug, Other, Other",Crossover Assignment,,,,Phase 2
4815,CH1701,Interventional,"Placebo Comparator, Placebo Comparator, Active Comparator, Placebo Comparator, Placebo Comparator, Placebo Comparator, Placebo Comparator","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4816,D0816C00020,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 3
4817,K01CA190659,Interventional,"Active Comparator, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Other,Parallel Assignment,,,,Not Applicable
4818,TOS-358-001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 1
4819,UW19-183,Interventional,"Experimental, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4820,2011P002580-207,Observational,,"Drug, Drug",,Cohort,,Non-Probability Sample,
4821,SI-B003-101,Interventional,Experimental,Drug,Sequential Assignment,,,,Phase 1
4822,PROT004,Interventional,"Active Comparator, Active Comparator","Device, Device",Parallel Assignment,,,,Not Applicable
4823,EK 1612/2018,Interventional,"Other, Other",Procedure,Parallel Assignment,,,,Not Applicable
4824,202006168,Interventional,"No Intervention, Experimental",Other,Sequential Assignment,,,,Not Applicable
4825,FT-003,Observational,,Genetic,,Case-Only,,Non-Probability Sample,
4826,BO41929,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4827,IRB202201399 -N-R,Interventional,"Experimental, Experimental",Behavioral,Parallel Assignment,,,,Not Applicable
4828,FLX475-02,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4829,2019-A02135-52,Interventional,"Other, Other, Other, Other, Other, Other, Other, Other",Genetic,Single Group Assignment,,,,Phase 2
4830,18-504,Interventional,Other,Behavioral,Single Group Assignment,,,,Not Applicable
4831,DB-1305-O-1001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Single Group Assignment,,,,"Phase 1, Phase 2"
4832,TAS0612-101,Interventional,"Experimental, Experimental",Drug,Single Group Assignment,,,,Phase 1
4833,IIT2021-07-Atkins-CARMA,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4834,1948-CL-0101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4835,CO-338-100,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4836,STUDY00020629,Interventional,Other,"Procedure, Other, Other, Other",Single Group Assignment,,,,Not Applicable
4837,E7766-G000-101,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4838,NRG-GU006,Interventional,"Placebo Comparator, Experimental","Drug, Radiation, Other",Parallel Assignment,,,,Phase 2
4839,BBI-20201001,Interventional,"Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4840,ZWI-ZW49-101,Interventional,Experimental,Drug,Parallel Assignment,,,,Phase 1
4841,SAHoWMU-CR2021-02-404,Observational,,Other,,Cohort,1 Day,Probability Sample,
4842,BVAC-B-P1,Interventional,Experimental,Biological,Single Group Assignment,,,,Phase 1
4843,IDE397-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4844,MDK-703-102,Interventional,"Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4845,19-011444,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,"Phase 2, Phase 3"
4846,ATTCK-34-01,Interventional,Experimental,"Biological, Drug",Single Group Assignment,,,,Phase 1
4847,BDTX-189-01,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4848,DB-1310-O-1001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4849,NRG-GU009,Interventional,"Active Comparator, Experimental, Active Comparator, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug, Other, Other, Radiation, Drug",Parallel Assignment,,,,Phase 3
4850,7101,Observational,,,,Cohort,,Non-Probability Sample,
4851,17504,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 1
4852,DGD-44-065,Interventional,"Experimental, Experimental, Other","Procedure, Procedure, Procedure, Procedure, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 4
4853,22-OBU-SH-CA-II-019,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 1
4854,20220586-01H,Interventional,"Experimental, No Intervention",Diagnostic Test,Parallel Assignment,,,,Not Applicable
4855,D8532C00004,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 1
4856,CLIN-17-008,Interventional,"Other, Other, Other, Other",Device,Single Group Assignment,,,,Not Applicable
4857,200-04,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4858,Ad-p53-002,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4859,TUMAGNOSTIC(CP506-001),Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4860,20210104,Interventional,"Experimental, Experimental",Drug,Sequential Assignment,,,,Phase 1
4861,01GS,Observational,,,,Cohort,,Non-Probability Sample,
4862,217228,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4863,FT516-102,Interventional,Experimental,"Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4864,19-110,Observational,,"Other, Other",,Cohort,,Non-Probability Sample,
4865,IMC-F106C-101,Interventional,"Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug",Sequential Assignment,,,,"Phase 1, Phase 2"
4866,TK-Onko,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4867,Pro00103812,Interventional,"No Intervention, Experimental","Drug, Drug",Single Group Assignment,,,,Phase 2
4868,17894,Interventional,"Experimental, Other","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4869,M19-345,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4870,21-00072,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 4
4871,20246,Interventional,"Experimental, Experimental","Drug, Drug",Crossover Assignment,,,,Phase 1
4872,UW21090,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4873,18-222,Interventional,"Experimental, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4874,4830-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Biological",Parallel Assignment,,,,Phase 1
4875,2020-002766-14,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,Phase 2
4876,17-01135,Observational,,Other,,Family-Based,,Probability Sample,
4877,2019-00134,Observational,,,,Cohort,,Non-Probability Sample,
4878,AG0315OG/CTC0140,Interventional,"Experimental, Active Comparator","Drug, Biological, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4879,63646,Interventional,"Active Comparator, Experimental","Other, Behavioral",Parallel Assignment,,,,Not Applicable
4880,19-007,Observational,,"Behavioral, Behavioral, Behavioral, Behavioral, Behavioral, Behavioral",,Cohort,,Probability Sample,
4881,2018-01B,Observational,,Other,,Cohort,,Non-Probability Sample,
4882,201617079.3,Interventional,"Active Comparator, Experimental","Radiation, Radiation",Parallel Assignment,,,,Not Applicable
4883,IOSI-COVID19-001,Observational,,Procedure,,Case-Only,,Non-Probability Sample,
4884,C4221015,Interventional,"Experimental, Experimental, Experimental, Experimental, Active Comparator, Experimental, Active Comparator","Drug, Drug, Drug, Drug, Drug, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4885,ARRAY-818-202,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4886,03.CP.0.3,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4887,0482-001,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Biological, Biological, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4888,GO42144,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug, Drug, Drug, Drug, Drug, Drug",Sequential Assignment,,,,Phase 1
4889,Ordu55,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4890,ORDU551,Interventional,"Other, Other, Other, Other","Other, Other, Other, Other",Crossover Assignment,,,,Not Applicable
4891,ONO-4059-09,Interventional,"Experimental, Experimental, Experimental","Drug, Drug, Drug",Parallel Assignment,,,,Phase 2
4892,19741,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Sequential Assignment,,,,Phase 1
4893,GOG-8030,Observational,,"Procedure, Other, Other",,,,Non-Probability Sample,
4894,JTX-8064-101,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental","Drug, Drug",Parallel Assignment,,,,"Phase 1, Phase 2"
4895,IBC0966-I/IIa,Interventional,"Experimental, Experimental, Experimental, Experimental, Experimental, Experimental, Experimental",Biological,Sequential Assignment,,,,"Phase 1, Phase 2"
4896,"019/026/ICI, CEI/1330/18",Interventional,"Experimental, Active Comparator","Other, Other, Other, Other",Parallel Assignment,,,,Not Applicable
4897,LCH-112020,Interventional,,Procedure,Single Group Assignment,,,,Phase 2
4898,HP-00070946,Interventional,"Other, Experimental, Experimental","Behavioral, Other, Behavioral",Parallel Assignment,,,,Not Applicable
4899,18HLGENE03,Observational,,Genetic,,Ecologic or Community,1 Day,Non-Probability Sample,
4900,FGCL-4592-898,Interventional,"Experimental, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4901,2000034075,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Not Applicable
4902,CR108454,Observational,,Other,,Cohort,,Non-Probability Sample,
4903,APHP180586,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4904,NCI-2020-07841,Interventional,Experimental,"Procedure, Procedure, Drug, Biological",Single Group Assignment,,,,Phase 1
4905,S60857,Interventional,"Experimental, Experimental, Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4906,MO19/127559,Observational,,,,Cohort,,Probability Sample,
4907,RPCR-breast 01,Observational,,Radiation,,Case-Only,5 Years,Non-Probability Sample,
4908,T30-0002,Interventional,Experimental,Device,Single Group Assignment,,,,"Phase 1, Phase 2"
4909,WP-2021-03,Observational,,Other,,Cohort,,Probability Sample,
4910,CAMH2_1001,Interventional,Experimental,Drug,Sequential Assignment,,,,"Phase 1, Phase 2"
4911,CIRB Ref. No: 2019/2135,Interventional,"Experimental, Placebo Comparator","Other, Other",Parallel Assignment,,,,Phase 2
4912,Nigeria World Cancer Walk 2022,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4913,NRG-HN010,Interventional,"Active Comparator, Experimental","Drug, Other, Biological, Biological",Parallel Assignment,,,,Phase 2
4914,D081SC00001Sub,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4915,FatebenefratelliH,Observational,,"Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",,Case-Only,5 Years,Non-Probability Sample,
4916,D081SC00001,Interventional,"Experimental, Placebo Comparator","Drug, Drug",Parallel Assignment,,,,Phase 3
4917,2019P001434-2,Observational,,,,Other,,Non-Probability Sample,
4918,H18-02052,Interventional,"Active Comparator, Active Comparator, Active Comparator, Active Comparator","Device, Device, Device, Device",Parallel Assignment,,,,Not Applicable
4919,REG-114-2019,Interventional,Experimental,Combination Product,Single Group Assignment,,,,Phase 2
4920,20-0270-E,Interventional,"Experimental, No Intervention",Other,Parallel Assignment,,,,Not Applicable
4921,PRO00104179,Interventional,"Experimental, Experimental","Behavioral, Behavioral, Behavioral",Sequential Assignment,,,,Not Applicable
4922,SJHH_PSPM,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4923,823871-iGame,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4924,2018-0419,Interventional,"Experimental, Experimental, Active Comparator","Genetic, Genetic, Genetic",Parallel Assignment,,,,Early Phase 1
4925,2019-00965,Interventional,"Experimental, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4926,COALESE/2021/103,Interventional,"Experimental, No Intervention","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4927,BC 09915,Observational,,Device,,Cohort,,Non-Probability Sample,
4928,7013,Observational,,,,Cohort,,Non-Probability Sample,
4929,2017_71,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4930,22-200,Observational,,Other,,Cohort,20 Years,Probability Sample,
4931,PYC001,Interventional,"Experimental, Experimental, Experimental, Experimental","Dietary Supplement, Dietary Supplement, Dietary Supplement, Dietary Supplement",Crossover Assignment,,,,Not Applicable
4932,22-01516,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4933,2U01HG007292-05,Interventional,"Active Comparator, Experimental","Other, Other",Parallel Assignment,,,,Not Applicable
4934,20201224,Interventional,Experimental,"Drug, Drug, Drug",Single Group Assignment,,,,Phase 2
4935,CTMS# 19-0069,Interventional,Experimental,Drug,Single Group Assignment,,,,Early Phase 1
4936,E2019453,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4937,21-103,Interventional,Experimental,Behavioral,Single Group Assignment,,,,Early Phase 1
4938,ABCSG C08,Interventional,"Experimental, Other","Other, Other",Parallel Assignment,,,,Not Applicable
4939,PCA001,Interventional,,"Biological, Biological",Single Group Assignment,,,,"Phase 1, Phase 2"
4940,CASE1121,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4941,Nigeria Cancer Walk,Interventional,"Active Comparator, No Intervention",Behavioral,Parallel Assignment,,,,Not Applicable
4942,20172841,Observational,,Other,,Cohort,10 Years,Non-Probability Sample,
4943,RC31/18/0440,Observational,,Drug,,Cohort,,Non-Probability Sample,
4944,SDLNOC,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4945,20-565,Interventional,"Experimental, Active Comparator","Procedure, Procedure",Parallel Assignment,,,,Phase 3
4946,Arabic BREAST-Q,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4947,UPCC 11919,Interventional,"Experimental, Experimental, Experimental, Experimental","Other, Other, Other",Parallel Assignment,,,,Not Applicable
4948,2021-1211,Observational,,Other,,Cohort,,Probability Sample,
4949,segmental thoracic TEA-spinal,Interventional,"Active Comparator, No Intervention",Procedure,Parallel Assignment,,,,Not Applicable
4950,IRB-22-34,Interventional,"Active Comparator, Active Comparator","Other, Other",Parallel Assignment,,,,Not Applicable
4951,PSCI-19-112,Interventional,Experimental,Other,Single Group Assignment,,,,Not Applicable
4952,LSHBSWMBC,Observational,,Diagnostic Test,,Case-Control,,Non-Probability Sample,
4953,2016-0463,Interventional,"Experimental, Experimental","Other, Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4954,IIT-0013,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4955,BND and RND,Interventional,"Experimental, Experimental","Device, Device",Parallel Assignment,,,,Not Applicable
4956,TheNethersole,Interventional,"Experimental, No Intervention","Other, Other",Parallel Assignment,,,,Not Applicable
4957,1655,Observational,,Genetic,,Cohort,,Probability Sample,
4958,N-111012422,Interventional,"Active Comparator, Active Comparator, Placebo Comparator, Placebo Comparator, No Intervention, No Intervention","Dietary Supplement, Other",Parallel Assignment,,,,Phase 1
4959,302,Interventional,Experimental,Biological,Single Group Assignment,,,,"Phase 1, Phase 2"
4960,MC01/01/19,Interventional,Experimental,"Procedure, Procedure",Single Group Assignment,,,,Not Applicable
4961,Colorectal Cancer,Observational,,Other,,Other,,Non-Probability Sample,
4962,LCCC1748,Interventional,"Experimental, Experimental","Device, Drug",Sequential Assignment,,,,Phase 4
4963,1992110-1,Observational,,Behavioral,,Other,,Non-Probability Sample,
4964,CSC-20200324,Observational,,Procedure,,Cohort,,Non-Probability Sample,
4965,69HCL22_0466,Interventional,Experimental,"Behavioral, Other",Single Group Assignment,,,,Not Applicable
4966,IMPACNEO,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
4967,0029-20-ZIV,Observational,,Diagnostic Test,,Cohort,,Non-Probability Sample,
4968,HKG-KZ-LNG-102,Observational,,,,Case-Control,,Non-Probability Sample,
4969,GCO 19-2707,Interventional,"Active Comparator, Active Comparator","Drug, Drug",Parallel Assignment,,,,Phase 2
4970,LIFT project,Observational,,,,Cohort,,Probability Sample,
4971,RECO_CT29A,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4972,INT 292/20,Interventional,"Experimental, Experimental","Diagnostic Test, Other",Parallel Assignment,,,,Not Applicable
4973,STUDY21020095,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4974,D967MC00001,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
4975,UHHeidelberg,Interventional,"No Intervention, Other",Other,Sequential Assignment,,,,Not Applicable
4976,R01CA205025,Interventional,"Experimental, Experimental, Active Comparator","Behavioral, Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4977,2019-PVSEP,Observational,,Other,,Case-Control,,Non-Probability Sample,
4978,HCB/2021/0130,Interventional,Experimental,Procedure,Single Group Assignment,,,,Not Applicable
4979,S1614,Interventional,"Experimental, Experimental, Experimental","Other, Drug, Drug, Drug",Parallel Assignment,,,,Phase 3
4980,TMHPO1763,Interventional,Other,Other,Single Group Assignment,,,,Not Applicable
4981,002.1,Observational,,Other,,Cohort,,Non-Probability Sample,
4982,LIFT,Observational,,,,Cohort,,Probability Sample,
4983,2767,Observational,,Diagnostic Test,,Cohort,2 Years,Probability Sample,
4984,APHP210359,Interventional,Other,Procedure,Single Group Assignment,,,,Not Applicable
4985,M16VIB,Interventional,"Experimental, Experimental",Drug,Parallel Assignment,,,,Phase 2
4986,EPOC1903,Interventional,Experimental,"Drug, Drug",Single Group Assignment,,,,Phase 2
4987,CASE2118,Interventional,Experimental,Device,Single Group Assignment,,,,Not Applicable
4988,PARALUC,Interventional,Experimental,"Diagnostic Test, Other",Single Group Assignment,,,,Not Applicable
4989,CTC20200417,Interventional,"Active Comparator, Experimental","Procedure, Procedure",Parallel Assignment,,,,Not Applicable
4990,09.2019.1026,Observational,,Other,,Cohort,,Non-Probability Sample,
4991,CASE4119,Interventional,"Active Comparator, Experimental","Procedure, Behavioral",Parallel Assignment,,,,Not Applicable
4992,EC/GOVT/24/IRB23,Observational,,,,Case-Only,,Non-Probability Sample,
4993,CFTSp195,Observational,,,,Cohort,,Non-Probability Sample,
4994,04/20,Observational,,"Drug, Drug",,Cohort,,Probability Sample,
4995,29BRC20.0021,Interventional,"Active Comparator, Experimental","Diagnostic Test, Diagnostic Test",Parallel Assignment,,,,Not Applicable
4996,MRI in urinary bladder tumors,Observational,,Device,,Case-Only,,Non-Probability Sample,
4997,CRUKD/21/004 - Treatment Arm 2,Interventional,Experimental,Drug,Single Group Assignment,,,,"Phase 2, Phase 3"
4998,20201491,Interventional,"Experimental, Active Comparator","Behavioral, Behavioral",Parallel Assignment,,,,Not Applicable
4999,32900654326,Interventional,"Placebo Comparator, Active Comparator, Active Comparator, Active Comparator","Procedure, Drug",Parallel Assignment,,,,Not Applicable
5000,ReDA 13176,Interventional,"Active Comparator, Experimental","Radiation, Drug, Drug, Drug, Drug, Other, Radiation, Procedure, Other, Radiation",Parallel Assignment,,,,Phase 3
5001,64121317.4.1001.5330,Interventional,Experimental,Drug,Single Group Assignment,,,,Phase 2
5002,3-2020-0038,Interventional,Experimental,Radiation,Single Group Assignment,,,,Not Applicable
5003,2018PS02,Observational,,Behavioral,,Ecologic or Community,,Non-Probability Sample,
